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Poly (ADP-ribose) polymerase 1 (PARP1) is a ubiquitously expressed enzyme that post-
translationally modifies proteins via poly (ADP-ribosylation) (PARylation). PARP1 serves 
various functions, including DNA damage repair, regulation of cell death pathways, chromatin 
modification, RNA processing, and transcriptional regulation. Accordingly, mutations in Parp1 
or Adprhl2 (encoding the protein ADP-ribosylhydrolase 3, which removes PAR polymers) cause 
intellectual disability, ataxia, episodic psychosis, neurodegeneration, and developmental delay. 
Altered PARP1 expression is also associated with numerous neurodegenerative and 
neuroimmune disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, 
rheumatoid arthritis, major depressive disorder, and epilepsy. Despite ubiquitous expression and 
an apparent connection with brain disorders, PARP1's role in neurodevelopment has not been 
widely studied.  
Our lab has recently uncovered a novel interaction between PARP1 and the receptor 
tyrosine kinase ErbB4, which binds its ligand NRG1 to mediate numerous functions during 
neurodevelopment, including radial migration of excitatory neurons, tangential migration of 
inhibitory neurons, synaptogenesis, and differentiation. Additionally, ErbB4 has multiple splice 
forms that confer different signaling modalities. Specifically, the ErbB4-juxtamembrane (JM)-a 
isoform is cleavable via the enzymes tumor necrosis factor-α (TACE) and presenilin/γ-secretase. 
Upon NRG1 binding and ErbB4-JMa cleavage, the ErbB4 intracellular domain (E4ICD) is 
released, which regulates transcription through direct promoter binding. Previous findings have 
 xiii 
shown that E4ICD complexes with co-factors to repress gliogenesis during early development. 
Due to PARP1's prominent roles in chromatin modification and transcriptional control, this begs 
the question as to whether PARP1 is likewise regulating glial gene expression via E4ICD. 
The aims of this dissertation are two-fold: 1) investigate the role of PARP1 in regulating 
astrocytic gene expression via E4ICD and 2) further characterize the effect of PARP1 loss on 
brain development. To explore the role of PARP1-E4ICD in the regulation of astrogenesis, I 
utilized mouse primary embryonic neural precursor cell (NPC) cultures and transgenic mice with 
a germline knockout of PARP1, ErbB4, or ErbB4-JMa. I found that NRG1-mediated repression 
of GFAP expression upon FGF removal from NPC cultures was dependent upon the presence of 
PARP1, ErbB4, and ErbB4-JMa. Additionally, I showed that PARP1 KO and ErbB4 KO mice 
overexpress GFAP at birth, indicating the importance of both proteins in vivo. 
To investigate the effect of PARP1 loss on neurodevelopment more broadly, I analyzed 
the brain and cortical size of PARP1 KO mice at birth, finding a reduction in brain weight 
relative to body size, which is associated with a thinner cortex and a reduced cortical surface 
area. Furthermore, I discovered that PARP1 loss alters early-born neuron migration and increases 
the density of deeper-layer neurons. To investigate changes in gene expression associated with 
these findings, I performed RNA-sequencing of the embryonic PARP1 KO cortex. I found that 
PARP1 loss increases the expression of genes involved in neuronal migration and adhesion, 
including Reln, which encodes the glycoprotein Reelin. Accordingly, my findings indicate that 
PARP1 loss increases the abundance of Reelin-expressing cells in the developing (E15.5) and 
adolescent (P5) mouse brain. I further demonstrated that PARP1 loss, inhibition, or acute 
knockdown increases Cajal-Retzius cell abundance in vitro, suggesting PARP1 regulates Cajal-
Retzius cell development via a cell-autonomous mechanism. Finally, atomic force microscopy 
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showed that NPCs isolated from the PARP1 KO cortex adhere more strongly to the cell adhesion 
molecule N-cadherin, likely due to excess Reelin. Overall, these findings demonstrate that 
PARP1 regulates astrogenesis, Cajal-Retzius cell development, and cell adhesion in the 
developing brain. 
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Chapter 1: Introduction 
1.1 Overview 
Cerebral cortex development is a highly ordered and temporally controlled process that 
involves the coordinated expression of countless proteins, including transcription factors, 
extracellular signaling molecules, trophic factors, enzymes, and more (Guillemot, 2005; Florio 
and Huttner, 2014). Misexpression or misregulation of single proteins can severely impair brain 
development to render the organism inviable, or it can result in more subtle effects that increase 
an individual's susceptibility for psychiatric disorders later in life, including schizophrenia (Pablo 
V. Bejman et al., 2011; Huang et al., 2014). Several single nucleotide polymorphisms (SNPs) in 
the genes encoding Neuregulin 1 (NRG1) or its receptor, ErbB4 (ErbB4), have been associated 
with schizophrenia (Munafò et al., 2006; Norton et al., 2006; Nicodemus et al., 2009; Feng et al., 
2017). Their connection to psychiatric disorders is thought to be due to their critical roles in 
regulating inhibitory interneuron migration during development (Flames et al., 2004; Li et al., 
2012). Accordingly, mice lacking ErbB4 or NRG1 have fewer Parvalbumin-expressing 
interneurons in the cortex, disrupting the balance between excitatory pyramidal neurons and 
inhibitory neurons, resulting in excess electrical activity (Fazzari et al., 2010; Neddens and 
Buonanno, 2010). Disrupted excitatory-inhibitory balance has likewise been found in patients 
diagnosed with psychiatric disorders (Selten et al., 2018). 
Additionally, NRG1 signaling through ErbB4 regulates the timing of astrogenesis onset 
in the developing cortex (Sardi et al., 2006). The primary cell types in the brain include neurons 
and glial cells, such as astrocytes and oligodendrocytes. During development, neural precursor 
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cells differentiate first into neurons, then switch to astrocyte and oligodendrocyte differentiation 
during later stages (Sauvageot, 2002; Guillemot, 2005; Jiang and Nardelli, 2016). NRG1 
signaling through ErbB4 represses the onset of astrogenesis at early developmental stages by 
inhibiting the transcription of glial-specific genes, such as glial fibrillary acidic protein (GFAP). 
Data suggests that this occurs by direct binding of the ErbB4 intracellular domain (E4ICD) to the 
promoter region of these genes (Sardi et al., 2006). Intriguingly, E4ICD is generated by full-
length ErbB4 cleavage by presenilin/γ-secretase, a causative factor for Alzheimer's disease when 
disrupted (De Strooper, 2007), indicating Alzheimer's pathology may be associated with altered 
ErbB4 expression and signaling.   
More recent unpublished data collected in the Corfas lab indicates that E4ICD's 
interaction with the GFAP promoter may be mediated through binding to Poly (ADP-Ribose) 
Polymerase 1 (PARP1). PARP1 is a ubiquitously expressed enzyme that binds and post-
translationally modifies proteins and DNA via the addition of ADP-ribose polymers, regulating 
diverse cellular processes, from DNA repair to transcriptional regulation to cell survival (Kraus, 
2008; Krishnakumar and Kraus, 2010b). As ErbB4 lacks a DNA binding domain, this interaction 
between E4ICD and PARP1 suggests that PARP1 may serve as a bridge to bind E4ICD to the 
GFAP promoter, thus inhibiting transcription. Similar to NRG1/ErbB4, PARP1 is implicated in 
the pathogenesis of numerous neurological disorders (Mao and Zhang, 2021). Furthermore, 
mutations in proteins affecting PARylation cause disorders that include symptoms such as 
episodic psychosis, ataxia, intellectual disability, and neurodegeneration (Najmabadi et al., 2011; 
Danhauser et al., 2018; Durmus et al., 2021). Together, these studies indicate that PARP1 may 
have other roles in brain development apart from regulating astrogenesis. A better understanding 
of how PARP1 loss-of-function alters cortical development will ultimately allow scientists to 
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understand its etiology further and develop more targeted therapies for associated neurological 
disorders. 
1.2 Cortical Development 
1.2.1 Neurogenesis and Gliogenesis 
Neurogenesis is the process by which progenitor cells within the embryonic brain 
generate neurons and expand the neocortex during development. In the rodent brain, the earliest 
born neurons arise around embryonic day 10.5 (E10.5), forming the preplate (Angevine and 
Sidman, 1961; Meyer et al., 1998). A few days later, the preplate splits to form the deeper 
subplate and superficial marginal zone. As neurogenesis begins, progenitor cells divide and 
produce immature neurons, which form the cortical plate in a layer between the subplate and 
marginal zone. These neurons eventually mature into excitatory pyramidal neurons that comprise 
the multilayered neocortex in mature animals (Marín-Padilla, 1992; Olson, 2014). On the other 
hand, gliogenesis is the process by which non-neuronal subtypes, or glial cells, are produced in 
the brain. These encompass astrocytes and oligodendrocytes, among others not discussed in this 
dissertation. This section will review mechanisms of proliferation and differentiation of these 
cell types within the cerebral cortex (overview depicted in Figure 1.1).  
1.2.1.1 Timeline and Mechanisms of Proliferation 
Just before the onset of neurogenesis at E10.5, the neuronal pool rapidly increases 
through the symmetric division of highly polarized neuroepithelial cells within the neural tube, 
expanding the cortex laterally and radially. At the onset of neurogenesis around E12.5 – E13.5, 
neuroepithelial cells become radial glial cells. Like neuroepithelial cells, radial glial cells have 
long processes that connect the basal lamina at the pial surface of the brain to the apical 
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ventricular zone, spanning the width of the early cortex (Rakic, 1995; Huttner and Brand, 1997; 
Hartfuss et al., 2001). Radial glial cells divide asymmetrically along the ventricular wall to 
generate two distinct cell types: a new radial glial cell and an intermediate progenitor cell (also 
known as a basal progenitor) or an immature neuron (Hartfuss et al., 2001; Malatesta et al., 2003; 
Noctor et al., 2004). Intermediate progenitor cells (IPCs), in turn, migrate dorsally outside of the 
ventricular zone, where most divide symmetrically to produce two immature neurons (Noctor et 
al., 2004). However, there is evidence that some IPCs undergo a round of symmetric 
proliferative division to increase the progenitor pool before producing neurons (Noctor et al., 
2004). Most neurons are generated in the neocortex through IPCs (Kowalczyk et al., 2009). 
While both symmetric IPC division and asymmetric radial glial cell division are occurring 
throughout neurogenesis (through E17.5), the predominant origin of newborn neurons during 
later stages of cortical development is via symmetric division of IPCs (Noctor et al., 2004; 
Zimmer et al., 2004; Wu et al., 2005). This switch allows the cortex to expand both radially and 
laterally during the later stages of brain development. 
The onset of gliogenesis in the rodent brain begins around E16.5-E17.5 as neurogenesis 
completes (Qian et al., 2000; Sauvageot, 2002; Mallamaci, 2013). The initial glial cells produced 
are astrocytes, which have many critical functions in the cortex, including regulation of synaptic 
function and neural homeostasis, formation and function of the blood-brain barrier, assistance in 
migration of some neural progenitors, and regulation of neuronal dendrite morphology (Abbott, 
2002; Haim and Rowitch, 2017; Vasile et al., 2017). Astrogenesis peaks around P2-3 in the 
rodent then recedes by P7-9 (Qian et al., 2000; Ge et al., 2012). Unlike neurons and other glial 
cell subtypes, astrocytes are generated exclusively in the pallium, otherwise known as the dorsal 
portion of the developing telencephalon. Like neurons, they can arise directly from former radial 
 5 
glial cells or indirectly from IPCs within the subventricular zone (Noctor et al., 2004). 
Mechanisms regulating the neurogenic to gliogenic fate switch of IPCs will be discussed further 
below.  
As astrogenesis declines, oligodendrocytes begin to differentiate from oligodendrocyte 
precursor cells (OPCs), with peak production near P14 in the cortex (Sauvageot, 2002). 
Oligodendrocytes form the myelin sheaths surrounding axons of neurons within the central 
nervous system. These myelin sheaths insulate axons to improve signal transduction while 
providing metabolic support (Kuhn et al., 2019). Unlike astrocytes, oligodendrocytes develop 
from precursors within the subpallium, or ventral telencephalon, as well as the pallium. In 
addition, OPC production occurs in three waves within each brain region: early embryonic stages 
(E11.5-12.5) within the medial ganglionic eminence (MGE), later embryonic stages (E15.5) 
within the lateral ganglionic eminence, and early postnatally within the cortex (Kessaris et al., 
2006). OPCs then migrate dorsally into the forebrain, where they eventually differentiate and 
mature into myelinating oligodendrocytes (Jiang and Nardelli, 2016) 
1.2.1.2 Molecular Regulation of Stem Cell Proliferation and Differentiation 
Cortical development is a highly temporally regulated process influenced by numerous 
transcription factors, morphogens such as Wnt, Fgf, and Shh, and epigenetic modifications (Jiang 
and Nardelli, 2016). Slight disruptions in genes that regulate this process can result in 
microcephaly, macrocephaly, and other neurodevelopmental disorders (Lindy et al., 2018; 
Santos-Cortez et al., 2018). In this section, many of the more critical molecular regulators of 
neurogenesis and astrogenesis will be discussed. 
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1.2.1.2.1 Neurogenesis 
The Notch signaling pathway is a well-established mechanism of stem cell renewal 
within the developing neocortex. Through its effectors Hes1 and Hes5, Notch maintains the 
undifferentiated state of radial glial cells by repressing other transcription factors that promote 
neural differentiation, including Neurogenin 1 (Ngn1), Neurogenin 2 (Ngn2), and Ascl1 (also 
known as Mash1) (Ohtsuka et al., 1999; Gaiano et al., 2000; Nieto et al., 2001; Gaiano and 
Fishell, 2002; Ochiai et al., 2009). The influence of Notch on stemness is demonstrated by 
experiments showing that after an asymmetric radial glial cell division, the daughter cell with 
higher Notch signaling remains a radial glial cell, while the lower Notch-expressing cell 
differentiates into a neuron (Ochiai et al., 2009; Dong et al., 2012). Interestingly, an 
autoinhibitory feedback loop continually oscillates Hes1 expression in radial glial cells 
(Imayoshi et al., 2013). This oscillation is hypothesized to contribute to the preservation of radial 
glial cell pluripotency, as maintained Hes expression at later developmental stages induces 
astrogenesis in radial glial cells. (Imayoshi et al., 2013).  
Wnt signaling through β-catenin is also an essential regulator of neurogenesis. Similar to 
Notch, Wnt has contrasting roles during neurodevelopment depending upon the timing of its 
expression and transcriptional partners.  For example, Wnt-mediated upregulation of Empty 
Spiracles Homeobox 2 (Emx2) expression promotes stem cell proliferation (Muzio et al., 2005), 
while Wnt-mediated upregulation of Paired Box 6 (Pax6), Ngn1/Ngn2, and N-Myc expression 
stimulates neuronal differentiation (Gunhaga et al., 2003; Hirabayashi et al., 2004; Kuwahara et 
al., 2010). Interestingly, the regulation of this switch in Wnt function may be mediated by 
Fibroblast Growth Factor 2 (FGF2) presence (which promotes proliferation) or absence (which 
promotes differentiation) (Israsena et al., 2004). In the chick developing brain, N-Myc represses 
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Notch signaling to promote neuronal differentiation, indicating that Wnt additionally promotes 
neurogenesis through N-Myc-mediated Notch repression (Zinin et al., 2014).  
In addition to Wnt and FGF, another signaling molecule that regulates neurogenesis is 
Sonic Hedgehog (Shh). Both Shh and FGF act in part through the Notch effector Hes1 to 
promote symmetric division and radial glial cell proliferation (Dave et al., 2011; Rash et al., 
2011). At the onset of neurogenesis, Shh decreases, which increases the activity of the Gli3 
repressor and promotes neuronal differentiation (Ruiz i Altaba, 1998; Wang et al., 2011a). 
Similarly, the absence of FGF signaling during development causes radial glial cell 
differentiation into IPCs, beginning the process of neurogenesis (Kang et al., 2009). Taken 
together, these studies display the interactive nature of Notch, Wnt, Shh, and FGF signaling in 
regulation of stem cell proliferation and neurogenesis. 
The transcription factors Pax6, Ngn2, and Ascl1 are some of the primary regulators of 
neurogenesis and cerebral cortex patterning (Nieto et al., 2001; Osumi et al., 2008, 6). Pax6 
promotes neurogenesis by increasing the expression of proneural genes such as Ngn2 and T-box 
Brain Protein 2 (Tbr2) while promoting stem cell proliferation (Warren et al., 1999; Sansom et 
al., 2009). These dual roles of Pax6 are hypothesized to be mediated in part by alternative 
splicing of the Pax6 transcript, which generates proteins that differ in their DNA binding 
subdomains, thus altering their gene targets (Walcher et al., 2013). Ascl1 is an additional bHLH 
transcription factor (along with Hes1) that oscillates its expression in neural progenitor cells 
while sustaining its expression in differentiated neurons (Imayoshi et al., 2013). Thus, loss of 
Ascl1 significantly impairs neurogenesis and causes precocious astrogenesis, while its 
overexpression induces rapid neuronal differentiation (Casarosa et al., 1999; Nieto et al., 2001; 
Nakada et al., 2004; Berninger et al., 2007). Genome-wide characterization of Ascl1 targets 
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further demonstrates that Ascl1 directly regulates genes involved in neuronal differentiation 
(Castro and Guillemot, 2011). Ngn2, in the same family of transcription factors as Ascl1, 
likewise induces neuronal differentiation when overexpressed, while its loss causes defects in 
radial glial cell organization and differentiation (Nieto et al., 2001; Berninger et al., 2007). 
Together, these studies demonstrate the importance of Pax6, Ngn2, and Ascl1 during early 
development to promote neural differentiation. 
1.2.1.2.1.1 Dorsal-Ventral Patterning 
The dorsoventral axis of the telencephalon is primarily regulated by Shh and Wnt 
signaling through mutual repression of opposing transcription factors. Ventral progenitor cells in 
the subpallium generally mature into GABAergic inhibitory interneurons, while dorsal 
progenitors in the pallium predominantly produce glutamatergic excitatory neurons. Shh, which 
is secreted by cells within the ventral cortex, represses the pro-dorsal activity of the Gli3 
repressor, which results in upregulated expression of ventral cell fate-specific genes, including 
Nk2 Homeobox 1 (Nkx2.1) and Gamma Glutamylcysteine Synthetase1 and 2 (Gsh1/2) (Rallu et 
al., 2002). In turn, Nkx2.1 induces LIM Homeobox 6 (Lhx6) expression while Gsh1/2 promotes 
transcription of Ascl1 and Distal-Less Homeobox 1 and 2 (Dlx1/2), which repress the dorsal cell 
fate and promote differentiation into inhibitory neurons (Casarosa et al., 1999; Toresson et al., 
2000; Du et al., 2008; Long et al., 2009; Wang et al., 2009).  
Meanwhile, Wnt secretion in the dorsal telencephalon induces the expression of Pax6 and 
Ngn1 (Gunhaga et al., 2003; Hirabayashi et al., 2004), which along with Ngn2 and Emx1/2 
specify the dorsal neuron fate by repressing the expression of ventral-specific transcription 
factors, including previously discussed Ascl1, Gsh2, and Dlx2 (Stoykova et al., 2000; Yun et al., 
2001, 6; Muzio et al., 2002; Quinn et al., 2007). Therefore, the absence of Pax6 and Emx2 results 
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in the complete lack of a cortex, leaving only ventral progenitor regions (Muzio et al., 2002). 
Other transcription factors involved in dorsal neuron specification include LIM Homeobox 2 
(Lhx2) and Forkhead Box G1 (Foxg1). Similar to Pax6 and Emx2, the absence of either of these 
proteins results in brains with expanded ventral regions (Bulchand et al., 2001; Monuki et al., 
2001; Muzio and Mallamaci, 2005), suggesting a similar mechanism. Through these complex 
opposing pathways, the dorsal telencephalon forms the mature neocortex composed of pyramidal 
neurons, while the ventral telencephalon develops into the basal ganglia and parts of the 
amygdala (Medina and Abellán, 2012). 
1.2.1.2.2 Astrogenesis 
One of the significant effectors regulating astrogenesis is Janus Kinase (JAK)/STAT 
signaling (Bonni et al., 1997), which is initiated through binding of pro-astrocytic cytokines, 
such as Ciliary Neurotrophic Factor (CNTF), Cardiotropin 1 (Ct1), and Leukemia Inhibiting 
Factor (LIF), to receptors gp130 and one of its partners (Davis et al., 1993). Ligand binding 
induces receptor dimerization and receptor-associated JAK autophosphorylation and activation 
(Lutticken et al., 1994). Activated JAK, in turn, phosphorylates its associated receptors, which 
recruit STAT3 to be phosphorylated by JAK (Stahl et al., 1995). Phosphorylation of STAT3 then 
induces its association with the co-factor complex CREB binding protein (CBP)/p300, which 
binds to promoter regions of astrocyte-specific genes, including Glial Fibrillary Acidic Protein 
(GFAP), to promote gene transcription (Bonni et al., 1997; Nakashima et al., 1999). 
Accordingly, STAT3 deletion or repression stimulates neuronal differentiation and prevents 
astrocytic differentiation (Kamakura et al., 2004; Gu et al., 2005; Cao et al., 2006, 2010). 
Additionally, astrogenesis is negatively regulated by transcription factors that promote 
neurogenesis, including Ngn1, Ngn2, Neuronal Differentiation 1 (NeuroD1), and Ascl1, by their 
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repression of glial-specific genes (Tomita et al., 2000; Nakashima et al., 2001, 2; Nieto et al., 
2001; Sun et al., 2001). For example, one mechanistic hypothesis postulates that Ngn1 and 
STAT compete for CBP/p300 binding. Thus, Ngn1 can sequester these co-factors away from 
gene promoter regions when its expression is elevated (Sun et al., 2001). At the same time, Ngn1 
inhibits STAT phosphorylation, preventing it from binding CBP/p300 (Sun et al., 2001). 
Therefore, as Ngn1 expression declines following neurogenesis, STAT is phosphorylated by 
JAK, and STAT instead binds CBP/p300 to promote gliogenesis (Sun et al., 2001). 
As previously discussed, Notch is crucial to repress neurogenesis and promote stem cell 
proliferation during early development stages (Gaiano and Fishell, 2002; Dave et al., 2011; Dong 
et al., 2012). However, in later stages of development, Notch activation induces astrocytic 
differentiation (Chambers et al., 2001; Grandbarbe et al., 2003). This switch from Notch 
promoting stem cell renewal to astrogenesis remains unclear. However, evidence shows that 
sustained rather than oscillating Hes1 expression promotes gliogenesis rather than proliferation 
(Imayoshi et al., 2013). Mechanistically, Notch promotes astrogenesis partially through 
activation of the JAK/STAT3 pathway. The Notch effector Hes1 binds nuclear STAT3, 
facilitating its interaction with JAK (Kamakura et al., 2004). In turn, JAK induces STAT3 
phosphorylation and the initiation of GFAP transcription (Kamakura et al., 2004). In addition to 
its influence on STAT3 activation, Notch epigenetically modifies the GFAP promoter region. 
Studies show that overexpressing the Notch intracellular domain (NICD), cleaved from full-
length Notch after ligand binding, promotes GFAP transcription through its downstream target 
Nuclear Factor 1A (NF1A). NF1A releases DNA Methyltransferase 1 (DNMT1) from the GFAP 
promoter, resulting in promoter demethylation, opening the chromatin, and allowing 
transcription to occur (Namihira et al., 2009). In addition to epigenetically modifying the GFAP 
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promoter, NICD also forms a complex with the transcription factor RBPJk/CSL and directly 
binds the GFAP promoter to promote transcription (Ge et al., 2002).  
Additionally, Neuregulin 1 (NRG1) signaling via its ErbB4 receptor inhibits astrogenesis, 
previously identified by the Corfas lab (Sardi et al., 2006). NRG1 binding to ErbB4 stimulates 
ErbB4 cleavage by TACE and presenilin/γ-secretase, releasing the ErbB4 intracellular domain 
(E4ICD) (Rio et al., 2000; Ni et al., 2001). E4ICD then binds to co-factors Nuclear Receptor Co-
Repressor (N-CoR) and TAK Binding Protein 2 (TAB2), which translocate to the nucleus to 
prevent GFAP transcription through its promoter (Sardi et al., 2006). Accordingly, ErbB4 
knockout mice display precocious astrogenesis (Sardi et al., 2006). Furthermore, it has been 
proposed that NICD and E4ICD/N-CoR/TAB2 interact with the GFAP promoter at the same 
binding site (RBPJ-k/CSL). Therefore, high levels of NRG1 and ErbB4 may prevent Notch-
induced astrogenesis during early stages of brain development (Ge et al., 2002; Hermanson et al., 
2002). When E4ICD levels decrease, the RBPJk/CSL binding site would be freed from N-CoR 
and bound by NICD, promoting glial gene expression. However, the mechanism behind GFAP 
repression by ErbB4 remains unclear and is the focus of Chapter 2 of this dissertation. 
1.2.2 Neuronal Migration  
As newborn excitatory neurons differentiate from radial glial cells and intermediate 
progenitors within the dorsal telencephalon, they migrate in an inside-out fashion within the 
developing neocortex to reach their final destinations (Rakic, 1995). Thus, early-born neurons 
are situated in deeper cortical layers (layers V and VI), and later-born neurons migrate past early-
born neurons to localize to more superficial cortical layers (II/III and IV). Excitatory neurons 
migrate radially through two different mechanisms: glial-independent migration (somal 
translocation) or glial-dependent migration (Nadarajah et al., 2001; Noctor et al., 2004). In 
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addition, GABAergic inhibitory interneurons migrate tangentially from the ventral subpallium to 
the dorsal pallium (Marín, 2013). The mechanisms of migration for excitatory and inhibitory 
neurons are discussed further below. 
1.2.2.1 Glial-independent migration 
During the early stages of brain development, the primary mode of neuron migration is 
glial-independent (Nadarajah and Parnavelas, 2002). To accomplish this, the migrating neuron's 
leading process attaches to the basal lamina at the pial surface of the brain and then retracts, 
which translocates the neuron's soma to its final position within the cortex (Nadarajah et al., 
2001). Thus, this type of migration is also called "somal translocation". This migration technique 
is also utilized at later developmental stages to terminate migration as later-born migrating 
neurons approach the brain's pial surface (Nadarajah et al., 2001). 
1.2.2.2 Glial-dependent migration 
The predominant method of newborn neuron migration within the developing cortex is 
glial-dependent migration, where radial glial cells form a "scaffold" for which neurons can 
migrate. This scaffold is increasingly crucial as the cortex expands radially during the latter 
stages of development when neurons migrate longer distances (Nadarajah et al., 2001). Neurons 
are born in the ventricular and subventricular zones, where they attach to radial glia fibers and 
migrate toward the brain's pial surface (Noctor et al., 2004). Both internal and external cues 
regulate glial-dependent migration. Intrinsic modifications involve modulating cytoskeleton 
elements, including the neuron's growth cone, leading, and trailing processes. In general, leading 
process extension is followed by nuclear translocation, then trailing process retraction (Tsai and 
Gleeson, 2005). Leading process extension is facilitated primarily by actin polymerization, while 
nuclear translocation is managed by interactions between microtubules within the cytoskeleton 
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and motor proteins such as myosin and dynein (Kriegstein and Noctor, 2004; Solecki et al., 
2009; Tsai et al., 2010). Cytoskeletal stabilization during nuclear translocation is aided by 
proteins including Lissencephaly 1 (Lis1) and Doublecortin (DCX) (Bai et al., 2003; Shu et al., 
2004, 1). The mechanisms behind trailing process retraction are not widely studied and remain 
unclear. 
Extrinsic factors controlling migration involve complex interactions between cell 
adhesion molecules, signaling molecules, scaffolding proteins, and neurons (Franco and Müller, 
2011; Cooper, 2013). One of the most essential and well-characterized signaling molecules 
regulating cell migration is Reelin, secreted by Cajal-Retzius cells (Ogawa et al., 1995). Further 
details regarding Reelin signaling will be described in section 1.2.3.3. In addition to Reelin, the 
cell adhesion molecule integrin and its ligand laminin promote adhesion between migrating 
neurons and radial glial cells (Cox and Huttenlocher, 1998). Accordingly, loss of β1 integrin or 
its ligand laminin α2 in mice disrupts radial glial anchorage to the basement membrane and 
slows neuronal migration, resulting in abnormal neocortical lamination (Graus-Porta et al., 2001; 
Loulier et al., 2009). In contrast, the deletion of laminin γ1 completely prevents radial neuron 
migration, suggesting that different laminin isoforms have varying effects on migration (Chen et 
al., 2009). Other cell adhesion molecules involved in regulating cell migration include NCAM, 
L1, and N-cadherin (Schmid and Maness, 2008; Shikanai et al., 2011; Lutz et al., 2017). Further 
discussion of cell adhesion molecules and their interaction with the brain’s extracellular matrix 
and influence on cell migration is addressed in later sections.  
Additionally, signaling by trophic factors such as soluble NRG1 promotes neuronal 
migration by directing migration along radial glial fibers while maintaining and elongating radial 
glia (Anton et al., 1997; Rio et al., 1997). This interaction appears to be mediated in part by brain 
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lipid-binding protein (BLBP), which is vital for radial glial fiber establishment and maintenance 
(Anton et al., 1997). An additional trophic signal that stabilizes leading processes of migrating 
neurons is Semaphorin 3A (Sema3A). This molecule is secreted near the cortical plate, forming a 
gradient (Chen et al., 2008). As ablating Sema3A receptor Neuropilin 1 on migrating neurons or 
overexpressing Sema3A in the ventricular zone disrupts radial migration, this molecule likely 
serves as a chemoattractant for migrating neurons (Chen et al., 2008). Together, intrinsic and 
extrinsic cues guide migrating neurons to their proper positions in the developing cortex. 
1.2.2.3 Tangential Interneuron Migration 
 Unlike excitatory neurons, inhibitory interneurons develop from precursors within the 
ventral telencephalon, specifically within the medial and caudal ganglionic eminences. These 
cells then migrate tangentially to their final locations in the dorsal cortex (Anderson et al., 2002; 
Marín, 2013; Chu and Anderson, 2015). Unlike unipolar migrating excitatory neurons, 
interneurons adopt a branched morphology to their leading processes and move by creating a 
new leading process in the direction of chemoattractants. This process appears to be the primary 
mechanism that drives the directionality of the migrating neuron (Martini et al., 2009). The 
initial movement of interneurons out of the ventral brain region is likely due to chemorepulsive 
rather than attractive cues, as the expression of Slit1 (which binds to its receptor Robo) and 
Ephrin-A5 (which binds to Ephrin receptors) within the ganglionic eminence repel interneurons 
(Zhu et al., 1999; Marillat et al., 2002; Zimmer et al., 2008; Rudolph et al., 2010).  
There are also chemoattractive cues, however, which include the trophic factors Brain-
Derived Neurotrophic Factor (BDNF), Glial-Derived Neurotrophic Factor (GDNF), 
Neurotrophin-4 (NT4), and NRG1 (Polleux et al., 2002; Pozas and Ibáñez, 2005). In vitro 
experiments demonstrate that BDNF, GDNF, and NT4 stimulate interneuron migration (Polleux 
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et al., 2002; Pozas and Ibáñez, 2005). However, the effects of these proteins in vivo remain less 
clear, as mice lacking the receptor for BDNF, TrkB, have unaltered tangential interneuron 
migration (Carmona et al., 2006; Sánchez-Huertas and Rico, 2011). In contrast, NRG1 signaling 
through its receptor ErbB4 has demonstrated effects in vivo, as ErbB4 KO mice have a decreased 
number of MGE-derived interneurons in their dorsal cortex and hippocampus (Flames et al., 
2004; Neddens and Buonanno, 2010). Interestingly, the membrane-bound and soluble isoforms 
of NRG1 are hypothesized to serve as short-range and long-range cues for migrating neurons, 
respectively, creating a gradient for tangentially migrating neurons to follow (Flames et al., 
2004).  
 Once the interneurons migrate from the ventral to dorsal telencephalon, different 
guidance cues direct their migration through the cortex to their final locations. Migratory streams 
of interneurons appear to be restricted to the marginal zone, subventricular zone, and subplate of 
the developing cortex, altogether avoiding the cortical plate where radial neuron migration is 
ongoing (Lavdas et al., 1999; Wichterle et al., 2001). Studies have shown that this is mediated 
through the chemoattractant molecules Netrin and Cxcl12 (Stumm et al., 2003). Cxcl12 is 
expressed in the meninges, in IPCs within the subventricular zone, and at lower levels in the 
subplate (Stumm et al., 2003; Daniel et al., 2005; Tiveron et al., 2006; Li et al., 2008). It signals 
through its G-protein coupled receptors, Cxcr4 and Cxcr7, which are expressed in migrating 
neurons (Stumm et al., 2003; Tiveron et al., 2006; Li et al., 2008). Cxcl12 also regulates the 
tangential-to-radial switch of interneurons during migration, as loss of Cxcl12 promotes the 
invasion of interneurons into the cortical plate as soon as they reach the cortex (López-Bendito et 
al., 2008). This finding indicates that a timely decrease in Cxcl12 expression allows neurons to 
respond to attractive cues within the cortical plate and reach their final destinations. Aligned with 
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their importance are studies showing that loss of Cxcl12, Cxcr4, or Cxcr7 in vivo impairs 
intracortical interneuron migration (Tiveron et al., 2006; Li et al., 2008; Sánchez-Alcañiz et al., 
2011; Wang et al., 2011b). On the other hand, Netrin attracts interneurons migrating specifically 
within the marginal zone migratory stream (Stanco et al., 2009). This combination of attractive 
and repulsive cues facilitates the tangential migration of neurons from their birthplaces in the 
ventral telencephalon to their final locations in the cortex. 
1.2.3 Cajal-Retzius Cells  
Cajal-Retzius cells are among the earliest-born neurons during cortical development, 
arising between E10.5 and E12.5 in rodents (Meyer et al., 1998). They localize to the brain's 
marginal zone and secrete Reelin, a critical signaling molecule for neuron migration and 
patterning of the cortex (Ogawa et al., 1995; Meyer et al., 1998). Mice with mutations in Reelin 
(known as reeler) have a severe disruption in cortical and cerebellar lamination, indicating the 
singular importance of Cajal-Retzius cells and Reelin signaling in regulating neuronal migration 
(Meier and Hoag, 1962; Hamburgh, 1963; Goffinet et al., 1984). In addition to Reelin, subsets of 
Cajal-Retzius cells express the calcium-binding proteins Calretinin and Calbindin, though the 
expression of these proteins is not restricted to Cajal-Retzius cells within layer I (Meyer et al., 
1998; Bielle et al., 2005). The tumor suppressor protein P73 additionally co-localizes with 
Reelin, and within layer I it is exclusively expressed in Cajal-Retzius cells (Meyer et al., 2002). 
1.2.3.1 Cajal-Retzius Cell Development 
Cajal-Retzius cells arise from progenitors within multiple areas of the developing brain, 
including the septum and ventral pallium, but most progenitors arise from the cortical hem 
(caudomedial region of the neocortex) (Takiguchi-Hayashi et al., 2004; Bielle et al., 2005; 
Griveau et al., 2010; Barber et al., 2015). Cajal-Retzius cells tangentially migrate until they reach 
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their final positions within the marginal zone of the neocortex (Soriano and del Río, 2005; 
Kirischuk et al., 2014). The marginal zone will eventually mature to form Layer I, the uppermost 
cortical layer. Like the tangential migration of inhibitory interneurons, Cajal-Retzius cell 
migration is regulated by Cxcl12 through its receptor Cxcr4, which is expressed in Cajal-Retzius 
cells (Borrell and Marín, 2006). These chemokines are especially critical for the migration of 
cortical hem-derived Cajal-Retzius cells toward the meninges, where Cxcl12 is secreted (Borrell 
and Marín, 2006). However, some Cajal-Retzius cells migrate to the marginal zone in the 
absence of Cxcr4, indicating that this is not the only chemoattractant stimulating progenitor cell 
migration (Borrell and Marín, 2006). Accordingly, recent data demonstrate that extracellular 
Pax6 also regulates the tangential migration of progenitors that originate from the cortical hem 
and septum (Kaddour et al., 2020). Furthermore, other transcription factors that control Cajal-
Retzius cell development are hypothesized to influence progenitor migration. These transcription 
factors are discussed in more detail below. 
Cajal-Retzius cell development and differentiation are regulated by signaling molecules, 
transcription factors, and miRNAs. Transcription factors include negative modulators Pax6, 
Lhx2, Foxg1, Hes1/3/5, and COUP Transcription Factor 1 (CoupTFI) (Stoykova et al., 2003; 
Studer et al., 2005; Imayoshi et al., 2008; Shibata et al., 2008), and positive modulators Emx1/2, 
Tbr1, Lhx5, and Ascl1 (Hevner et al., 2001; Shinozaki et al., 2002; Miquelajáuregui et al., 2010; 
Dixit et al., 2011). Loss of Pax6 disrupts preplate formation and doubles the number of Reelin-
expressing cells in the developing brain's marginal zone. This finding is hypothesized to be 
partially due to the increased migration of Cajal-Retzius progenitor cells (Stoykova et al., 2003; 
Kaddour et al., 2020). Lhx2 and Foxg1 indirectly repress Cajal-Retzius cell differentiation by 
regulating the development of the cortical hem and progenitors that arise there (Roy et al., 2014; 
 18 
Liu et al., 2018). CoupTFI acts more directly, as CoupTFI overexpression downregulates 
multiple Cajal-Retzius cell proteins, including Reelin and Calretinin (Studer et al., 2005). 
Finally, the Notch effectors Hes1/3/5 repress the Cajal-Retzius cell fate by downregulating 
Ngn2, instead promoting a choroid plexus cell fate (Imayoshi et al., 2008). These findings also 
indicate that Ngn2 promotes Cajal-Retzius cell differentiation (Imayoshi et al., 2008).  
As previously discussed, Ascl1 is highly expressed in ventral progenitor neurons and has 
a definable role in specifying the ventral cell fate. However, it is also expressed to a lesser extent 
in dorsal progenitors, promoting Cajal-Retzius cell differentiation. Accordingly, Ascl1 depletion 
slightly but significantly decreases the number of Cajal-Retzius cells at E15.5 (Dixit et al., 2011).  
Lhx5 loss likewise decreases the density of Reelin-expressing cells in the cortex 
(Miquelajáuregui et al., 2010). Emx1/2 double knockout completely prevents Cajal-Retzius cells 
from developing, which may be due to defective tangential migration (Shinozaki et al., 2002). 
Rather than a loss of Cajal-Retzius cells, loss of Tbr1 decreases the expression of Reelin within 
existing Cajal-Retzius cells (Hevner et al., 2001). Interestingly, Tbr1 loss disrupts preplate 
formation similar to the loss of Pax6, indicating that decreased or increased Reelin expression 
has comparable effects on preplate development (Hevner et al., 2001; Stoykova et al., 2003). 
Taken together, these studies show that Cajal-Retzius cell development is a complex process that 
can be disrupted through the altered expression of many different transcription factors.  
Signaling molecules that influence Cajal-Retzius cell development include BDNF and 
Transforming Growth Factor β (TGFβ) (Ringstedt et al., 1998; Siegenthaler and Miller, 2008). 
BDNF expression is detected at low levels during embryonic development, starting as early as 
E13.5, and signals through its receptor TrkB, which is expressed in Cajal-Retzius cells 
(Friedman et al., 1991; Timmusk et al., 1994; Marty et al., 1996; Brunstrom et al., 1997). BDNF 
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treatment in vitro downregulates Reelin expression, while BDNF overexpression in vivo reduces 
Reelin expression within Cajal-Retzius cells and causes Cajal-Retzius cells with abnormal 
morphology to cluster within the marginal zone (Ringstedt et al., 1998). Similarly, BDNF loss 
increases Reelin expression within Cajal-Retzius cells (Ringstedt et al., 1998). In addition, TGFβ 
signals through p21 and Foxo3a to promote the production of Cajal-Retzius cells (Siegenthaler 
and Miller, 2008). Together, these studies demonstrate that extracellular and intracellular cues 
influence the generation of Cajal-Retzius cells. 
A total disruption in miRNA biogenesis through the loss of Dicer increases Cajal-Retzius 
cell abundance, indicating that miRNAs are an essential regulator of Cajal-Retzius cell 
development (McLoughlin et al., 2012). miRNAs are short single-stranded RNAs produced from 
double-stranded RNA folded into a hairpin loop. This hairpin is cleaved from the remaining 
RNA molecule by Drosha and Pasha to form pre-miRNA, then further cleaved by the enzyme 
Dicer to eventually form mature miRNA (O’Brien et al., 2018). miRNAs disrupt mRNAs by 
binding and cleaving them, destabilizing them, or hindering transcription (Huntzinger and 
Izaurralde, 2011; O’Brien et al., 2018). Specifically, miRNA-9 indirectly regulates Cajal-Retzius 
cell development by targeting Foxg1, which, as previously discussed, suppresses Cajal-Retzius 
cell differentiation by regulating cortical hem development (Shibata et al., 2008).  miRNA-200c, 
however, has been demonstrated to directly target Reln mRNA following ischemic stroke (Stary 
Creed M. et al., 2015), and miRNA-128 targets Reln in neuroblastoma cells (Evangelisti et al., 
2009); however, it remains unclear if these miRNAs affect Cajal-Retzius cell development in the 
embryonic brain.  
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1.2.3.2 Cajal-Retzius Cell Apoptosis 
Cajal-Retzius cells are programmed to undergo apoptosis within the first two weeks of 
postnatal life, as Cajal-Retzius cells are not present in the adult brain (del Río et al., 1995). This 
process is not well understood, but evidence shows Cajal-Retzius cell death is mediated partially 
through changes in neuronal activity. In cell culture experiments, inhibition of neuronal activity 
using tetrodotoxin prevents Cajal-Retzius cell death (Blanquie et al., 2017). Similarly, in vitro 
inhibition of glutamate receptors, which mediate excitatory neuronal signaling, has a similar 
effect, while activating glutamate or GABA receptors causes Cajal-Retzius cells to disappear in 
vivo (Blanquie et al., 2017). Cell death through GABA receptors occurs through an NKCC1-
dependent process, whereby blockade of the chloride transporter NKCC1 rescues Cajal-Retzius 
cells from apoptosis (Blanquie et al., 2017). Additionally, hyperpolarization prevents the death of 
septal-derived Cajal-Retzius cells (Riva et al., 2019).  
P73, whose TAp73 and ΔNp73 isoforms promote neuronal survival (Miller, 2016), also 
prevents Cajal-Retzius cell apoptosis. Accordingly, deletion of P73 or ΔNp73 in mice reduces 
Cajal-Retzius cell abundance significantly (Meyer et al., 2004; Tissir et al., 2009). Furthermore, 
programmed cell death of septal-derived Cajal-Retzius cells is regulated via the proapoptotic 
protein Bax (Ledonne et al., 2016). Accordingly, conditional knockout of Bax in ΔNp73-
expressing septal-derived Cajal-Retzius cells significantly increases the abundance of Cajal-
Retzius cells at P24, long after Cajal-Retzius cell death occurs in wild-type mice (Ledonne et al., 
2016). In contrast, conditional knockout of Bax from Wnt3a-expressing cortical hem-derived 
Cajal-Retzius cells does not affect Cajal-Retzius cell survival, indicating normal apoptosis 
(Ledonne et al., 2016). These findings suggest that Cajal-Retzius cell origin dictates its 
mechanism of programmed cell death. Interestingly, no changes in caspase 3 expression have 
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been detected in Cajal-Retzius during apoptosis (Blanquie et al., 2017), nor is hippocampal 
Cajal-Retzius cell degeneration dependent upon caspase 3 activation (Anstötz et al., 2016), 
indicating that Cajal-Retzius cell apoptosis occurs mainly through caspase 3-independent 
mechanisms. 
1.2.3.3 Roles of Reelin Signaling in Brain Development  
Reelin signals predominantly by bindings to its receptors Very Low Density Lipoprotein 
Receptor (VLDLR) and ApoE Receptor Type 2 (ApoER2), stimulating phosphorylation of the 
adapter protein DAB Adapter Protein 1 (Dab1) and resulting in the initiation of corresponding 
intracellular kinase cascades, including Crk/C3G, PI3K/Akt, and Src family kinases, each of 
which has different targets (D’Arcangelo et al., 1999; Hiesberger et al., 1999; Howell et al., 
1999; Lambert de Rouvroit et al., 1999; Bock et al., 2003; Huang et al., 2004). Accordingly, 
mice deficient in VLDLR and ApoER2, Dab1, or Src family kinases have phenotypes similar to 
reeler (Sweet et al., 1996; Sheldon et al., 1997; Trommsdorff et al., 1999; Howell et al., 2000; 
Kuo et al., 2005). Functions of Reelin include regulation of migration, cell adhesion, and 
dendrite development (Niu et al., 2004; Hirota and Nakajima, 2017). Accordingly, changes in 
Reelin expression are associated with numerous psychiatric and neurodevelopmental diseases, 
including schizophrenia, autism, and depression (Ovadia and Shifman, 2011; Ishii et al., 2016). 
Further details regarding each of Reelin's functions in the developing brain will be discussed 
below. 
1.2.3.3.1 Migration 
As previously discussed, newborn neurons migrate independently of radial glia or 
dependent upon radial glia (Nadarajah et al., 2001). Studies have found that Reelin has roles in 
regulating both modes of migration during development. One significant indication that Reelin is 
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required for somal translocation is that preplate splitting is impaired in reeler mice. As 
previously discussed, preplate splitting occurs very early in development, when most neurons 
migrate via somal translocation (Nadarajah et al., 2001). Instead of a clear division between the 
marginal zone and subplate in reeler mice, the subplate and marginal zone cells are mixed and 
disorganized (Sheppard and Pearlman, 1997). During somal translocation, Reelin stabilizes the 
actin cytoskeleton through PI3-Kinase (PI3K)-mediated phosphorylation of N-cofilin after LIM 
Kinase (LIMK) activation (Chai et al., 2009). N-cofilin phosphorylation prevents the protein 
from depolymerizing F-actin, preventing actin's disassembly and stabilizing the neuron's leading 
process (Chai et al., 2009). Additionally, Reelin signaling through Dab1 and Rap1 activates 
integrin α5β1, promoting neuronal processes' binding to fibronectin localized to the marginal 
zone (Sekine et al., 2012). Finally, Reelin stabilizes the leading process of migrating neurons 
through Rap1 regulation of the cell adhesion molecule N-cadherin, similarly promoting the 
attachment of leading processes of migrating neurons (Franco et al., 2011). Taken together, these 
studies suggest that Reelin aids in stabilizing and anchoring leading neuronal processes to the 
marginal zone, which is a crucial step during somal translocation. 
There is also evidence that Reelin regulates aspects of glial-dependent migration prior to 
locomotion onset. Glial-dependent migration is the primary form of neuronal migration from the 
subventricular and intermediate zones of the developing brain (Nadarajah and Parnavelas, 2002), 
and evidence from reeler mice suggests that migration through these areas is altered (Hamburgh, 
1963). Indeed, studies show a low level of Reelin expression within the intermediate zone of the 
brain (Yoshida et al., 2006). It remains unclear, however, how this Reelin pool specifically 
contributes to neuron migration. Changes in neuronal migration may be due to regulation of N-
cadherin's cell surface expression by Rap1 via Reelin (Franco et al., 2011), as N-cadherin is 
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important for glial-dependent neuronal migration (Shikanai et al., 2011; Gärtner et al., 2012). 
Furthermore, overexpression of LIMK or N-cofilin within the brain's intermediate zone partially 
rescues migration defects in reeler mice (Chai et al., 2016), suggesting that Reelin-induced N-
cofilin phosphorylation partially contributes to radial glial-dependent migration in addition to 
somal translocation.  
1.2.3.3.2 Adhesion 
Reelin modulates the function of cell adhesion molecules to promote interactions 
between neurons and Cajal-Retzius cells. For example, Reelin facilitates interactions between 
neurons and Cajal-Retzius cells through Nectins and N-cadherin (Gil-Sanz et al., 2013). Other 
studies have shown that Reelin transiently strengthens adhesive bonds between N-cadherin and 
neurons such that Reelin overexpression causes neuronal clustering (Matsunaga et al., 2017). 
Further studies demonstrated that this effect is dependent upon Dab1 and ApoER2, but not 
VLDLR (Matsunaga et al., 2017; Hirota et al., 2018, 2; Hirota and Nakajima, 2020). This 
functionality may regulate the aggregation of neurons at the primitive cortical zone, which is 
localized at the top of the cortical plate and regulates layer formation in the mature cortex 
(Ajioka and Nakajima, 2005). However, the significance of neuronal clustering within this area 
for normal brain development remains unclear. Reelin also cleaves the cell adhesion molecule 
L1, promoting neurite outgrowth and neuronal migration independently of canonical signaling 
through its receptors or Dab1 (Lutz et al., 2017). Accordingly, L1 loss causes abnormalities in 
neuronal migration partially consistent with reeler mice, including abnormal neuronal orientation 
and misplaced neurons (Lutz et al., 2017). These experiments demonstrate the importance of 
Reelin-regulated adhesion as an additional mechanism by which it controls neuronal migration. 
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1.2.3.3.3 Dendrite morphogenesis 
In addition to regulation of neuronal migration and aggregation, Reelin influences 
dendrite development and morphology. Reelin appears to be particularly important in regulating 
dendrite morphology within the pyramidal neurons of the hippocampus, both during 
development and postnatally (Niu et al., 2004, 2008). Similar to its regulation of migration, this 
process depends upon Dab1 signaling (Niu et al., 2004). Therefore, in the absence of Reelin, 
hippocampal neurons have impaired dendrite development (Stanfield et al., 1979; Niu et al., 
2008), while Reelin haploinsufficiency causes a relatively mild decrease in dendritic spine 
density within the motor prefrontal cortex (Liu et al., 2001). These experiments suggest that 
Reelin also regulates synapse formation and neurotransmission in the adult brain by modulating 
dendrite development and morphology. 
1.2.3.4 Reelin-independent functions of Cajal-Retzius cells 
Reelin is specifically and highly expressed in Cajal-Retzius cells, so it can be challenging 
to identify the specific functions of Cajal-Retzius cells independently of Reelin expression. One 
such study to address this divide utilized a transgenic P73 knockout mouse. As discussed 
previously, P73 is expressed in Cajal-Retzius cells and promotes survival (Tissir et al., 2009). 
Loss of P73, therefore, causes a severe decrease in the abundance of Reelin-expressing Cajal-
Retzius cells yet maintains a low level of Reelin expression within the marginal zone (Meyer et 
al., 2004). Despite the near-total loss of Cajal-Retzius cells, P73 knockout mice have relatively 
minor defects in cortical development (Meyer et al., 2004). Cortical lamination is mostly normal 
despite a reduced cortical thickness, which is more prevalent in the posterior cortex. The preplate 
also split into the marginal zone and subplate at early development stages without defects (Meyer 
et al., 2004). Similarly, ablation of cortical-hem-derived Cajal-Retzius cells does not result in 
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large-scale disruptions in cortical layering despite a near-complete loss of Reelin in the marginal 
zone (Yoshida et al., 2006). These results suggest that 1) Reelin is responsible for a majority of 
the cortical development defects associated with Cajal-Retzius cell loss and 2) low levels of 
Reelin expression or compensation in later-appearing Reelin-expressing interneurons is 
sufficient for relatively normal development. 
In a separate study that wished to differentiate the effects of Reelin on migration 
independently of abnormal preplate formation, researchers pharmacologically ablated Cajal-
Retzius cells at birth (Supèr et al., 2000). They identified that ablation at birth impaired the 
migration of later-born neurons, reduced the number of radial glial cells, and increased astrocyte 
abundance (Supèr et al., 2000). These results suggest that Cajal-Retzius cells protect the radial 
glial cell identity and prevent premature differentiation into astrocytes. They also demonstrate 
that disruption of preplate formation is not solely responsible for neuronal migration deficits 
present with loss of Reelin (Supèr et al., 2000). However, this study does not desegregate Reelin 
signaling from Cajal-Retzius cells, so it is not known how many of these findings are attributed 
to the loss of Reelin signaling. 
1.2.4 The Extracellular Matrix 
The brain's extracellular matrix comprises glycoproteins, such as chondroitin and heparin 
Sulfate proteoglycans, laminins, tenascins, and Reelin (Barros et al., 2011; Franco and Müller, 
2011). This network of extracellular cues is critical for neuronal migration, synapse formation, 
and myelination (Franco and Müller, 2011). Laminins are expressed within the brain's basal 
lamina at the pial surface and within the ventricular zone. They maintain radial glial cell 
orientation and function (Ferent et al., 2020). Heparin and chondroitin sulfate proteoglycans 
include Perlecan, Glypican, Phosphacan, Versican, and Neurocan (Maeda, 2015). Finally, the 
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glycoproteins Tenascin-C, Tenascin-R, and Reelin are critical to extracellular matrix 
composition and function (Barros et al., 2011; Franco and Müller, 2011). 
1.2.4.1 Extracellular Matrix Regulation of Migration  
The major proteins that comprise the basal lamina at the brain's pial surface are the 
laminins, which are crucial to maintaining radial glial cell attachment and survival (Timpl et al., 
1979; Radakovits et al., 2009). Studies demonstrate that removing the basal lamina severely 
disrupts brain lamination, indicating its necessity for proper neuronal migration (Sievers et al., 
1994; Radakovits et al., 2009). Similarly, mutations in or loss of laminins or their integrin 
receptors cause defects in cortical layering (Smyth et al., 1999; Graus-Porta et al., 2001; Halfter 
et al., 2002; Chen et al., 2009). These defects are associated with the detachment of radial glial 
endfeet from the basal lamina (Halfter et al., 2002; Chen et al., 2009). The specific deletion of 
integrin from migrating neurons does not cause severe changes in lamination, suggesting that 
disruptions in migration after integrin loss are most likely due to radial glial cell endfeet 
detachment rather than a direct effect on migrating neurons (Graus-Porta et al., 2001). Laminins 
are also expressed within the brain's ventricular region, promoting neural stem cell expansion 
and differentiation. Similar to loss of integrin within the basal lamina, disruption in integrin 
function within the ventricular zone causes detachment of radial glial cell apical processes 
(Loulier et al., 2009). 
Proteoglycans make up a large portion of the brain's extracellular matrix (Maeda, 2015). 
Similar to laminin and integrin, disruption of specific heparin sulfate proteoglycans or heparin 
sulfate biosynthesis overall result in basal lamina disruptions with microcephaly, altered 
neurogenesis, and minor lamination defects (Inatani et al., 2003; Haubst et al., 2006; Girós et al., 
2007; Jen et al., 2009). In addition, evidence suggests that chondroitin sulfate proteoglycans 
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(CSPGs) regulate aspects of neuronal migration, as depletion of sulfotransferases that generate 
the sulfate groups on CSPGs disrupts the multipolar-to-bipolar transition of migrating neurons 
(Ishii and Maeda, 2008). These findings indicate that sulfate groups on CSPGs may be binding 
sites for trophic factors that guide migrating neurons. Likewise, there is evidence that CSPGs 
located in the striatum regulate tangential interneuron migration through binding to the repulsive 
cue Semaphorin 3A (Sema3A), suggesting that CSPGs bind and retain Sema3A in the striatum to 
repel tangentially migrating neurons away from this area of the brain (Zimmer et al., 2010). In 
addition to Sema3A, CSPGs bind many attractive and repulsive guidance cues, including 
Cxcl12, neurotrophins NT4, NT3, BDNF, and NGF, Slit2, Netrin, and multiple Ephrins 
(Mbemba et al., 2000; Shipp and Hsieh-Wilson, 2007; Rogers et al., 2011; Mizumoto et al., 
2013; Maeda, 2015), suggesting CSPGs may additionally regulate tangential migration through 
binding with these molecules. However, these studies were completed in vitro using biochemical 
assays, so it remains to be seen whether these interactions occur in the developing brain. 
Glycoprotein tenascin family members Tenascin-C (TNC) and Tenascin-R (TNR) are 
highly expressed in the developing cortex (Garcion et al., 2004; Ayachi et al., 2011). TNC is 
predominantly expressed in radial glial cells and is thought to regulate radial glial cell 
differentiation, as TNC-deficient mice have a reduced number of RC2-expressing radial glial 
cells (Garcion et al., 2004). Likewise, a separate study found that TNC knockout mice have an 
increased density of neurons and astrocytes, suggesting enhanced neurogenesis and gliogenesis 
(Irintchev et al., 2005). This study also found that TNC loss causes a reduced density of 
Parvalbumin-expressing interneurons, reduced percentage of oligodendrocytes, and alterations in 
dendritic spine morphology (Irintchev et al., 2005), indicating TNC has a broad range of effects 
on brain development. Despite all of these changes in brain composition, current evidence does 
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not support a role for TNC in modulating neuronal migration. TNR, however, has been 
specifically demonstrated to inhibit the migration of neurons derived from neural progenitor cells 
in vitro (Huang et al., 2009); however, its effects on migration in vivo remain unclear. 
1.2.5 Human Cortical Development 
 Human and primate cortical development differ from rodent development in several 
crucial ways. One of the main distinctions between human and rodent brains is the additional 
gyrification in primates. It has been hypothesized that gyrification evolved to increase the brain's 
surface area and the number of neurons without drastically increasing skull size (Zilles et al., 
2013). Accordingly, human brains have significantly more neurons than rodent brains (Azevedo 
et al., 2009). There are a couple of different ways that the neuronal pool is expanded in humans. 
First, neurogenesis onset is delayed in humans relative to rodents (Rakic, 1995; Kornack and 
Rakic, 1998). As previously discussed, the earliest precursors of radial glial cells,  
neuroepithelial cells, undergo rounds of cell division to expand the cortex during the early stages 
of brain development (Rakic, 1995). In the human brain, delayed neurogenesis allows 
neuroepithelial cells to undergo many more divisions, producing more progenitor and radial glial 
cells than are present in rodents (Rakic, 1995; Kornack and Rakic, 1998).  
Additionally, the neurogenic period is expanded ten-fold in primates, further increasing 
the progenitor pool that produces neurons (Caviness et al., 1995; Rakic, 1995). Moreover, while 
rodent IPCs generally undergo one or zero rounds of symmetric cell division before terminal 
differentiation, human IPCs undergo multiple rounds of division, drastically increasing the 
progenitor pool and the number of neurons that can be produced (Fietz et al., 2010; Hansen et al., 
2010; Betizeau et al., 2013). Finally, the expanded radial size of the human cortex correlates with 
an additional progenitor cell type localized closer to the apical surface of the brain. These cells 
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are known as outer radial glia; their endfeet attach to the pial surface of the brain, while their 
soma lies outside of the ventricular zone in a new layer called the outer subventricular zone 
(Smart et al., 2002; Lukaszewicz et al., 2005; Howard et al., 2006; Fietz et al., 2010; Betizeau et 
al., 2013). These cells make up the vast majority of progenitor cells in the human cortex, with 
four times as many cells as present in the ventricular and inner subventricular zones (Smart et al., 
2002). Thus, although the rodent is a suitable model system to study aspects of brain 
development, human brain development differs in its complexity and scale. 
1.3 NRG1/ErbB4 Signaling 
 As previously discussed, NRG1 signaling through ErbB4 is a crucial regulator of brain 
development. Studies from the Corfas lab and others show that these molecules are critically 
important to regulate astrogenesis, radial neuron migration, interneuron migration, and 
myelination in the developing brain (Rio et al., 1997; Flames et al., 2004; Sardi et al., 2006; 
Neddens and Buonanno, 2010; Makinodan et al., 2012). However, the specifics of ErbB4 
intracellular domain (E4ICD)-mediated regulation of astrogenesis remain to be identified. 
1.3.1 ErbB/EGFR Family of Receptor Tyrosine Kinases 
ErbB4 is a member of the ErbB/EGFR family of receptor tyrosine kinases, which are 
receptors that contain extracellular, transmembrane, and intracellular domains that have intrinsic 
tyrosine kinase activity (Plowman et al., 1993a). Additional family members include 
EGFR/ErbB1, ErbB2, and ErbB3. These receptors bind growth factors such as Neuregulins 
(NRG), Epidermal Growth Factor (EGF), Epiregulin, Amphiregulin, and others. ErbB4 
specifically binds NRG1, NRG2, NRG3, NRG4, and NRG5 as well as β-cellulin (BTC), 
Epiregulin, and Heparin-binding EGF-like Growth Factor (HB-EGF) (Mei and Nave, 2014). 
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Ligand binding stimulates receptor phosphorylation and downstream kinase cascades (Plowman 
et al., 1993a, 1993b).  
Typically, receptor tyrosine kinases dimerize to function. Interestingly, the EGFR family 
of receptors can heterodimerize or homodimerize; however, some homodimers are not 
functionally active (Guy et al., 1994; Tzahar et al., 1996). For example, EGFR and ErbB2 lack a 
ligand-binding domain, whereas ErbB3 lacks a tyrosine phosphorylation domain (Guy et al., 
1994; Tzahar et al., 1996). Therefore, homodimers of these receptors cannot bind ligands or are 
catalytically inactive (Guy et al., 1994). ErbB4, on the other hand, has a ligand-binding domain 
and a phosphorylation site, which means it is the only EGFR family member that can 
homodimerize, bind ligands, and phosphorylate itself (Plowman et al., 1993b, 1993a). 
1.3.2 ErbB4 Structure and Signaling 
ErbB4 has multiple alternative splice forms that vary in the juxtamembrane (JM) domain 
and the intracellular cytoplasmic (CYT) domain, with two primary alternative splice forms for 
each (Figure 1.2). Thus, alternative splicing of ErbB4 predominantly generates four different 
proteins (Mei and Nave, 2014). CYT-1 is produced by the inclusion of exon 26, whereas CYT-2 
is generated upon its exclusion (Sawyer et al., 1998). Furthermore, the PI3K binding domain 
localizes within exon 26, so only ErbB4-CYT-1 can activate PI3K (Sawyer et al., 1998). The two 
primary JM splice forms are JMa and JMb, which either include exon 16 or exon 15, respectively 
(Elenius et al., 1997). There is also some evidence of ErbB4-JMc and JMd isoforms, which 
exclude or include both exons, respectively (Zeng et al., 2009). However, these isoforms are not 
well characterized or studied. Significantly, ErbB4-JMa and ErbB4-JMb differ in their potential 
signaling mechanisms, which are discussed further below (Elenius et al., 1997).  
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1.3.2.1 ErbB4 Canonical Signaling 
As is the case for other receptor tyrosine kinases, ligand binding to ErbB4 causes receptor 
dimerization, tyrosine autophosphorylation of the receptor intracellular domain, and activation of 
intracellular signaling pathways through adapter proteins. These signaling pathways include 
Raf/MEK/ERK, PI3K/Akt/S6K, and activation of Src family kinases, which stimulate 
transcription factors that modulate cell function (Yarden and Sliwkowski, 2001; Mei and Nave, 
2014). Specific functions associated with these signaling pathways are discussed in later 
sections. 
1.3.2.2 ErbB4 Non-Canonical Intracellular Domain Signaling 
In addition to canonical signaling, ErbB4 functions "non-canonically" via ErbB4-JMa. 
Exon 16, only expressed in ErbB4-JMa, contains a cleavage site for tumor necrosis factor α-
converting enzyme (TACE) (Elenius et al., 1997; Rio et al., 2000). As with canonical signaling, 
NRG1 binding to ErbB4-JMa stimulates receptor dimerization and autophosphorylation. 
However, instead of adapter protein stimulation of intracellular kinase cascades, ErbB4 is 
cleaved by TACE within the JM domain (Rio et al., 2000), followed by γ-secretase in the 
transmembrane domain (Lee et al., 2002).  These cleavage events release the soluble ErbB4 
intracellular domain (E4ICD), which translocates to the cell's nucleus to directly influence 
transcription (Lee et al., 2002; Sardi et al., 2006).  
1.3.3 Roles in Brain Development 
NRG1/ErbB4 signaling regulates various aspects of brain development, including 
differentiation, migration, synapse formation, and myelination (Mei and Xiong, 2008; Mei and 
Nave, 2014; Kataria et al., 2019). During development, ErbB4 is expressed in progenitor cells 
within the subventricular zone and the MGE (Rio et al., 1997; Flames et al., 2004; Fox and 
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Kornblum, 2005). In the adult brain, ErbB4 is expressed in inhibitory somatostatin and 
parvalbumin-expressing neurons, where it localizes to the cell’s postsynaptic synapse, binding to 
postsynaptic density protein 95 (PSD-95) (Huang et al., 2000; Vullhorst et al., 2009; Fazzari et 
al., 2010).  
1.3.3.1 Transcriptional Regulation of Gliogenesis 
One of the functions associated with E4ICD nuclear signaling is repression of 
astrogenesis, identified previously by the Corfas lab. Upon NRG1 binding to ErbB4-JMa in 
neural progenitor cells, ErbB4 is phosphorylated and cleaved, releasing E4ICD as described 
above (Elenius et al., 1997). Our lab further demonstrated that E4ICD binds with the adapter 
protein TAB2 and the co-repressor N-CoR and shuttles to the nucleus to repress glial gene 
transcription through direct promoter binding (Sardi et al., 2006). Furthermore, this process is 
dependent upon ErbB4-JMa cleavage and tyrosine phosphorylation. Expression of ErbB4-JMb, 
inhibition of ErbB4-JMa cleavage, or expression of a kinase-dead form of JMa inhibit complex 
formation and promoter binding (Sardi et al., 2006). This function of ErbB4-JMa is hypothesized 
to repress astrogenesis while neurogenesis is ongoing during the early stages of brain 
development. Accordingly, ErbB4 KO mice have increased GFAP and S100b protein expression 
at E17.5, the age of astrogenesis onset in rodents (Sardi et al., 2006).  
1.3.3.2 Neuron Migration 
In addition to regulation of differentiation, NRG1/ErbB4 signaling regulates both radial 
migration of immature excitatory neurons and tangential migration of interneurons from the 
ganglionic eminences to the dorsal telencephalon (Rio et al., 1997; Flames et al., 2004).  
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1.3.3.2.1 Radial Migration 
NRG1 is secreted by neurons and promotes radial glial cell formation and process 
extension (Anton et al., 1997; Schmid et al., 2003). NRG1 also stimulates the migration of 
neurons along radial glia fibers, such that in vitro NRG1 treatment of migrating neurons attached 
to radial glial fibers causes a dose-dependent increase in their migration speed (Anton et al., 
1997). However, NRG1 regulation of radial glia development and neuron migration in the cortex 
is mediated through ErbB2, which is expressed in radial glial cells, rather than ErbB4 (Schmid et 
al., 2003). ErbB4 instead is important in cerebellar development. Like in the developing cortex, 
newborn cerebellar granule neurons migrate along Bergmann glial fibers. Inhibition of ErbB4 in 
cerebellar glial cells impairs migration of NRG1-expressing granule cells in vitro (Rio et al., 
1997). However, despite NRG1’s alleged role in cell migration in vitro, in vivo evidence has 
failed to recapitulate this significance. First, conditional deletion of NRG1 from neuronal 
precursors does not result in apparent changes in cortical lamination (Brinkmann et al., 2008). 
Furthermore, loss of ErbB2, ErbB4, or both ErbB2 and ErbB4 does not cause significant changes 
in cortical or cerebellar structures (Barros et al., 2009). These findings underlie potential 
compensatory mechanisms in vivo, indicating that redundancies in signaling mechanisms that 
regulate migration may make NRG1 dispensable for radial neuron migration. 
1.3.3.2.2 Tangential Migration 
In contrast to radial migration, the role of NRG1/ErbB4 signaling in regulating tangential 
interneuron migration is much more substantiated. Studies show that NRG1 is secreted from 
neurons in the dorsal telencephalon, while ErbB4 is expressed in migrating interneurons (Flames 
et al., 2004). The mechanism of migration, however, has been debated. In one study, researchers 
found through in vitro and in vivo experiments that migrating interneurons are attracted by 
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soluble NRG1 and membrane-bound NRG1. They hypothesize that membrane-bound NRG1 
expressed in lateral ganglionic eminence (LGE) neurons serves as a short-term cue to permit 
migrating neurons to travel from the MGE and through the LGE, while soluble NRG1 that is 
secreted from neurons in the dorsal telencephalon functions as an attractive long-range signal 
(Flames et al., 2004). In contrast, a separate study found that NRG1 acts as a repulsive cue to 
funnel inhibitory neurons through the cortex to their final destinations (Li et al., 2012). In vitro, 
NRG1 repelled neurons derived from the MGE. In vivo, in utero electroporation of NRG1-
expressing plasmids repelled and even blocked migrating interneurons from reaching the dorsal 
telencephalon (Li et al., 2012). In any case, loss of ErbB4 or NRG1 reduces the number of 
inhibitory interneurons present in the adult cortex, indicating a defect in interneuron migration or 
survival (Flames et al., 2004; Neddens and Buonanno, 2010; Li et al., 2012). 
 Interestingly, NRG1 signaling through ErbB4 also promotes the tangential migration of 
the second wave (arising around E16.5) of ErbB4-expressing OPCs that colonize the optic nerve 
(Ortega et al., 2012). NRG1 treatment stimulates OPCs to extend extra and lengthier processes, 
which may be altering their migration. These findings correspond with impaired migration of 
OPCs in ErbB4 KO mice (Ortega et al., 2012). 
1.3.3.3 Synapse Formation 
ErbB4 localizes to the postsynaptic density of neurons at the subcellular level, indicating 
that it may regulate synapse formation or transmission (Huang et al., 2000; Krivosheya et al., 
2008; Fazzari et al., 2010). Indeed, through its interaction with and potential stabilization of 
PSD-95, it contributes to the formation and maturation of excitatory synapses on interneurons 
(Abe et al., 2011; Ting et al., 2011; del Pino et al., 2013). Accordingly, NRG1 increases the 
intensity and frequency of miniature excitatory postsynaptic potentials in brain slices from 
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juvenile mice and interneurons in vitro (Abe et al., 2011; Ting et al., 2011). Furthermore, 
overexpression of ErbB4 increases the intensity of proteins that localize to excitatory axon 
terminals, while loss of ErbB4 reduces miniature excitatory postsynaptic potential frequency and 
the density of glutamatergic axon terminals in inhibitory interneurons (Krivosheya et al., 2008; 
Ting et al., 2011). Together, these experiments demonstrate the necessity of NRG1 signaling 
through ErbB4 in excitatory synapse formation on ErbB4-expressing GABAergic interneurons.  
Evidence suggests that NRG1/ErbB4-mediated regulation of synaptogenesis is mediated 
partially through schizophrenia-associated protein Disrupted in schizophrenia 1 (DISC1) binding 
to ErbB4 in inhibitory neurons. Researchers found that a NRG1-induced increase in 
glutamatergic synapse formation onto inhibitory neurons is blocked by DISC1 loss (Unda et al., 
2016). Furthermore, NRG1 induces DISC1 expression and localization to glutamatergic 
synapses, where it binds to ErbB4 (Unda et al., 2016). In contrast to excitatory-inhibitory neuron 
synapses, NRG1/ErbB4 signaling does not appear to have an essential role in synapses between 
interneurons (Yang et al., 2013).  
1.3.3.4 Axon and Dendrite Development 
NRG1 treatment has been shown to promote neurite outgrowth, dendritic arborization, 
axon elongation, and branching of processes in ErbB4-expressing neurons (Krivosheya et al., 
2008; Fazzari et al., 2010). Accordingly, ErbB4 knockdown in vitro decreases the number of 
primary neurites of inhibitory neurons. This process appears to be mediated through PI3K 
phosphorylation, which is a common mechanism of canonical ErbB4 signaling (Krivosheya et 
al., 2008). In addition to dendritic outgrowth and branching, NRG1 regulates dendritic spine 
formation. Accordingly, double knockout of ErbB2 and ErbB4 decreases dendritic spine density 
in neurons derived from the cortex and hippocampus (Barros et al., 2009), and single knockdown 
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of ErbB4 reduces dendritic spine formation (Li et al., 2007). Likewise, the specific loss of ErbB4 
from parvalbumin-expressing interneurons decreases neuronal dendritic spine density (del Pino 
et al., 2013; Yin et al., 2013).  
1.3.3.5 Central Nervous System Myelination 
One of the final stages of brain development is myelination, whereby oligodendrocytes 
mature and myelinate axons in the central nervous system. NRG1/ErbB4 signaling promotes the 
maturation of OPCs, which may be facilitated through E4ICD nuclear signaling (Lai and Feng, 
2004; Ortega et al., 2012). In the central nervous system, NRG1 regulates myelination during an 
early postnatal critical period (Makinodan et al., 2012). In this previous study out of the Corfas 
lab, mouse social isolation immediately after weaning reduces NRG1 expression and causes 
hypomyelination. These phenotypes are recapitulated in mice that lack ErbB3 within 
oligodendrocytes, indicating that NRG1 may be acting through ErbB3 to facilitate this process 
(Makinodan et al., 2012). In addition, mice with blocked ErbB4 signaling in oligodendrocytes 
have cortical hypomyelination, altered oligodendrocyte morphology, and decreased conduction 
velocity, suggesting that ErbB4 function is critical for normal oligodendrocyte development and 
myelination (Roy et al., 2007). However, other studies of overt loss of NRG1, ErbB3, or ErbB4 
in mice show no impairments in myelination in vivo (Brinkmann et al., 2008; Barros et al., 
2009), while a significant overexpression of NRG1 appears to cause hypermyelination 
(Brinkmann et al., 2008). These studies show that while NRG1 influences myelination, the role 
of NRG1 and ErbB4 in central nervous system myelination is context-dependent and may be 
compensated for after overt loss. 
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1.3.4 Associations with Neurological and Psychiatric Diseases 
Many studies demonstrate that altered NRG1 and ErbB4 expression are associated with 
schizophrenia (Roy and Corfas, 2008). Multiple single nucleotide polymorphisms (SNPs) have 
been found in the NRG1 gene, mostly intronic, within the noncoding regions, and a few exonic 
(Mei and Nave, 2014). Phenotypically, these SNPs are associated with reduced white matter and 
gray matter or increased ventricle volume in schizophrenia patients, possibly indicating that 
NRG1-induced myelination is disrupted (Mata et al., 2010; Barnes et al., 2012; Cannon et al., 
2012). SNPs in the NRG1 gene are associated with either increased or decreased NRG1 
expression, suggesting downregulation or upregulation can contribute to schizophrenia (Mei and 
Nave, 2014). In addition, there are many ErbB4 SNPs associated with schizophrenia, mostly in 
intronic regions of the gene. In general, ErbB4 expression is upregulated in schizophrenia 
patients, predominantly ErbB4-JMa, implicating the potential effect of proteolytic ErbB4 
cleavage in contributing to schizophrenia etiology (Silberberg et al., 2006; Law et al., 2007; 
Joshi et al., 2014; Mei and Nave, 2014; Chung et al., 2016). Furthermore, behavioral studies of 
NRG1 and ErbB4 knockout transgenic mice indicate that they have deficits associated with 
schizophrenia, including hyperactivity and impaired social behavior (Golub et al., 2004; 
O’Tuathaigh et al., 2007). In addition to schizophrenia, SNPs in NRG1 have been identified in 
patients with bipolar disorder, major depressive disorder, and Hirschsprung’s disease, while 
SNPs in ErbB4 have been associated with bipolar disorder (Mei and Nave, 2014).  
Altered expression of NRG1 and ErbB4 have also been found in human studies of  
neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, and 
Amyotrophic lateral sclerosis (ALS) (Chaudhury et al., 2003; Woo et al., 2010; Depboylu et al., 
2012; Takahashi et al., 2019; Sun et al., 2020). For example, in Alzheimer’s disease patients, 
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NRG1 and ErbB4 expression co-localize with neuritic plaques and apoptotic hippocampal 
neurons, while NRG1 levels are elevated in the patient’s cerebrospinal fluid (Chaudhury et al., 
2003; Woo et al., 2010; Mouton-Liger et al., 2020). Accordingly, mouse models of Alzheimer’s 
disease show increased ErbB4 expression within the cortex and hippocampus and in neuritic 
plaques (Chaudhury et al., 2003; Woo et al., 2011, 4). Genetically, one study identified a NRG1 
SNP that is associated with psychosis in patients with late-onset Alzheimer’s disease (Go et al., 
2005); however, a more recent study found no association between NRG1 SNPs and 
Alzheimer’s-associated psychosis (Middle et al., 2010), disputing the influence of NRG1 SNPs 
in Alzheimer’s disease. Elevated ErbB4 expression has also been identified in dopaminergic 
midbrain neurons in human patients with Parkinson’s disease. However, unlike in Alzheimer’s 
disease, ErbB4 upregulation is hypothesized to be a protective mechanism (Depboylu et al., 
2012). 
1.4 Poly (ADP-Ribose) Polymerase 1 (PARP1) 
Recently, our lab identified a direct interaction between the intracellular domain of 
ErbB4 (E4ICD) and Poly (ADP-ribose) Polymerase 1 (PARP1). PARP1 is a ubiquitously 
expressed enzyme with various functions within and outside of the nervous system and has the 
capability to directly bind DNA and regulate transcription (Kraus, 2008; Krishnakumar and 
Kraus, 2010b). This suggests that PARP1 may facilitate E4ICD’s interaction with the GFAP 
promoter to repress astrogenesis. Additionally, a PARP1 mutation has been linked to Autosomal 
Recessive Intellectual Disability (ARID) in humans, and PARP1 knockout mice display 
neurological deficits (Najmabadi et al., 2011; Plane et al., 2012; Hong et al., 2019). Together, 
these studies suggest that PARP1 has roles in brain development.  
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1.4.1 PARP Family of Proteins 
PARP1 is the first identified member of a family of 17 PARP proteins, also known as the 
ADP-ribosyl transferase (ART) family (Alkhatib et al., 1987; Cherney et al., 1987; Suzuki et al., 
1987; Amé et al., 2004). These proteins are characterized by a signature “PARP” motif within 
their catalytic domain, which contains an acceptor site for adenosine and a donor site for 
nicotinamide (Amé et al., 2004; Krishnakumar and Kraus, 2010b). PARP1s 1-5 post-
translationally modify proteins via poly-ADP-ribosylation (PARylation), whereas PARPs 6-8, 
10-12, and 14-16 catalyze only mono-ADP-ribosylation (MARylation) reactions. PARP9 and 
PARP13 are missing nicotinamide binding residues within their catalytic domain, rendering them 
likely inactive (Krishnakumar and Kraus, 2010b). The different PARP family members also 
localize to various subcellular components. While PARP1, PARP2, and PARP3 are primarily 
nuclear, other PARPs are also found outside the cell’s nucleus, including within the cytoplasm 
and mitochondria (Krishnakumar and Kraus, 2010b). PARP1 is responsible for 90% of 
PARylation activity in response to DNA damage in cells, with additional events catalyzed by 
PARP2 (Shieh et al., 1998; D’Amours et al., 1999). Therefore, double knockout of PARP1 and 
PARP2 is embryonic lethal, and embryos die at the onset of gastrulation (Ménissier de Murcia et 
al., 2003). However, loss of PARP1 or PARP2 alone is not lethal in mice (Shieh et al., 1998; 
D’Amours et al., 1999; Shall and de Murcia, 2000; Ménissier de Murcia et al., 2003; Beck et al., 
2014). This finding demonstrates the importance of PARP1 and PARP2 in regulating 
PARylation events and the significance of PARylation during early development, as the lack of 
both enzymes renders organisms non-viable. 
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1.4.2 PARP1 Protein Structure and Catalytic Activity 
The PARP1 protein contains a DNA-binding domain which includes a nuclear 
localization sequence, an automodification domain with a BRCT motif to mediate protein-
protein interactions, a WGR motif that may facilitate nucleic acid binding, and a catalytic 
domain, responsible for facilitating PARylation (D’Amours et al., 1999; Amé et al., 2004) 
(Figure 1.3). The DNA binding domain and nuclear localization sequences allow PARP1 to 
localize to the cell’s nucleus and directly bind to DNA to facilitate various functions, including 
chromatin modifications to regulate transcription and DNA repair (Kraus, 2008; Ray Chaudhuri 
and Nussenzweig, 2017). The BRCT motif allows PARP1 to bind to other proteins to PARylate 
them, thus regulating their activity, and the auto-modification domain allows PARP1 to 
PARylate itself (D’Amours et al., 1999).  
PARP1 catalyzes PARylation reactions using NAD+ as a substrate to synthesize ADP-
ribose polymers (PAR) on acceptor proteins (D’Amours et al., 1999) (Figure 1.4). PAR groups 
are large negatively charged polymers linked together via glycosidic ribose-ribose bonds in 
linear or branched chains (Chambon et al., 1966; Reeder et al., 1967). The process of PARylation 
is reversible through the enzymatic activity of poly (ADP-ribose) glycohydrolase (PARG) and 
ADP-ribosylhydrolase 3 (ARH3) which remove PAR groups from proteins (Figure 1.4) (Miwa et 
al., 1975; Ono et al., 2006). PARP1 auto-PARylation has been shown to inhibit its DNA binding 
and catalytic activity, which is one mechanism through which PARP1 might self-regulate its 
activity (Cervantes-Laurean et al., 1996; D’Amours et al., 1999; Kauppinen et al., 2005).  
1.4.3 PARP1 Functions 
The various domains that are included within the PARP1 protein confer a wide variety of 
functions. These include the regulation of DNA damage repair and transcription, processing and 
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regulation of mRNAs and miRNAs, control of apoptosis and necrosis, and modulation of 
immune system functionality (Kraus, 2008; Krishnakumar and Kraus, 2010b; Beck et al., 2014; 
Ke et al., 2019). Each of these functions will be discussed further in the sections below. 
1.4.3.1 DNA Damage Repair  
The most widely studied and well-known function of PARP1 is as a facilitator of DNA 
damage repair, including base excision repair, single and double-strand break repair, and 
homologous recombination (Durkacz et al., 1980; Bouchard et al., 2003; Krishnakumar and 
Kraus, 2010b; Beck et al., 2014). PARP1 recognizes DNA single-strand and double-strand 
breaks, activates itself, and PARylates nucleosome proteins H1 and H2B at breakage sites 
(Gilbert de Murcia and Josiane Menissier de Murcia, 1994). These histone modifications cause 
the chromatin to unravel and relax, allowing it to be accessible by DNA repair proteins (Poirier 
et al., 1982; Kraus, 2008; Ray Chaudhuri and Nussenzweig, 2017). PARylation of chromatin 
also serves as a signal for DNA repair proteins to localize to the break site and repair the DNA. 
For example, for PARP1-mediated repair via repair protein XRCC1, PARP1 is necessary for  
XRCC1 to be recruited to the site of damaged DNA, where XRCC1 serves as a scaffold for other 
repair proteins such as DNA ligase 3 (Caldecott et al., 1996, 1; Masson et al., 1998; El-Khamisy 
et al., 2003). During DNA double-strand break repair, ataxia telangiectasia mutated (ATM) 
recruits repair proteins such as p53 and SMC1. ATM is PARylated by PARP1, which stimulates 
its activity (Murcia et al., 2001; Aguilar-Quesada et al., 2007). PARP1 also facilitates 
homologous recombination by recruiting meiotic recombination protein 11 (Mre11) and the 
breast cancer susceptibility protein BRCA1 to the DNA (Haince et al., 2008; Li and Yu, 2013; 
Hu et al., 2014). Mre11 is critical during the end resection process in homologous recombination 
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(Haince et al., 2008), and PARP1 regulation of BRCA1 has been hypothesized to fine-tune the 
homologous recombination process (Hu et al., 2014).  
Given the importance of PARP1 in regulating various aspects of DNA damage repair, 
cells deficient in PARP1 display greater intensities of damage upon treatment with DNA 
damaging agents (Wang et al., 1995; de Murcia et al., 1997; Trucco et al., 1998; Masutani et al., 
1999; Shall and de Murcia, 2000). Accordingly, mice lacking PARP1 are more susceptible to 
DNA damage due to genotoxic insults, exhibit spontaneous carcinogenesis, and age at an 
accelerated rate (Wang et al., 1995; de Murcia et al., 1997; Masutani et al., 1999; Piskunova et 
al., 2008). The process of DNA repair is critical for cancer cell replication; thus, PARP inhibitors 
are widely used in the treatment of various cancers (Dziadkowiec et al., 2016; Pommier et al., 
2016; Rose et al., 2020; Wengner et al., 2020). 
1.4.3.2 Transcriptional Regulation 
PARP1 modulates transcription through several different mechanisms. For example, it 
can directly modify chromatin to facilitate transcription factor binding and gene activation, 
PARylate transcription factors or chromatin modifiers to activate or deactivate them, and bind to 
enhancer regions of the genome (Kraus, 2008).  
1.4.3.2.1 Chromatin Binding 
Given PARP1’s ability to directly modify chromatin at the sites of DNA damage to 
facilitate DNA damage repair, it is unsurprising that chromatin modifications via PARP1 also 
regulate gene transcription (Ray Chaudhuri and Nussenzweig, 2017). Similar to other post-
translational chromatin modifications, such as acetylation or methylation, histone PARylation 
modifies chromatin structure (Kim et al., 2004; Ray Chaudhuri and Nussenzweig, 2017). For 
example, PARylation of linker Histone H1 or PARP1 binding to the nucleosome causes Histone 
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H1’s eviction from the target gene’s promoter, which results in chromatin relaxation, allowing 
for transcription factors to bind to the gene promoter and promote transcription (Poirier et al., 
1982; Huletsky et al., 1989; Kim et al., 2004). This is the mechanism by which PARP1 regulates 
transcription of Doublecortin (Dcx) in neuronal cells, specifically by PARP1 recruitment to its 
promoter via transcription factors PBX and MEIS (Hau et al., 2017). In contrast, PARP1 
represses transcription by binding to nucleosomes and causing chromatin to compact. 
Interestingly, this function of PARP1 only occurs when the protein is unmodified in the absence 
of NAD+ (Kim et al., 2004). PARP1 may also facilitate chromatin compaction through a 
chromatin-binding protein called DEK. PARP1 activation after the addition of NAD+ causes 
PARP1 PARylation of DEK and the removal of PARP1 and DEK from chromatin, allowing 
transcription to occur (Gamble and Fisher, 2007).  
1.4.3.2.2 Regulation of Chromatin Modifying Enzymes 
In addition to directly modifying chromatin, PARP1 can PARylate chromatin-modifying 
proteins, such as enzymes that regulate DNA or histone methylation and acetylation (Kraus, 
2008). The process of methylation and acetylation can either repress or activate transcription 
depending upon the specific nature and site of modification by opening or condensing chromatin 
to allow or prevent transcription factors from accessing promoter regions of genes (Rothbart and 
Strahl, 2014; Tessarz and Kouzarides, 2014; Barnes et al., 2019).  
DNA methyltransferase 1 (DNMT1) is an enzyme that methylates cytosine residues on 
DNA, which prevents transcription. PARP1 binds to the promoter of the Dnmt1 gene to protect it 
from silencing via DNA methylation, thus promoting transcription of the gene when PARP1 is 
activated (Zampieri et al., 2009). PARP1 PARylation of the DNMT1 protein, in contrast, inhibits 
DNMT1’s catalytic activity, thus preventing DNA methylation and promoting transcription 
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(Reale et al., 2005).  PARP1 also interacts with Ten-eleven-translocation 1 (Tet1), which 
catalyzes the formation of hydroxymethyl groups on cytosine residues (Zhang et al., 2010; 
Ciccarone et al., 2015). These are epigenetic modifications associated with transcription factor 
binding sites (Zhang et al., 2010). Through Tet1 PARylation, PARP1 can increase or decrease its 
enzymatic activity and alter downstream functions associated with Tet1 (Ciccarone et al., 2015).  
PARylation of a lysine methyltransferase, Ezh2, inhibits its activity and decreases its 
association with chromatin, preventing its methylation of lysine residues on histone H3 
(H3K27me3), a repressive epigenetic modification (Caruso et al., 2018). Therefore, PARP1 
activation promotes transcription via decreased H3K27me3. PARP1 also regulates H3K27me3 
levels via repression of Ezh2 gene transcription (Martin et al., 2015). In addition to methylases, 
PARP1 interacts with histone-associated lysine demethylases Kdm5b and Kdm4d 
(Krishnakumar and Kraus, 2010a; Le May et al., 2012). Kdm5b is a lysine-specific demethylase 
that regulates methylation levels of lysine four on histone H3 (H3K4me3), which are found at 
sites of active transcription (Tan et al., 2003; Sims and Reinberg, 2006; Christensen et al., 2007). 
PARylation of Kdm5b by PARP1 inhibits its recruitment to gene promoters, preventing it from 
silencing genes, which leads to increased transcription of Kdm5b-dependent genes 
(Krishnakumar and Kraus, 2010a). PARP1 also PARylates Kdm4d, which impairs its 
recruitment to promoters that are responsive to retinoic acid (RA). Loss of Kdm4d retains the 
methylated state of lysine residues on Histone H3 (H3K9me2), which is an epigenetic 
modification that represses transcription (Le May et al., 2012; Ninova et al., 2019). 
Consequently, co-localization of the enzyme that de-PARylates proteins (known as PARG) with 
Kdm4d at RA-responsive gene promoters restores demethylation and allows transcription to 
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occur (Le May et al., 2012). Taken together, these studies indicate that PARP1 inhibition of 
different demethylases can either promote or repress transcription. 
Another histone modification that controls the accessibility of chromatin is acetylation 
(Barnes et al., 2019). PARP1 interacts with the protein deacetylase known as Sirt1, which 
regulates the expression of genes that control cell differentiation, survival, and stress responses 
(Herskovits and Guarente, 2014; Cai et al., 2016). Experimental evidence demonstrates that Sirt1 
and PARP1 have an antagonistic relationship, whereby Sirt1 knockout increases PARP1 activity 
while its activation decreases PARP1 activity (Kolthur-Seetharam et al., 2006; Rajamohan et al., 
2009). This antagonism is hypothesized to be due to their competition for available NAD+ to 
catalyze reactions. Additionally, activated Sirt1 also represses transcription of the Parp1 gene 
through deacetylation to further suppress the activity of PARP1 (Rajamohan et al., 2009).  
1.4.3.2.3 Modification of Transcription Factors  
PARP1 modifies transcription factors that regulate gene expression in many cell types, 
including neurons. One such transcriptional repressor is MeCP2, a methyl binding protein that 
associates with corepressor complexes and directs their binding to methylated sites on DNA, 
compacting chromatin (Cheng and Qiu, 2014). Endogenous MeCP2 protein within the mouse 
brain is PARylated, which prevents it from binding to chromatin and inducing chromatin 
aggregation (Becker et al., 2016). Thus, in the absence of PARP1, MeCP2 binding to 
heterochromatin increases, and chromatin is more prone to aggregate (Becker et al., 2016). 
PARP1 also indirectly influences transcription factor Elk1 activity via Erk2 (Cohen-Armon et 
al., 2007). Erk2 phosphorylation stimulates its binding to and subsequent activation of PARP1. 
Activated PARP1 then increases Erk2-mediated phosphorylation of the transcription factor Elk1, 
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promoting the expression of its target gene, c-fos, an immediate-early gene essential for neuronal 
function (Cohen-Armon et al., 2007).  
PARP1 is also a binding partner of subunits of the transcription factor NF-ƙB, which 
regulates genes that contribute to immune functions in cells. Its interaction with subunits p50, 
p65, and p300 facilitates NF-ƙB-dependent gene expression (Hassa and Hottiger, 1999; Hassa et 
al., 2003). Thus, following immune system activation in PARP1 KO cells, the expression of 
genes that NF-ƙB control, including IL-6, are dysregulated (Hassa et al., 2003; Minotti et al., 
2015). Examples of other transcription factors that PARP1 modifies include STAT3, SRY-Box 
Transcription Factor 2 (Sox2), Hes1, CCAAT Enhancer Binding Protein (C/EBP), and Liver X 
Receptors (LXRs) (Ju et al., 2004; Gao et al., 2009; Shrestha et al., 2016; Luo et al., 2017; Ding 
et al., 2019). Taken together, these studies demonstrate that PARP1 regulates transcription 
factors that alter pathways necessary for cell differentiation, survival, and immune function. 
1.4.3.2.4 Direct Promoter or Enhancer Binding  
Direct PARP1 binding to DNA within putative gene promoter or enhancer regions  
regulates the expression of the chemokine CXCL1 and the transcription factor BCL6 (Amiri et 
al., 2006; Ambrose et al., 2007). Inactive PARP1 binding to DNA upstream of the CXCL1 
promoter inhibits binding of its associated transcription factor, NF-ƙB (Amiri et al., 2006). Upon 
PARP1 activation and auto-PARylation, PARP1 becomes unbound from the promoter, allowing 
transcription of CXCL1 to occur. Therefore, PARP1 loss increases CXCL1 expression, while 
PARP1 inhibition decreases CXCL1 expression (Amiri et al., 2006). Additionally, chromatin 
immunoprecipitation assays demonstrate that PARP1 binds to a DNA sequence within the first 
intron of the BCL6 gene that represses its expression. Therefore, PARP1 knockdown and 
inhibition increase the expression of BCL6 (Ambrose et al., 2007). Interestingly, PARP1 also 
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binds to hairpin structures associated with its own promoter region to decrease its expression. In 
cells lacking PARP1, the PARP1 promoter region is overactive, while the reintroduction of 
PARP1 into these cells downregulates its promoter activity (Soldatenkov et al., 2002). 
1.4.3.3 mRNA Processing and Regulation  
Recent evidence shows that PARP1 can post-transcriptionally modify mRNA expression 
by regulating mRNA stability, alternative splicing, and 3’ polyadenylation (Ke et al., 2019). For 
example, PARP1 loss in mouse fibroblast cells decreases the stability of the IP-10 transcript 
without altering its promoter activity (Galbis-Martínez et al., 2010). Similarly, PARP1 loss or 
inhibition in Drosophila cells decreases the stability of AKAP200 and CAPER (Matveeva et al., 
2019). This effect may be mediated through changes in alternative splicing, as PARP1 
knockdown alters the splicing products of these mRNAs (Matveeva et al., 2019). In addition, a 
study of PARP1 transcriptome-wide binding sites to RNAs showed that it binds primarily to 
mRNAs and within introns. This study also found that loss of PARP1 alters alternative splicing 
of pre-mRNAs for a significant number of genes in human HeLa cells (Melikishvili et al., 2017). 
This finding agrees with a previous study in Drosophila showing that PARP1 localizes to 
intron/exon boundaries, where it possibly recruits splicing factors to pre-mRNAs (Matveeva et 
al., 2016).  
PARP1 also indirectly modulates RNA stability through the RNA-binding protein Human 
Antigen R (HuR) (Ke et al., 2017). HuR is a ubiquitously expressed protein that binds and 
stabilizes various mRNA transcripts.  A recent study showed that PARP1 binding and 
subsequent PARylation of HuR enhance its binding to mRNAs, promoting mRNA stability (Ke 
et al., 2017). This is purportedly the mechanism by which PARP1 regulates the stability of the 
pro-inflammatory cytokine Cxcl2 in primary macrophages isolated from mice (Ke et al., 2017). 
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Interestingly, PARP1 also affects the process of 3’ polyadenylation through modification of 
Poly(A) Polymerase (PAP) (Di Giammartino et al., 2013). PAP is an enzyme that catalyzes the 
synthesis of the poly(A) tail onto the 3’ end of pre-mRNA and is supported by ~80 proteins, 
including PARP1 (Shi et al., 2009). PARP1 binding and PARylation of PAP inhibit its 
polyadenylation activity due to decreased PAP binding to RNA (Di Giammartino et al., 2013). In 
the stressful environment of heat shock, this mechanism is crucial to inhibit polyadenylation and 
repress mature mRNA production (Di Giammartino et al., 2013). 
1.4.3.4 miRNA Regulation 
miRNAs are small RNA molecules that bind to and degrade specific mRNAs (Huntzinger 
and Izaurralde, 2011; O’Brien et al., 2018). PARP1 has been demonstrated to regulate the 
expression of several miRNAs, including miR-204, miR-365, miR-196, miR-203, and miR-98 
(Nozaki et al., 2018; Wang et al., 2019). In exosomes derived from PARP1 KO embryonic stem 
cells, researchers identified 329 miRNAs that were altered by more than 2-fold, either 
upregulated or downregulated (Nozaki et al., 2018). In vascular smooth muscle cells, PARP1 
suppresses the expression of miR-204 via IL-6/STAT3 phosphorylation, which results in 
overexpression of its target gene, Runx2. Further experiments demonstrated that PARP1 loss 
increases Runx2 expression without altering its promoter activity (Wang et al., 2019). 
Additionally, a transcriptome-wide assay for PARP1-RNA binding identified miRNAs bound 
directly by PARP1, though it was only 1% of all bound RNAs (Melikishvili et al., 2017).  
Therefore, miRNA regulation is an additional method by which PARP1 post-transcriptionally 
modifies mRNAs. 
 49 
1.4.3.5 Regulation of Cell Death 
PARP1 can regulate cell death through two different methods. In one mechanism, PARP1 
plays a crucial role in programmed cell death signaling cascades, otherwise known as apoptosis. 
Cells initiate apoptosis by activating suicide proteases, including caspases, calpain, cathepsins, 
and granzymes, that cleave PARP1 and other molecules that are critical for cell survival (Fischer 
et al., 2003). PARP1 cleavage into multiple fragments prevents it from binding and repairing 
DNA, ultimately resulting in cell death (Kaufmann et al., 1993; Soldani et al., 2001). PARP1 
overactivation also causes cell death in a process known as necrosis, which occurs when cells 
have severely damaged DNA (Eguchi et al., 1997). As previously discussed, PARP1 utilizes 
NAD+ to catalyze PARylation reactions. PARP1 overactivation due to severe DNA damage 
overutilizes NAD+, depleting it from cells. Therefore, cells are prevented from using NAD+ to 
produce ATP during glycolysis, ultimately resulting in cell death (Eguchi et al., 1997). In 
addition, excessive PAR production activates the mitochondrial protein Apoptosis Inducing 
Factor (AIF), releasing it from mitochondria, after which it travels to the nucleus to stimulate 
endonucleases that cause apoptosis (Yu et al., 2002). 
1.4.3.6 Immune Functions 
During the immune system’s response to a threat, inflammation is the initial response that 
activates the body’s innate immune response. As previously discussed, PARP1 activates the 
transcription factor NF-ƙB (Hassa and Hottiger, 1999; Hassa et al., 2003), which regulates the 
inflammatory response during immune activation via transcriptional regulation of TNFα, IL-1β, 
IL-2, IL-5, and IL-8, as well as some adhesion molecules (Bhatt and Ghosh, 2014). Accordingly, 
PARP1 promotes inflammatory cytokine expression, including IL-6, IL-1β, and TNFα (Huang et 
al., 2008, 1; Robaszkiewicz et al., 2016). Interestingly, extracellularly released PARs have been 
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shown to stimulate macrophages to induce cytokine and chemokine production, a method by 
which cells may be able to communicate that they have been damaged (Krukenberg et al., 2015). 
Accordingly, loss of PARP1 is protective in disorders that are associated with chronic 
inflammation, such as arthritis, inflammatory bowel disease, asthma, diabetes, ischemia, and 
some neurodegenerative diseases (Eliasson et al., 1997; Jijon et al., 2000, 1; Szabó, 2005; 
Matsuura et al., 2011; García and Conde, 2015; Kam et al., 2018; Sethi et al., 2019; Mao and 
Zhang, 2021). Likewise, overexpressed PARP1 is associated with multiple sclerosis (MS), a 
disease of excessive inflammation (Kauppinen et al., 2005). Accordingly, PARP1 inhibition in a 
mouse model of MS ameliorates symptoms (Farez et al., 2009); however, the genetic deletion of 
PARP1 before the onset of experimental autoimmune encephalomyelitis (EAE) worsens 
symptoms, disputing the potential therapeutic effect of PARP1 inhibition in MS treatment 
(Selvaraj et al., 2009). 
1.4.4 Roles in Brain Development 
Very little is known about the roles of PARP1 in brain development. Multiple studies 
have found that the brains of PARP1 KO mice tend to weigh less than controls at postnatal ages 
(Plane et al., 2012; Hong et al., 2019). Embryonically, PARP1 loss causes enlarged ventricles at 
E14.5 and increased cell death at E16.5 and E18.5 (Hong et al., 2019). PARP1 loss also impairs 
the proliferation of neural stem cells derived from the embryonic cortex, likely through 
regulation of PDGFRα and embryonic stem cell phosphatase (ESP) (also known as PTPRV) 
expression (Hong et al., 2019; Son et al., 2020). Studies have also found increased or decreased 
adult stem cell proliferation in the subventricular zone or hippocampal dentate gyrus in PARP1 
KO mice, respectively (Plane et al., 2012; Hong et al., 2019). Adult stem cells from the 
subventricular zone or embryonic-derived neural progenitor cells are also more prone to 
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differentiate into glial cells, either oligodendrocytes or astrocytes, in the absence of PARP1 
(Plane et al., 2012; Hong et al., 2019). Glial differentiation occurs at the expense of neuronal 
differentiation, as PARP1 KO cells show decreased differentiation into MAP2-expressing 
neurons in both studies (Plane et al., 2012; Hong et al., 2019). Taken together, loss of PARP1 
causes minor defects in brain development, but the few studies examining PARP1’s role fail to 
go into great depth regarding potential embryonic developmental abnormalities. 
1.4.5 Roles in Neurological and Psychiatric Diseases  
PARP1 has been implicated in numerous neurological and psychiatric disorders. These 
include ischemic stroke, Alzheimer’s disease (AD), Parkinson’s disease (PD), MS, major 
depressive disorder, glioblastoma, and epilepsy (Mao and Zhang, 2021). In many of these 
disorders, PARP1 is overexpressed or overactive, contributing to associated cellular stress and 
neurodegeneration (Chiarugi, 2005; Kauppinen et al., 2005; Farez et al., 2009; Szebeni et al., 
2016). For example, in PD, a recent study suggests that aggregation of pathological α-Synuclein 
in dopaminergic neurons, a hallmark of PD, is driven by PARP1 PARylation (Kam et al., 2018). 
Furthermore, PAR-driven aggregation increases the toxicity of pathological α-Synuclein and 
subsequent cell death in cell culture experiments. These effects were abrogated in both PARP1 
KO neurons and with inhibition of PARP1 (Kam et al., 2018). Accordingly, PAR levels are 
elevated in the cerebrospinal fluid and substantia nigra of PD patients (Kam et al., 2018). In 
postmortem brain tissue from PD patients, researchers found a dramatic reduction in PARP1 
expression in the nucleus of affected cells in the substantia nigra, dorsal motor nucleus of vagus, 
and frontal and cingulate cortices, suggesting an altered subcellular location of PARP1 in 
diseased cells (Salemi et al., 2021). They also observed a colocalization between PARP1 and α-
Synuclein in the cytoplasm of affected neurons (Salemi et al., 2021).  
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Similarly, PARP1 co-localizes with Tau tangles and Aβ plaques in the brain of AD 
patients, is further activated by Aβ, and promotes the formation of Tau tangles that contribute to 
AD pathogenesis (Abeti et al., 2011; Mao and Zhang, 2021). In mice, PARP1 loss or inhibition 
causes Schizophrenia-associated behaviors, including increased anxiety, decreased social 
interaction, and impaired pre-pulse inhibition, as well as defects in short-term and long-term 
memory (Goldberg et al., 2009; Hong et al., 2019). In human studies, mutations in genes that 
affect PARylation, such as Parp1 or Adprhl2, are associated with increased risk of stroke, 
cognitive dysfunction, ataxia, episodic psychosis, and neurodegeneration (Najmabadi et al., 
2011; Danhauser et al., 2018; Durmus et al., 2021). Taken together, PARP1 loss of function or 
overexpression can negatively impact brain development and function in multiple ways. 
1.5 Summary and Dissertation Outline  
While PARP1 has various functions in different tissues, it is clear that it is implicated in 
brain development and function and that alterations in its protein activity result in brain 
development defects and related disorders. Therefore, further study of its specific roles in the 
developing brain will help scientists understand the etiology of associated neurodevelopmental 
diseases. Consequently, the main aims of my dissertation are to 1) further validate the role of 
PARP1 in NRG1/ErbB4 regulation of astrogenesis and 2) identify other roles for PARP1 in the 
developing brain.  
Chapter 2 will examine the role of PARP1 in the regulation of astrogenesis through 
E4ICD nuclear signaling. This chapter expands upon previous work in the Corfas lab utilizing 
neural precursor cells isolated from rats and establishes methods to investigate this interaction in 
mouse cells. Specifically, I show that NRG1 induces PARylation in mouse NPCs and that 
PARP1 is essential for NRG1 to repress GFAP expression in vitro. Accordingly, loss of PARP1 
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or ErbB4 increases the expression of GFAP in the mouse cortex at birth. Chapter 3 identifies 
changes in gene expression associated with PARP1 loss in the embryonic brain, including the 
glycoprotein Reelin. I further demonstrate that PARP1 regulates Cajal-Retzius cell development, 
cortical morphology, neuronal migration, and adhesion to N-cadherin in vitro. Chapter 4 
summarizes and discusses the findings of the previous two chapters and delineates future 
directions. Overall, these data demonstrate that PARP1 regulates the expression of numerous 
genes in the developing brain and that its loss causes changes in brain morphology that may 





Figure 1.1 Overview of neurogenesis and gliogenesis in the rodent brain. Just before the 
onset of neurogenesis, neural epithelial cells (NECs) divide symmetrically to expand their pool 
rapidly. The earliest born neuronal subtypes are Cajal-Retzius cells (born around E10.5), which 
are located in the developing brain’s marginal zone (MZ) and direct neuronal migration. At the 
onset of neurogenesis (around E12.5), NECs become radial glial cells (RGCs), whose cell bodies 
are localized to the ventricular zone (VZ) and have endfeet that extend to the basal and apical 
surfaces of the brain. RGCs divide symmetrically to form two new radial glial cells or 
asymmetrically to form one radial glial cell and one neuron or one radial glial cell and one 
intermediate progenitor cell (IPC). RGCs can also divide into two IPCs, which are located in the 
subventricular zone (SVZ). IPCs, in turn, proliferate to form additional IPCs (in rare cases) or 
two migrating neurons. In early development, neurons migrate independently of radial glial cells 
or dependent upon radial glial cell fibers, which serve as scaffolding. Migration at later stages of 
development when the cortical plate is thicker usually occurs along radial glial cell fibers. 
Neurons that have completed migration form the cortical plate (CP), splitting the MZ from the 
subplate (SP). The brain develops inside-out so that earlier-born neurons migrate to deeper 
cortical layers, while later-born neurons migrate beyond early-born neurons to more superficial 
brain layers. At the end of neurogenesis, around E17.5, IPCs and RGCs differentiate into 







Figure 1.2 ErbB4 alternative splicing. Alternative splicing of ErbB4 generates different 
isoforms with the inclusion of exon 15 (ErbB4-JMb) or exon 16 (ErbB4-JMa), exon 26 (Cyt-1) 
or lack of exon 26 (Cyt-2). The TACE cleavage site is located within exon 16, while the 
presenilin/γ-secretase cleavage site is within the transmembrane (TM) domain. Only ErbB4-JMa 
can be cleaved by both TACE and γ-secretase to release the ErbB4 intracellular domain. Exon 26 




Figure 1.3 PARP1 protein structure. PARP1 contains a DNA-binding domain, 
automodification domain, and catalytic domain. The DNA-binding domain contains three Zinc-
finger binding motifs (Zn1, Zn2, and Zn3) and a nuclear localization sequence (NLS). The 
automodification domain contains the breast-cancer-susceptibility protein carboxy terminus 
(BRCT) and WGR domain. The catalytic domain contains the helical subdomain (HD) and ADP-






Figure 1.4 PARP1 enzymatic function. PARP1 uses NAD+ as a substrate to add ADP-ribose 
polymers to acceptor proteins, converting NAD+ to Nicotinamide in the process. ADP-ribose 
polymers are removed from proteins by reverse enzymes Poly (ADP-ribose) Glycohydrolase 
(PARG) or ADP-Ribose Glycohydrolase 3 (ARH3).
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Chapter 2: ErbB4 Interacts with PARP1 to Regulate Astrogenesis1 
2.1 Introduction 
ErbB4 is a receptor tyrosine kinase highly expressed in the developing brain, of which 
Neuregulin 1 (NRG1) is a ligand (Fox and Kornblum, 2005). NRG1 binding to ErbB4 induces 
the receptor to dimerize and autophosphorylate within the protein’s intracellular domain, 
activating other kinases to stimulate an intracellular signaling cascade which ultimately regulates 
transcriptional activity in the cell (Plowman et al., 1993b, 1993a). This type of signaling is 
known as canonical ErbB4 signaling. However, an additional splice form of ErbB4, which 
differs in the juxtamembrane (JM) domain of the transcript (known as JMa), can signal directly 
via the protein’s intracellular domain (Elenius et al., 1997; Ni et al., 2001). ErbB4-JMa contains 
a cleavage site for TACE, while ErbB4-JMb does not (Rio et al., 2000). Thus, NRG1 binding 
and ErbB4-JMa autophosphorylation induce cleavage by TACE in the JM domain, allowing a 
secondary cleavage by presenilin-1/γ-secretase within the intramembrane domain (Ni et al., 
2001; Lee et al., 2002). These sequential cleavage events  release ErbB4’s intracellular domain 
(E4ICD), which complexes with TAB2 and N-CoR, and together they travel directly to the cell’s 
nucleus and bind to the promoter of astrocytic genes to repress their transcription (Sardi et al., 
2006). We hypothesize that this complex serves as a “break” on astrogenesis while neurogenesis 
is ongoing at the early stages of neurodevelopment. Therefore, a reduction in ErbB4 expression 
at later stages of neurodevelopment would release this “break” and promote the expression of 
glial-specific genes. 
 
1 Some data and figures presented in this chapter were collected and prepared by previous Corfas lab members Dr. 
Falak Sher, Dr. Pablo Sardi, and Dr. Anna Kane and current lab member Robert Doherty. 
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Unpublished data from the Corfas lab implicates Poly (ADP-Ribose) Polymerase 1 
(PARP1) in this complex as well. PARP1 is an enzyme that post-translationally modifies 
proteins and chromatin via poly(ADP-ribosyl)ation (PARylation) using NAD+ as a substrate. 
These modifications can influence transcription via altering protein activity, promoter 
accessibility, or chromatin compaction (Kraus, 2008). As ErbB4 contains a nuclear localization 
signal but lacks a DNA-binding domain, E4ICD, TAB2, and N-CoR may bind to PARP1, which 
then binds to the gene promoter of astrocytic genes. Indeed, our data indicate that a constitutively 
active form of E4ICD (LexA-E4ICD) interacts with PARP1 as indicated via a yeast 2-hybrid 
assay and a proteomic screening analysis of E4ICD binding partners (Figure 2.1A,B). This 
interaction is specific to active E4ICD, as E4ICD with a mutated kinase domain (kinase-dead) 
does not interact with PARP1 (Figure 2.1C,D). Further co-immunoprecipitation experiments in 
transfected N2A cells and mouse neural progenitor cells (NPCs) or cortical lysates indicate that 
this interaction is specific to ErbB4-JMa, requires ErbB4 cleavage by TACE and presenilin-1/γ-
secretase, and is dependent upon NRG1 stimulation and ErbB4 phosphorylation (Figure 2.1E-H). 
Together, these experiments suggest that NRG1-induced activation of ErbB4 and subsequent 
cleavage by TACE and presenilin-1/γ-secretase preclude its binding to PARP1.  
Corfas lab members next sought to determine if ErbB4-JMa activation and cleavage 
stimulate PARP1 activity, finding that NRG1 induces PARylation in mouse NPCs to a level 
similar to H2O2, a known DNA damaging molecule that stimulates PARP1 (Figure 2.2A). 
Additionally, inhibition of ErbB4 cleavage via treatment with TACE inhibitor TAPI or 
presenilin-1/γ-secretase inhibitor DAPT prevents NRG1 from activating PARP1 in ErbB4-JMa 
transfected N2A cells (Figure 2.2B) or mouse NPCs (Figure 2.2C), suggesting that E4ICD 
mediates PARP1 activation, likely through its binding to PARP1. After confirming the 
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interaction between E4ICD and PARP1, Corfas lab members questioned whether PARP1 was 
necessary for E4ICD/TAB2/N-CoR to repress transcription of the gene glial fibrillary acidic 
protein (GFAP). Indeed, while ciliary neurotrophic factor (CNTF)-induced GFAP promoter 
activity was reduced by NRG1 treatment in NPCs isolated from rat cortex, this effect was 
blocked by co-transfection of PARP1 constructs with mutations in either the DNA-binding 
domain or catalytic domain. Similarly, PARP1 inhibition via 3-ABA blocked NRG1 function, 
indicating both PARP1’s ability to bind DNA and PARylate proteins are critical for NRG1-
mediated GFAP repression (Figure 2.3A,B). Finally, chromatin immunoprecipitation 
experiments show that both PARP1 and ErbB4 bind to the same region of the GFAP promoter 
following treatment with NRG1 (Figure 2.3C). Together with the evidence that NRG1 influences 
GFAP promoter activity, this finding suggests that E4ICD-PARP1 regulates GFAP expression 
by modulating its transcription through the promoter. 
Taken together, these findings suggest that NRG1-induced autophosphorylation of 
ErbB4, cleavage and release of E4ICD, binding to N-CoR and TAB2, translocation to the 
nucleus, and subsequent binding and activation of PARP1 represses transcription of astrocyte-
specific genes, such as GFAP. However, many of these experiments need to be replicated and 
validated in mouse NPCs to take advantage of transgenic mice as negative controls. Furthermore, 
it is unknown if loss of PARP1 causes precocious astrogenesis as previously observed in ErbB4 
KO mice. To validate the role of PARP1 in regulating astrogenesis, I developed a model of 
NRG1-mediated repression of GFAP expression in mouse NPCs. We further demonstrated that 
this repression is dependent upon the presence of PARP1 and ErbB4-JMa. Finally, I found that 
GFAP expression is increased to a similar extent in PARP1 KO and ErbB4 KO cortex of mice at 
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birth, suggesting E4ICD-PARP1-mediated repression of astrogenesis has an essential role in 
vivo. 
2.2 Materials and Methods 
2.2.1 PARP1 KO Mice 
The PARP1 KO mouse line 129S-Parp1tm1Zqw/J64 was obtained from the Jackson 
Laboratory and maintained on a 129S1/SvImJ background. All animals were kept under a 12/12 
hr light/dark cycle and allowed food ad libitum. Animal procedures were reviewed and approved 
by the University of Michigan Institutional Animal Care and Use Committee. Embryonic dating 
was performed with vaginal plugging denoted as embryonic day 0.5 (E0.5).  
2.2.2 Generation of ErbB4-JMa-/- mice 
Two single guide RNAs (sgRNA) were designed to create cut sites in the ErbB4-JMa 
sequence within Exon 16. Repair of the chromosome breaks by non-homologous end joining was 
expected to create mutations in ErbB4 Exon 16 and introduce a premature termination codon 
which could lead to nonsense-mediated decay (NMD) and therefore result in specific loss of 
ErbB4-JMa expression. The sgRNAs were co-injected into fertilized C57BL/6 embryos with the 
CRISPR/Cas9 components and ultramer oligonucleotide bearing the mutations. From more than 
300 injections with both sgRNAs, 39 putative founder mice were created. Genotyping of Exon 
16 by PCR and sequencing identified 20 founder mice with other uninterpretable mutations.  
To generate founders carrying a single mutant allele, 12 potential founders were crossed 
with wild-type C57BL/6 mice, and ErbB4 Exon 16 was sequenced in the progeny, two of which 
had a single base pair deletion creating a premature termination codon within ErbB4 Exon 16. 
Male and female heterozygote offspring from the founders were back-crossed, a step that 
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generated viable homozygote offspring for each line with the expected Mendelian ratio, 
indicating that the mutations do not compromise viability. The mutant allele was named ErbB4-
JMa-, indicative of the mice bearing a premature termination codon, resulting in NMD of ErbB4-
JMa transcript. 
Mouse generation was completed with the aid of the University of Michigan Transgenic 
Animal Core. All animals were kept under a 12/12 hr light/dark cycle and allowed food ad 
libitum. Animal procedures were reviewed and approved by the University of Michigan 
Institutional Animal Care and Use Committee. 
2.2.3 Cell Culture and Treatments 
For primary NPC cell cultures, pregnant females were euthanized via cervical 
dislocation. Telencephalons were dissected from E14.5 embryos in ice-cold phosphate-buffered 
saline (PBS), meninges were removed, and cortices were dissociated into single cells with 
StemPro Accutase (ThermoFisher) for 5 min. NPCs were seeded as neurospheres in T75 flasks at 
500,000 cells/mL and expanded for 2 days in NPC media (DMEM with GlutaMAX, 1% 
penicillin/streptomycin, and 2% B27 without RA) supplemented with epidermal growth factor 
(EGF, 20 ng/mL) and basic fibroblast growth factor (bFGF, 20 ng/mL) in a humidified 5% 
CO2/95% air incubator at 37°C. Half of the media was changed every day, with replenishment of 
EGF and bFGF each day. On day 3, neurospheres were dissociated with Accutase into a single 
cell suspension and plated in NPC media supplemented with bFGF. Plates were pre-prepared by 
incubating in Poly-L-Lysine (Sigma) 30 min or overnight followed by Fibronectin (1 µg/mL, 
Corning) for 2 hrs.  
To inhibit PARP1 enzymatic activity, NPCs were treated with Olaparib (a gift of C. 
Brenner) at the indicated concentrations (10, 30, 50 nM) for 48 hrs starting on day 1 following 
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plating. Half of the media was replenished each day, and cells were re-treated with Olaparib 
every 24 hrs. To measure the effect of NRG1 on GFAP expression, NPCs were cultured as 
adherent cells as previously described. 24 hrs following culturing, bFGF was removed from 
media by replacing with NPC media containing only B27 without RA. Simultaneously, NPCs 
were treated with NRG1 (2 nM). 24 hrs later, NPCs were lysed, and RNA was extracted. 
2.2.4 shRNA-mediated PARP1 knockdown 
Lentiviral packaging plasmids and scramble shRNA or Parp1 shRNA constructs were 
transfected into HEK 293T cells using Lipofectamine 3000 (Invitrogen). Lentiviral supernatants 
were collected and concentrated using Lenti-X Concentrator (Clontech) and titered with 
puromycin selection. Parp1 shRNA plasmid was obtained from Sigma (clone ID 
TRCN0000305949) with the following target sequence: 5’- GGTTCATCTTTGCTTTAATTT-
3’. Lentiviral packaging plasmids and scramble shRNA plasmid were gifts of S. Iwase. To 
knockdown PARP1, NPCs were transduced with Parp1 shRNA expressing lentivirus or 
scramble shRNA lentivirus (at multiplicity of infection 3) for 48 hrs prior to FGF removal and 
NRG1 (2 nM) treatment, following the protocol described above. 
2.2.5 Luciferase Assay 
NPCs were cultured as adherent cells as previously described. 24 hrs following plating, 
NPCs were co-transfected with a construct expressing the rat GFAP promoter upstream of firefly 
luciferase and a construct expressing CMV-renilla (50:1 ratio). 24 hrs later, media was replaced 
with NPC media containing only B27 without RA with simultaneous treatment of NRG1 (2 nM). 
24 hrs later, media was replenished, and NPCs were re-treated with NRG1. 48 hrs following 
initial treatment, luciferase activity was measured using the Dual-Glo Luciferase Kit (Promega), 
following the manufacturer’s protocol. Luciferase intensity was measured using a BioTek plate 
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reader. Final values were obtained by normalizing firefly luciferase to Renilla luciferase. 
Technical replicates were measured in triplicate. 
2.2.6 PARylation Assay 
NPCs were plated onto round glass coverslips as adherent NPCs. The next day following 
plating, NPCs were treated with NRG1 (2 nM) or H2O2 (100 µM) for 5 min. NPCs were then 
fixed in 4% paraformaldehyde (PFA) in PBS for 10 min, then washed 3x in PBS. For fluorescent 
immunostaining, coverslips were blocked in 10% normal donkey serum in 0.2% triton in PBS 
then incubated in mouse anti-PAR primary antibody (Trevigen #4335-MC-100, 1:500 dilution) 
overnight diluted in blocking buffer. The following day, coverslips were washed 3x in 0.2% 
triton in PBS then incubated in Alexa-Fluor donkey anti-mouse 568 secondary antibody 
(Invitrogen, 1:500 dilution). Z-stack images were taken with Leica SP8 confocal microscope at 
63x magnification. 
2.2.7 RNA Isolation  
RNA was isolated from P0 cortex after removal of meninges and ganglionic eminences 
or cultured NPCs using Qiagen RNeasy Kit following the manufacturer’s instructions. RNA 
extraction from tissue was completed with on-column DNase digestion (Qiagen).  
2.2.8 RT-PCR and RT-qPCR 
For RT-qPCR, equal amounts of RNA (1 µg) were reverse transcribed into cDNA using 
an iScript cDNA Synthesis Kit (Bio-Rad) in 20 µL reaction volume following the manufacturer’s 
instructions. cDNA was diluted 5-fold for the PCR reaction. Quantitative PCR was performed 
using an iTaq SYBR Green Supermix (Bio-Rad) with a Bio-Rad CFX96 Thermocycler. Each 
sample was run in duplicate. Each well of the 96-well plate contained 5 µL iTaq SYBR Green 
 64 
Supermix, 2.5 µL diluted cDNA, and 3 pmol of each forward and reverse primer. The cycling 
conditions were as follows:  95°C for 30 s followed by 39 cycles of 95°C for 5 s and 60°C for 30 
s. Normalized Gene Expression (NGE) was calculated using the efficiency of each primer with 
the following formula: [efficiency_target-CTtarget/efficiency_reference
-CT
ref]. Fold changes in 
mRNA level were then calculated relative to controls for each experiment.  
For non-quantitative RT-PCR, equal amounts of RNA were reverse transcribed into 
cDNA using an iScript cDNA Synthesis kit (Bio-Rad), as previously described. Equal amounts 
of cDNA were amplified with primers spanning the ErbB4 juxtamembrane domain with the 
following PCR cycling conditions: 94° for 3 min, then 30 cycles of 63°C for 30 s, 72°C for 30 s, 
and 94°C for 30 s, followed by 72°C for 20 min. PCR products were run on 2% agarose gels 
stained with Ethidium Bromide. The expected size for ErbB4 JMa is 273 bp, and the expected 
size for ErbB4 JMb is 243 bp. 
Primer sequences are as follows (5’-3’): GFAP F: GCAGGAGTACCAGGATCTACT; 
GFAP R: TGGAGGTTGGAGAAAGTCTGT; GAPDH F: TCACTGCCACCCAGAAGA; 
GAPDH R: GCCAAGCCCTGAGCATAA; PARP1 F: GGCAGCCTGATGTTGAGGT; PARP1 
R: GCGTACTCCGCTAAAAAGTCAC; DCX F: GCCAGGGAGAACAAGGACTTT; DCX R: 
CACCCCACTGCGGATGA; NeuN F: CCAGGCACTGAGGCCAGCACACAGC NeuN R: 
CTCCGTGGGGTCGGAAGGGTGG RPL19 F: ACCTGGATGAGAAGGATGAG; RPL19 R: 
ACCTTCAGGTACAGGCTGTG; ErbB4 JM F: GAAATGTCCAGATGGCCTACAGGG ; 
ErbB4 JM R: CTTTTTGATGCTCTTTCTTCTGAC 
2.2.9 ErbB4 Immunoprecipitation 
For NPCs, two 10 cm dishes of adherent NPCs were treated with TPA (100 ng/mL for 45 
mins) or PBS control. Cells were washed 2x with PBS and lysed in RIPA buffer (Sigma) with 
 65 
protease and phosphatase inhibitors for 15 mins, then centrifuged for 10 mins at 14,000 rpm, and 
supernatant was collected. Cerebellum was lysed directly in RIPA buffer (Sigma) with protease 
and phosphatase inhibitors by homogenization on ice for 15 mins, then centrifuged for 10 mins at 
14,000 rpm, and supernatant was collected. Samples were normalized to 1 µg/µl by BCA assay, 
and 500 µl lysate was incubated overnight at 4°C with 30 µl washed anti-ErbB4-conjugated 
beads (ErbB4 antibody (C-7) agarose conjugated, sc-8050 AC, Santa Cruz). The following day, 
beads were washed 4x in RIPA buffer, and the sample was eluted in 1.5x Laemmli sample buffer 
for 5 mins at 95°C. Western blot from input, IP, and supernatant was carried out with ErbB4 
antibody (HER4/ErbB4 (111B2) Rabbit mAb #4795, Cell Signaling Technology) according to 
standard procedures. 
2.3 Results 
2.3.1 NRG1-induced PARylation in mouse NPCs is dependent upon PARP1 and ErbB4 
PARP1 functions enzymatically by post-translationally modifying proteins via the 
addition of (ADP-Ribose) polymers (PAR). Typically, PARP1 is activated by DNA damage; 
however, there are incidences in which PARP1 is stimulated by other proteins (Cohen-Armon et 
al., 2007; Visochek et al., 2016). Our lab previously observed in WT mouse NPCs that NRG1 
activates PARP1, resulting in increased PARylation. To test if this effect is specific to ErbB4 and 
PARP1, I treated NPCs isolated from WT, PARP1 KO, and ErbB4 KO mice with NRG1 or H2O2 
as a positive control. As observed previously, NRG1 increased cellular PAR levels in WT NPCs, 
but not in ErbB4 KO or PARP1 KO NPCs (Figure 2.4), indicating that both ErbB4 and PARP1 
are required for NRG1-induced PARylation. 
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2.3.2 Generation and Validation of the ErbB4-JMa-/- mouse 
To further investigate the role of the cleavable form of ErbB4, ErbB4-JMa, in vivo, our 
lab developed a transgenic mouse using CRISPR/Cas9 to edit ErbB4 exon 16. This directed 
targeting introduced a mutation that resulted in predicted nonsense-mediated decay of the ErbB4-
JMa transcript while retaining ErbB4-JMb. To test the validity of this prediction, we isolated 
NPCs from WT or ErbB4-JMa-/- embryos and assessed the expression of the ErbB4-JMa and 
JMb transcripts using RT-PCR with primers flanking the juxtamembrane (JM) region. In WT 
NPCs, we detected both JMa and JMb, however in ErbB4-JMa-/- NPCs, we identified only 
ErbB4-JMb (Figure 2.5A), consistent with our expectation of ErbB4-JMa nonsense-mediated 
decay. Furthermore, stimulation of TACE with tissue-type plasminogen activator (TPA) 
treatment causes ErbB4 intracellular domain cleavage, indicated by the accumulation of the 80 
kD E4ICD. As expected, no E4ICD is detectable in ErbB4 KO or ErbB4-JMa-/- NPCs upon TPA 
treatment, indicating no cleavable form of ErbB4 remains in JMa-/- NPCs (Figure 2.5B). Notably, 
full-length ErbB4 is expressed in ErbB4-JMa-/- tissues (Figure 2.5B). Similarly, we confirmed 
the lack of E4ICD in vivo with cerebellar lysates from adult ErbB4-JMa-/- mice (Figure 2.5C,D). 
Taken together, these experiments verify that ErbB4-JMa and E4ICD are lost in the ErbB4-JMa-
/- mouse brain, indicating that these mice are suitable to assess the effect of E4ICD loss without 
the loss of ErbB4-JMb canonical signaling. 
2.3.3 NRG1 repression of GFAP expression following FGF removal depends upon PARP1 
and ErbB4-JMa 
 Given previous observations of NRG1-mediated repression of GFAP expression after 
induction with CNTF in rat NPCs, we sought to establish a similar model in mouse NPCs. I 
found that removal of bFGF from NPC media drastically increases GFAP expression 24 hrs 
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later. However, concurrent removal of FGF with NRG1 treatment suppresses the increase in 
GFAP expression by about 50% in WT NPCs (Figure 2.6A). To assess the necessity of PARP1 
and ErbB4 for NRG1-mediated repression, I measured GFAP transcript levels after FGF removal 
and NRG1 treatment in ErbB4 KO and PARP1 KO NPCs. Similar to our findings in rat NPCs, I 
found that loss of either PARP1 or ErbB4 abolished NRG1-mediated GFAP repression (Figure 
2.6B). Importantly, this repression was specific to glial genes, as I observed no change in DCX or 
NeuN, which are expressed in immature or mature neurons, respectively. I observed similar 
results with PARP1 knockdown in WT NPCs via a PARP1 shRNA-expressing lentivirus (Figure 
2.6C), further validating the necessity of PARP1.  
To test if NRG1-mediated repression of GFAP is specific to ErbB4-JMa, as our lab had 
found previously in rat NPCs, we removed FGF and treated NPCs isolated from ErbB4-JMa-/- 
mice with NRG1. As previously discussed, NPCs isolated from this mouse express ErbB4-JMb 
normally. As expected, the lack of the cleavable form of ErbB4 abolished the effect of NRG1, 
strongly suggesting that ErbB4 cleavage and its interaction with PARP1 are necessary to repress 
GFAP expression (Figure 2.6B). We verified that NRG1 suppresses GFAP expression after FGF 
removal through the GFAP promoter by transfecting WT NPCs with a GFAP-luciferase 
construct which expresses luciferase downstream of the GFAP promoter. Similar to GFAP 
transcript levels, removal of FGF increases GFAP-luciferase activity while concurrent NRG1 
treatment represses the induction (Figure 2.6D). Furthermore, PARP1 inhibition alone increases 
GFAP expression, suggesting that lack of PARP1’s enzymatic function interrupts GFAP 
repression by NRG1 (Figure 2.6E). Together, these results indicate that PARP1 PARylation is 
critical for NRG1/ErbB4-JMa repression of GFAP expression and that this effect is mediated 
through the GFAP promoter.  
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2.3.4 Loss of PARP1 or ErbB4 increases cortical GFAP expression at birth 
 In mice, astrogenesis begins around E17.5 and continues through several days after birth 
(Sauvageot, 2002). Previous data suggest that ErbB4 KO animals have precocious astrogenesis, 
or increased expression of glial genes in the developing cortex (Sardi et al., 2006). Given the 
interaction between E4ICD and PARP1, this finding suggests that loss of PARP1 also causes 
precocious astrogenesis. To test this hypothesis, we measured GFAP expression in the P0 cortex 
of ErbB4 KO and PARP1 KO mice. Indeed, we observed an upregulation in GFAP expression in 
both transgenic mice (Figure 2.7), suggesting that the inability of NRG1 to repress GFAP 
expression in cells lacking ErbB4 or PARP1 results in overexpression of the transcript in vivo. 
2.4 Discussion 
Here, we identified a novel role for PARP1 in mediating the repression of astrogenesis 
through ErbB4 nuclear signaling. We show that this repression depends on NRG1-induced 
phosphorylation of ErbB4-JMa and PARP1 activation, which represses GFAP expression 
through GFAP promoter activity. We also identified a mechanism for PARP1 activation that is 
not triggered by DNA damage but by NRG1 binding and subsequent phosphorylation of the 
ErbB4 receptor and cleavage of E4ICD. PARP1 activation independently of DNA damage has 
been shown to occur in other instances as well. For example, neuronal stimulation with a high-
frequency electrical signal causes Erk2 phosphorylation, which induces PARP1 binding to Erk2 
and subsequent PARP1 activation. PARP1 then PARylates itself and chromatin at promoters of 
Erk2-associated immediate-early neuronal genes. PARylation of Histone H1 at these promoter 
sites causes the linker histone to dissociate from the complex, allowing transcription to occur 
(Cohen-Armon et al., 2007; Visochek et al., 2016). We propose a similar mechanism, whereby 
stimulation of ErbB4 with NRG1 and subsequent ErbB4 phosphorylation and E4ICD cleavage 
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induces PARP1 binding to E4ICD and promotes PARylation. However, it remains unclear 
whether PARP1 PARylates itself, other proteins in the complex, chromatin at the GFAP 
promoter, or multiple of these. Further studies are needed to elucidate the specifics of PARP1 
activation and its effects on the GFAP promoter.  
In accordance with our findings, previous studies investigating the role of PARP1 in 
differentiation have identified that progenitor cells lacking PARP1 are more prone to 
differentiate into glial cells at the expense of neuronal cells, including GFAP-expressing 
astrocytes and Olig2-expressing oligodendrocytes (Plane et al., 2012; Hong et al., 2019). Hong et 
al. hypothesized that increased glial gene expression in the absence of PARP1 is caused by 
decreased neurogenesis due to reduced expression of Ascl1 and Ngn2, two crucial transcriptional 
regulators of neurogenesis (Hong et al., 2019). Similarly, Plane and colleagues hypothesized that 
PARP1 promotes neurogenesis by regulating Sox2 expression; thus, PARP1 loss disrupts 
neurogenesis and causes progenitor differentiation into glial subtypes (Plane et al., 2012). Here, 
we propose an additional mechanism for glial cell fate repression by PARP1. Specifically, via 
direct repression of GFAP expression through promoter modulation. As ErbB4-JMa expression 
declines at later stages of development (Fox and Kornblum, 2005), repression of GFAP by 
E4ICD and PARP1 would be released, allowing astrogenesis to occur. 
Intriguingly, a previous study found that PARP1 PARylates STAT3, a well-known 
transcription factor promoting astrogenesis (Bonni et al., 1997; Kamakura et al., 2004; Ding et 
al., 2019). They identified that PARP1 PARylation of STAT3 inhibits STAT3 phosphorylation 
and its ability to promote transcription, ultimately repressing the expression of PD-L1 in cancer 
cells (Ding et al., 2019). If this pathway is also active in NPCs, it may be an additional 
mechanism by which activated PARP1 represses GFAP expression during neurogenesis. By 
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suppressing STAT3 activity, STAT3 would be unable to bind to the GFAP promoter and 
promote transcription. However, further studies are needed to examine the interaction between 
PARP1 and STAT3 in neuronal cells. 
The GFAP promoter region has several sites where transcription factors bind to repress or 
promote its expression. Our data indicate that E4ICD and PARP1 bind to the region of the GFAP 
promoter where the Notch intracellular domain (NICD) has been suggested to bind. Similar to 
ErbB4, ligand binding to the Notch receptor induces its cleavage and the release of its 
intracellular domain. NICD then forms a complex with transcriptional activator CSL (also 
known as RBPJk), which directly binds to the GFAP promoter to activate transcription (Ge et al., 
2002).  N-CoR also complexes with CSL/RBPJk; however, binding of this complex to the GFAP 
promoter represses transcription (Hermanson et al., 2002). Given that E4ICD binds N-CoR, these 
findings suggest that N-CoR/CSL may facilitate E4ICD binding to the CSL/RBPJk binding site 
of the GFAP promoter. Therefore, our data indicate that E4ICD-PARP1 binding during 
neurogenesis may prevent NICD/CSL from binding to the promoter and activating GFAP 
transcription. However, future studies will be needed to ascertain whether E4ICD participates in 
reciprocal binding with NICD to regulate astrogenesis. 
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Figure 2.1 PARP1 interacts with E4ICD in a kinase-specific manner (A) Yeast 2 hybrid 
screen indicates that PARP1 interacts with a wild-type (WT), but not kinase dead (KD) LexA-
E4ICD construct. Blue coloration indicates interaction. Interaction between TAB2 and LexA-
E4ICD included as a positive control. (B) Mass spectometry analysis of proteins that bind LexA-
E4ICD shows large coverage of PARP1 amino acids (highlighted in red). (C) N2A cells 
transfected with WT LexA-E4ICD, but not KD LexA-E4ICD, show an interaction between 
E4ICD and PARP1. PY = phosphotyrosine. (D) PARP1 co-IP shows PARP1 binding to WT 
E4ICD in LexA-E4ICD-transfected N2A cells. (E) Only N2A cells transfected with cleavable 
ErbB4-JMa and treated with NRG1 demonstrate an interaction between ErbB4 and PARP1 via 
ErbB4 co-IP. (F) ErbB4 co-IP in mouse NPCs shows binding to PARP1 following NRG1 
treatment. (G) ErbB4 co-IP in E14.5 cortical lysates demonstrates an interaction between ErbB4 
and PARP1 in wild-type (WT) cortex, but not ErbB4 knockout (KO) cortex. (H) Inhibition of 
TACE with TAPI (100 µM) or presenilin/γ-secretase with DAPT (1 µM) 30 min prior to NRG1 
treatment (2 nM, 40 min.) prevents interaction between ErbB4 and PARP1 in N2A cells 
transfected with ErbB4-JMa. These experiments were performed by Pablo Sardi, Falak Sher, and 
Anna Kane. 
Figure 2.2 NRG1 treatment induces PARP1 PARylation in an E4ICD-specific manner (A) 
NRG1 (2 nM) treatment induces PARylation in a similar time frame as H2O2 (80 µM) in mouse 
NPCs. (B) Inhibition of TACE cleavage with TAPI (100 µM) or presenilin/γ-secretase cleavage 
with DAPT (1 µM) prevents NRG1-induced PARylation in ErbB4-JMa transfected N2A cells. 
TAPI nor DAPT prevent PARylation in H2O2 treated cells. NRG1 does not induce PARylation in 
ErbB4-JMb transfected N2A cells. (C) Western blotting for PARP1 shows increased PARylated 
PARP1 following NRG1 treatment in the absence of inhibitors of ErbB4 cleavage in mouse 









Figure 2.3 PARP1 DNA binding and enzymatic activity are necessary to repress CNTF-
induced GFAP promoter activity in rat NPCs (A) NRG1 (1 nM) pre-treatment represses 
CNTF (0.3 ng/mL)-induced GFAP promoter activity in rat NPCs transfected with WT PARP1-
expressing plasmids, but fails to repress GFAP promoter activity in rat NPCs transfected with 
PARP1 constructs with mutations in the DNA binding domain (C21G) or catalytic domain 
(E988A). PARP1 cleavage by caspase 3 is not necessary for NRG1-induced repression of GFAP 
as indicated by transfection with a PARP1 constructed with a mutated caspace 3 cleavage site 
(D214A). (B) Inhibition of PARP1 with 3-ABA prevents NRG1 from repressing CNTF-induced 
GFAP promoter activity in rat NPCs. (C) PARP1 and ErbB4 localize to the GFAP promoter, but 
not the Hes1 promoter, following NRG1 stimulation in rat NPCs as indicated by chromatin 
immunoprecipitation. Pre-treatment with DAPT to inhibit presenilin/γ-secretase prevents 
promoter localization. These experiments were completed by Pablo Sardi. 
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Figure 2.4 PARP1 and ErbB4 are necessary for NRG1-induced PARylation in mouse NPCs 
(A) 5 min NRG1 (2 nM) treatment increases PAR in WT but not ErbB4 KO mouse NPCs. 5 min 
H2O2 treatment (100 µM) included as positive control.  (B) PARP1 KO abolishes NRG1 and 
H2O2-induced PARylation in NPCs. Scale bar = 10 µM. n = 2 ErbB4 WT, n = 4 ErbB4 KO, n = 













Figure 2.5 ErbB4-JMa-/- mutant mice lack ErbB4-JMa and E4ICD expression (A) NPCs 
isolated from JMa-/- mouse cortex express ErbB4-JMb, but not ErbB4-JMa via RT-PCR with 
primers that span the ErbB4 juxtamembrane domain. (B) Enrichment of ErbB4 with ErbB4 
immunoprecipitation (IP) in mouse NPCs shows increased E4ICD following TACE stimulation 
with TPA treatment (100 ng/mL) for 45 min in WT, but not ErbB4 knockout (KO) or JMa-/- 
NPCs. (C) ErbB4 IP from adult cerebellar lysates shows presence of E4ICD in WT, but not KO 
or JMa-/- mice. (D) Quantification of E4ICD expression in cerebellar lysates in multiple 
replicates (n = 3 of each genotype). ***p < 0.001 by one-way ANOVA with multiple 






Figure 2.6 PARP1 and ErbB4-JMa are necessary for NRG1-induced repression of GFAP 
expression after FGF removal in mouse NPCs (A) Removal of FGF (20 ng/mL) from NPC 
media increases GFAP expression 100-500 fold after 24 hrs, while concurrent NRG1 (2 nM) 
treatment represses this increase in WT mouse NPCs. (B) PARP1 KO, ErbB4 KO, or ErbB4-
JMa loss abolish the ability of NRG1 to repress GFAP expression following FGF removal. 
Repression is specific to glial gene GFAP, as neuronal genes DCX and NeuN are unaffected by 
NRG1 treatment. Gene expression is normalized to reference gene GAPDH. *p < 0.05 by 
Wilcoxon test. (n = 7 WT, n = 7 PARP1 KO, n = 6 ErbB4 KO, and n = 7 JMa-/- independent 
cultures) (C) Knockdown of PARP1 in WT NPCs prior to FGF removal abolishes repression of 
GFAP expression by NRG1. *p < 0.05 by Wilcoxon test. Gene expression is normalized to 
reference gene GAPDH (D) NRG1 represses GFAP-promoter activity induced by FGF removal 
in WT NPCs. *p < 0.05 by Student’s paired t-test (n = 6 cultures). Relative GFAP-luciferase 
values were normalized with CMV-Renilla. (E) PARP1 inhibition with Olaparib at the indicated 
concentrations increases GFAP expression in WT NPCs. Gene expression is normalized to 








Figure 2.7 PARP1 or ErbB4 loss increase GFAP expression in the mouse cortex at birth. P0 
cortex isolated from ErbB4 KO or PARP1 KO mice overexpress GFAP relative to their 
respective WT controls. Gene expression is normalized to RPL19. *p < 0.05, ***p < 0.001 by 
Mann-Whitney test.
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Poly (ADP-ribose) Polymerase 1 (PARP1) is a ubiquitously expressed enzyme that plays 
roles in a variety of key biological processes, including DNA repair, inflammation, transcription, 
and programmed cell death (Kraus, 2008; Krishnakumar and Kraus, 2010b; Jubin et al., 2017). 
PARP1 exerts its functions by protein PARylation, a post-translational modification consisting of 
the covalent attachment of ADP-ribose polymers (PAR) to itself and other proteins using NAD+ 
as a substrate (Krishnakumar and Kraus, 2010b). Extensive evidence implicates PARP1 in a 
number of nervous system diseases, including neurodegenerative disorders (Mao and Zhang, 
2021), ischemic stroke (Endres et al., 1997; Chiarugi, 2005), glioma (Galia et al., 2012; Murnyák 
et al., 2017), epilepsy (Kim et al., 2014), traumatic brain injury (Stoica et al., 2014), and 
psychiatric disorders (Szebeni et al., 2016). Furthermore, pharmacological inhibition of PARP1 
in vivo causes defects in long-term memory (Goldberg et al., 2009), while complete loss of 
PARP1 causes impaired short-term memory formation (Hong et al., 2019). Additionally, adult 
PARP1 KO mice have a reduced brain weight, altered neuronal proliferation within the brain’s 
dentate gyrus (Plane et al., 2012) and subventricular zone (Hong et al., 2019), and display 
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schizophrenia-like behaviors, including defects in pre-pulse inhibition, decreased social 
interaction, and increased anxiety-like behaviors (Hong et al., 2019). Accordingly, human studies 
have linked mutations in genes affecting PARylation to episodic psychosis, intellectual 
disability, peripheral neuropathy, ataxia, and increased risk of stroke (Najmabadi et al., 2011; 
Danhauser et al., 2018; Meng et al., 2018; Durmus et al., 2021).  
Despite evidence that PARP1 dysregulation contributes to aberrant brain function and 
related disorders in humans and mice, very few studies have examined the roles of PARP1 in 
brain development.  It has been reported that PARP1 loss in mice causes enlarged ventricles at 
E14.5, increases cortical cell death at E16.5 and E18.5, and impairs the proliferation of neural 
stem cells derived from embryonic telencephalon (Hong et al., 2019). This study also found that 
PARP1  influences neural stem cell differentiation by repressing a glial cell fate in vitro (Hong et 
al., 2019). While it is apparent that loss of PARP1 has detrimental effects on brain development 
and function, little is known about its role in the regulation of neuronal migration and cortical 
patterning. Furthermore, no studies have yet assessed the effect of PARP1 loss on gene 
expression in the embryonic brain.  
Here, we show that PARP1 loss causes alterations in early-born neuron migration, 
decreases cortical thickness, and increases neuronal density in deeper cortical layers at birth. 
These changes are associated with increased Cajal-Retzius (CR) cell abundance and Reln mRNA 
levels in the PARP1 KO embryonic brain and neural progenitor cells (NPCs) derived from the 
embryonic mutant telencephalon. Accordingly, PARP1 KO NPCs show excess adhesion to N-
cadherin, likely through Reelin signaling. Additionally, RNA-sequencing of the PARP1 KO 
E15.5 cortex demonstrates that PARP1 loss increases expression levels of many genes associated 
with neuronal migration and adhesion during embryonic brain development. Taken together, our 
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findings uncover a new role for PARP1 in regulating CR cell development, neuronal migration, 
and cell adhesion.  
 
3.2 Materials and Methods 
3.2.1 PARP1 KO Mice 
The PARP1 KO mouse line 129S-Parp1tm1Zqw/J64 was obtained from the Jackson 
Laboratory and maintained on a 129S1/SvImJ background. All animals were kept under a 12/12 
hr light/dark cycle and allowed food ad libitum. Animal procedures were reviewed and approved 
by the University of Michigan Institutional Animal Care and Use Committee. Embryonic dating 
was performed with vaginal plugging denoted as embryonic day 0.5 (E0.5). Following vaginal 
plugging, females were separated and sacrificed at the indicated time points. 
3.2.2 Cell Culture and Treatments 
For primary NPC cell cultures, pregnant females were euthanized via cervical 
dislocation. Telencephalons were dissected from E14.5 embryos in ice-cold phosphate-buffered 
saline (PBS), meninges were removed, and cortices were dissociated into single cells with 
StemPro Accutase (ThermoFisher) for 5 min. NPCs were seeded as neurospheres in T75 flasks at 
500,000 cells/mL and expanded for 2 days in NPC media (DMEM with GlutaMAX, 1% 
penicillin/streptomycin, and 2% B27 without RA) supplemented with epidermal growth factor 
(EGF, 20 ng/mL) and basic fibroblast growth factor (bFGF, 20 ng/mL) in a humidified 5% 
CO2/95% air incubator at 37°C. Half of the media was changed every day, with replenishment of 
EGF and bFGF each day. On day 3, neurospheres were dissociated with Accutase into a single 
cell suspension and plated in NPC media supplemented with bFGF. Plates were pre-prepared by 
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incubating in Poly-L-Lysine (Sigma) 30 min or overnight followed by Fibronectin (1 µg/mL, 
Corning) for 2 hrs. Experiments on adherent NPCs were performed on day 2 after plating unless 
otherwise indicated.  
To inhibit PARP1 enzymatic activity, NPCs were treated with Olaparib (a gift of C. 
Brenner) at the indicated concentrations (30, 50, or 100 nM) for 48 hrs starting on day 1 
following plating. Half of the media was replenished each day, and cells were re-treated with 
Olaparib every 24 hrs. For Reelin-positive cell quantification, NPCs were plated on coverslips 
and treated with 50 nM Olaparib for 72 hrs. To test Olaparib efficacy, NPCs were pre-treated 
with 30, 50, or 100 nM Olaparib for 1 hr prior to 10 min treatment with 50 µM H2O2. To assess 
RNA stability, NPCs were treated with Actinomycin D (10 µg/mL) for 2 hrs or 4 hrs in the 
presence or absence of Olaparib (100 nM). HEK293T cells were maintained in DMEM with 
GlutaMAX, 1% penicillin/streptomycin, and 10% fetal bovine serum in a humidified 5% 
CO2/95% air incubator at 37°C. 
3.2.3 RNA-Sequencing and Analysis 
Pregnant females were euthanized via cervical dislocation. E15.5 embryos were placed in 
ice-cold PBS, brains were dissected, and the cortical hemispheres were isolated. The meninges 
and ganglionic eminences were removed from the cortex, and the tissue was stored in RNAlater 
(Invitrogen) until RNA extraction. RNA was extracted from wild-type (WT) and PARP1 KO 
dorsal cortex using the Qiagen RNeasy Mini Kit with on-column DNase digestion (Qiagen), then 
analyzed with a BioAnalyzer to measure RNA quality. RNA with RNA integrity numbers (RINs) 
greater than 8 were sequenced (n = 4 of each genotype). Non-strand specific polyA-selected 
cDNA libraries were prepared. Single-end sequencing was then completed with read lengths of 
50 nucleotides using an Illumina HiSeq-4000 Sequencing System. cDNA library preparation and 
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sequencing were carried out by the University of Michigan DNA Sequencing Core. Sequences 
were mapped to the mouse genome (mm9) using HISAT, transcript counts obtained with HTseq-
count, and differential gene expression analysis completed using DESeq2. All analysis was 
carried out with Galaxy (www.usegalaxy.org). The volcano plot was generated with RStudio. P-
values adjusted for multiple comparisons (q-value) < 0.05 indicated genes with statistically 
significant differences. Gene Ontology Analysis of dysregulated genes was performed using the 
Panther Classification system (www.pantherdb.org). Protein interaction analysis was completed 
using Cytoscape software. 
3.2.4 Immunofluorescence and Quantification 
Whole brains were dissected from E15.5 embryos or P0 pups in ice-cold PBS, fixed in 
4% paraformaldehyde (PFA) in 1x PBS for 24 hrs, cryoprotected in 30% sucrose, embedded in 
OCT Compound (Fisher), and snap frozen in isopentane on dry ice. Frozen brains were 
cryosectioned at a thickness of 14 µm onto Superfrost plus slides (Fisher). Sections were blocked 
in 5% Normal Goat Serum (Jackson ImmunoResearch) with 2% Triton in PBS for 1 hr, then 
incubated overnight at 4°C in primary antibody diluted in blocking buffer. The next day, sections 
were washed 3x in 1x PBS, incubated in corresponding Alexa-Fluor secondary antibodies 
(Invitrogen) diluted in blocking buffer (1:500) 1-2 hrs, and coverslipped with Fluoro-Gel II with 
DAPI (Electron Microscopy Services). Confocal z-stack images through the full depth of each 
section with a z-step of 2 µm were taken at a magnification of 20x or 40x with a Leica SP8 
confocal microscope. For each biological replicate, cells from 3 sections and 3 images per 
section were quantified by an individual blind to the genotype and averaged. Cell number and 
area quantification were completed using Fiji software.  
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For Reelin NPC immunostaining, NPCs were plated on round glass coverslips. On day 2 
after plating, coverslips were fixed in 4% PFA for 10 min, washed 3x in 1x PBS, then blocked in 
10% Normal Goat Serum (Jackson ImmunoResearch) with 0.2% Triton in PBS for 1 hr. 
Coverslips were then incubated in Reelin primary antibody overnight diluted in blocking buffer. 
Following 3 washes in 0.2% triton in PBS, coverslips were incubated in the corresponding 
Alexa-Fluor secondary antibody diluted in blocking buffer (1:500, Invitrogen) for 1-2 hrs, then 
mounted on slides with Fluoro-Gel II with DAPI (Electron Microscopy Services). For Reelin-
expressing cell quantification in WT and PARP1 KO NPCs, images of whole coverslips were 
taken with a Leica SP8 confocal at 20x magnification with image stitching. For quantification of 
Reelin-expressing cells after PARP1 inhibition with Olaparib (50 µM) or shRNA-mediated 
knockdown, images of whole coverslips were taken with a Nikon TE300 inverted fluorescent 
microscope equipped with Stereoinvestigator (MBF Bioscience), using the slide scan module. 
For each biological replicate, all Reelin-expressing cells from 3 coverslips were quantified and 
averaged. Quantification and mean fluorescence intensity analysis were completed using Fiji. 
The following primary antibodies and concentrations were used in this study: mouse anti-Reelin 
(1:500, clone G10, Millipore #MAB5364), rabbit anti-TBR1 (1:250, Abcam #ab31940), and rat 
anti-CTIP2 (1:500, Abcam #ab18465).  
3.2.5 Cresyl Violet Staining and Brain Volume Quantification 
WT and PARP1 KO littermates were sacrificed at birth, and their brains were dissected 
then fixed in 4% paraformaldehyde for 24 hrs. Brains were cryoprotected in 30% sucrose, 
embedded in OCT, then cryosectioned with a section thickness of 70 µm. Serial sections were 
stained with 0.5% cresyl violet using standard procedures. Slides were digitally scanned with the 
assistance of the University of Michigan In-Vivo Animal Core (IVAC), and surface areas of each 
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brain section were quantified with Fiji. To calculate the brain volume, the surface areas of each 
section were summed together and multiplied by the section thickness. Cortical surface area and 
thickness were quantified with Fiji.  
3.2.6 EdU Labeling in vivo 
Pregnant dams from PARP1 heterozygous crosses were injected intraperitoneally with 
EdU (50 mg/kg) at E13.5 or E15.5. Littermate P0 pups were transcardially perfused at birth with 
PBS followed by 4% PFA, then whole brains were dissected and postfixed in 4% PFA for 24 hrs. 
Brains were then either cryoprotected in 30% sucrose, embedded in OCT, and cryosectioned at a 
thickness of 20 µm or embedded in 4% agarose and sectioned on a vibratome at a thickness of 50 
µm. EdU was visualized using the Click-iT EdU Cell Proliferation Kit (Invitrogen), following 
the manufacturer’s protocol. Nuclei were counterstained with Hoechst 33342 (1:2000, 
Invitrogen). Slides were coverslipped using Aqua Poly/Mount (Polysciences). Confocal z-stack 
images through the full depth each section were taken at 20x magnification with a Leica SP8 
confocal microscope. Each image was separated vertically into 8 bins of equal size and the 
number of EdU positive cells within each bin was counted by an individual blind to the 
genotype. For each biological replicate, 3 sections and 3 images per section were quantified and 
averaged. Quantification was completed using Fiji. 
3.2.7 RNA Isolation and RT-qPCR 
RNA was isolated from the cortex after removal of meninges and ganglionic eminences 
or from cultured NPCs using a Qiagen RNeasy Kit or ThermoFisher PureLink RNA Mini Kit, 
following the manufacturer’s instructions. RNA extraction from tissue was completed with on-
column DNase digestion (Qiagen). Equal amounts of RNA (400 ng -1 µg) were reverse 
transcribed into cDNA using an iScript cDNA Synthesis Kit (Bio-Rad) following manufacturer’s 
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instructions. cDNA was diluted 5-fold for the PCR reaction. Quantitative PCR was performed 
using iTaq SYBR Green Supermix (Bio-Rad) with a Bio-Rad CFX96 Thermocycler. Each 
sample was run in duplicate. Each well of the 96-well plate contained 5 µL iTaq SYBR Green 
Supermix, 2.5 µL diluted cDNA, and 3 pmol of each forward and reverse primer. The cycling 
conditions were as follows:  95°C for 30 s followed by 39 cycles of 95°C for 5 s and 60°C for 30 
s. Normalized Gene Expression (NGE) was calculated using the efficiency of each primer with 
the following formula: [efficiency_target-CTtarget/efficiency_reference
-CT
ref]. Fold changes in 
mRNA level were then calculated relative to controls for each experiment. All primer sequences 
are in Table 1.   
3.2.8 shRNA-mediated PARP1 Knockdown 
Lentiviral packaging plasmids and scramble shRNA or Parp1 shRNA constructs were 
transfected into HEK 293T cells using Lipofectamine 3000 (Invitrogen). Lentiviral supernatants 
were collected and concentrated using Lenti-X Concentrator (Clontech) and titered with 
puromycin selection. To test the efficacy of PARP1 protein knockdown, NPCs were transduced 
with scramble or Parp1 shRNA-expressing lentivirus at multiplicity of infection (MOI) 2 for 48 
hrs. To assess the effects of PARP1 knockdown on gene expression, NPCs were transduced with 
scramble or Parp1 shRNA-expressing lentivirus at MOI 3 for 48 hrs, then media was replaced 
with fresh NPC media and cells were lysed 24 hrs later. bFGF (20 ng/mL) was supplemented 
every 24 hrs. Parp1 shRNA plasmid was obtained from Sigma (clone ID NM_007415.2-
3021s21c1) with the following sequence: 5’-
CCGGGAGTACATTGTCTACGACATTCTCGAGAATGTCGTAGACAATGTACTCTTTTT
G-3’. Lentiviral packaging plasmids and scramble shRNA plasmid were gifts of S. Iwase. 
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3.2.9 Luciferase Assay 
NPCs were co-transfected with a Reln-promoter luciferase construct that contained 2600 
bp upstream of the Reln transcription start site (Chen et al., 2002) (a gift of D. Grayson) and 
CMV-Renilla at a 50:1 ratio with Lipofectamine 3000. NPCs were treated with either Olaparib 
(100 nM) for 24 hrs or 48 hrs or Valproic Acid (VPA, 1 mM) for 12 hrs or 24 hrs. Luciferase 
activity was measured using a Dual-Luciferase Assay Kit (Promega), following the 
manufacturer’s instructions. Luciferase intensity was measured with a BioTek plate reader. Final 
values were obtained by normalizing firefly luciferase to Renilla luciferase. Technical replicates 
were obtained in triplicate. 
3.2.10 Western Blot 
For Reelin western blots, NPCs were lysed in RIPA buffer (Sigma) containing protease 
and phosphatase inhibitors. Equal amounts of protein were diluted in 4x Laemmli buffer with 
10% β-mercaptoethanol (BME) and run on 4-15% SDS polyacrylamide gels. For western 
blotting of conditioned media, protein concentrations were quantified, and equal amounts of 
protein were diluted in 4x Laemmli buffer with 10% BME and run on 6% SDS polyacrylamide 
gels. Reelin in conditioned media was normalized to GAPDH in corresponding cell lysates. Gels 
were transferred onto PVDF membranes overnight at 4°C (wet transfer at 40 mA). Blots were 
subsequently blocked in Intercept Blocking Buffer (Licor) (for Reelin) or 5% Bovine Serum 
Albumin (BSA) (for GAPDH), incubated in primary antibody for 3 hrs, washed in 0.2% tween in 
PBS, then incubated in HRP-conjugated secondary antibody (Cell Signaling Technology). For 
pDab1 and PARP1 western blot, samples were lysed in RIPA buffer (Sigma) containing protease 
and phosphatase inhibitors. For PAR western blot, PARG inhibitor (1 μM ADP-HPD) was also 
added to RIPA lysis buffer. Equal amounts of protein were diluted in 4x Laemmli buffer with 
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10% BME and run on 7.5% or 8% SDS polyacrylamide gels, then transferred for 1.5 hrs onto 
PVDF membrane with a semi-dry transfer unit. Blots were then blocked in 5% BSA and 
immunoblotted for primary antibody overnight. The next day, blots were washed in 0.2% tween 
in PBS, then incubated in HRP-conjugated secondary antibody (Cell Signaling Technology). All 
blots were exposed with Pierce ECL Chemiluminescent Substrate and imaged on a BioRad 
Chemidoc. 
The following primary antibodies and concentrations were used: mouse anti-Reelin 
(1:2000, Millipore #MAB5364), mouse anti-PAR (1:1000, Trevigen #4335), mouse anti-
GAPDH (1:2000, ThermoFisher #MA5-15738), rabbit anti-PARP1 (1:2000, Cell Signaling 
Technology #9532) and rabbit anti-pDab1 (1:1000, Cell Signaling Technology #3325). For all 
antibodies used, linearity was assessed, and the amount of total protein loaded onto gels was 
within the linear range of the antibody. Band densities were quantified using Image Lab software 
(Bio-Rad) and normalized to internal control GAPDH. 
3.2.11 Reelin Conditioned Media 
HEK 293T cells were transfected with pcDNA3 or Reelin ORF (10 kb)-expressing 
plasmids (D’Arcangelo et al., 1997) (Addgene plasmid #122443) with Lipofectamine 3000 
(Invitrogen). 24 hrs after transfection, media was replaced with serum-free media. 24 hrs later, 
conditioned media was collected and stored at -80°C. For pDab1 induction, NPCs were treated 
with 200 or 400 µL conditioned media for 10 min.  Conditioned media from WT and KO NPCs 
was collected from adherent cultures 48 hrs after plating. For induction of pDab1, protein 
secretion was blocked by pre-treating NPCs with Brefeldin A (BFA, 0.75 µg/mL, Sigma) for 3 
hrs. NPCs were then treated with 2 mL conditioned media from wild-type NPCs (supplemented 
with 0.75 µg/mL BFA) for 20 min. 
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3.2.12 Chromatin Immunoprecipitation 
PARP1 chromatin immunoprecipitation was carried out using a SimpleChIP Plus 
Enzymatic Chromatin IP Kit with magnetic beads (Cell Signaling Technology, #9005), 
following the manufacturer's instructions. 2 µg of each antibody was incubated with magnetic 
beads overnight, and 0.5 µL micrococcal nuclease was used per sample to digest chromatin. The 
following antibodies were used: rabbit anti-PARP1 (Cell Signaling Technology, #9532S), rabbit 
anti-Histone H3 (CST #4620), and normal rabbit IgG (CST #2729). Primer sequences are 
indicated in Table 3.2. 
3.2.13 RNA Immunoprecipitation 
RNA immunoprecipitation was completed as described previously (Dahm et al., 2012) 
with the lysate pre-clearing step. Briefly, NPCs were lysed in passive lysis buffer containing 
protease, phosphatase, and RNAse inhibitors. Pre-swelled Protein A Sepharose beads were 
incubated with 30 µg rabbit anti-PARP1 antibody (CST #9532S) overnight at 4°C. Following 5 
washes in NT2 buffer, beads were resuspended in RNAse inhibitors and 1 mg NPC lysate, 
incubating at room temperature for 2.5 hours. Following 5 washes in NT2 buffer, beads were 
resuspended in RNase-free DNase and incubated at 37°C for 10 min. Beads were then 
resuspended in proteinase K at 55°C for 30 min to release ribonucleoprotein complexes. Beads 
were pelleted, and the supernatant was collected. RNA was then isolated from the supernatant 
via phenol-chloroform extraction, eluting in 11 µL H2O per sample. 10 µL RNA was reverse 
transcribed using the iScript cDNA synthesis kit in a 20 µL reaction volume. Quantitative PCR 
for the Reln transcript was completed in 50 µL reaction volume with 20 µL cDNA, 25 µL iTaq 
SYBR green, 1.5 µL of each forward and reverse primer (10 µM stock), and 2 µL H2O with 
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standard iTaq qPCR cycling parameters for 40 cycles. Primer sequences are indicated in Table 
3.1. Fold enrichment was quantified relative to rabbit IgG control antibody. 
3.2.14 Atomic Force Microscopy (AFM) 
AFM force-distance (F-D) measurements were performed using a TT-AFM (AFM 
Workshop, South Carolina, USA) using contact mode AFM probes of 0.2 N/m nominal stiffness 
(PPP-CONTAuD from Nanosensors).  Probes were functionalized by incubating the tip 
overnight at 4°C in 100 µg/mL N-cadherin.  Immediately prior to measurements, probes were 
rinsed 4x in PBS.  Probe stiffness was determined by the Sader method in air (Sader, 1998).  The 
optical lever sensitivity was determined in fluid for each sample using the thermal noise method 
(Heim et al., 2004; Hutter, 2005). 
Cells were cultured on round glass coverslips.  Approximately 30 min prior to the 
beginning of measurements, a cell-coated coverslip was epoxied to an AFM stub and transferred 
to a fluid AFM imaging chamber with NPC media containing 10 mM HEPES and bFGF (20 
ng/mL) and maintained at 37°C throughout measurements, which were taken within 
approximately 1 hr for each sample.  For conditioned media treatment, cells were treated with 
control or Reelin conditioned media for 30 min prior to the beginning of measurements. For each 
F-D measurement, the probe was engaged with the surface with approximately 9 nN force for 5 s 
before retracting at a rate of 2000 nm/s.  F-D curves were evaluated using a custom Matlab script 
to objectively parse the maximum adhesion force developed, the adhesive force for stepwise 
detachments, and integrated work performed for each trace. These experiments were completed 
in collaboration with the Single Molecule Analysis in Real-Time (SMART) Center at the 
University of Michigan. Statistical outliers were excluded from the datasets (<Q1-
1.5*interquartile range (IQR) or >Q3+1.5*IQR). Statistical significance in average values was 
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assessed via Mann-Whitney analysis and differences in histogram distributions were assessed 
with a Kolmogorov-Smirnov test. 
3.2.15 Statistics 
All statistical analyses were performed using GraphPad Prism version 7.0, except for 
two-way ANOVA analysis of litter size, genotype, and P0 brain weight, which was performed 
using SAS in collaboration with the University of Michigan Center for Cancer Biostatistics. Bars 
for each of the graphs represent mean ± standard error of the mean. Legends for each figure 
contain statistical tests performed, number of biological replicates, and specific significance 
values. 
3.3 Results 
3.3.1 PARP1 KO mice have brain development defects 
Previous studies reported that brain size is reduced in PARP1 KO mice from P11 to 
adulthood (Plane et al., 2012; Hong et al., 2019). We now find that both body and brain weights 
are smaller in PARP1 KO mice at birth (Figure 3.1A,B), but that brain weight is reduced to a 
larger relative extent than the mass of the entire body (Figure 3.1C). While there is an inverse 
correlation between litter size and brain weight in wild-type mice, two-way ANOVA analysis 
showed no significant interaction between genotype and litter size (Figure 3.1D), indicating that 
decreased brain weight in PARP1 KO animals is driven exclusively by genotype. To assess 
whether decreased brain weight is due to a reduction in brain size in a specific area, we collected 
serial coronal sections from WT and PARP1 KO P0 brains, measuring the surface area of each 
section on the rostral-caudal axis. We found that the surface area of PARP1 KO brain sections 
tends to be smaller than their WT littermates at each level along the rostral-caudal axis, 
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indicating that brain size is reduced overall rather than in a specific area (Figure 3.1E). This 
corresponds with a reduction in brain volume in PARP1 KO animals (Figure 3.1F). Finally, we 
found that decreased brain size in PARP1 KO mice is associated with a reduced cortical surface 
area and thickness (Figure 3.1G-I). 
These findings suggest that PARP1 loss alters brain development. One of the key events 
in brain formation is neuronal migration, the process by which newborn neurons reach their final 
destinations in the cortex (Valiente and Marín, 2010). During mouse brain development, 
neurogenesis begins near E11.5 and concludes around E17.5 (Guillemot, 2005). To determine if 
the migration of early-born neurons is affected by the loss of PARP1, we injected EdU at E13.5 
and analyzed the distribution of the labeled cells at birth. PARP1 loss leads to a decreased 
number of early-born neurons in the deepest portion of the cortex (Figure 3.2A,B) without 
altering the total number of EdU-positive cells (Figure 3.2C). In contrast, we found no 
differences in the position of neurons born at E15.5 (data not shown). Similar to previous, we 
observed a reduction in cortical thickness in PARP1 KO animals (Figure 3.2D). To further 
characterize the impact of PARP1 KO on cortical development, we immunostained brains at 
birth for markers of layer V and VI neurons (CTIP2 and TBR1, respectively) (Figure 3.2E). We 
found that PARP1 loss increases neuronal density but decreases the surface area each layer 
occupies, resulting in a normal number of more densely packed cells (Figure 3.2F-H). Together, 
these results suggest that reduced brain weight in PARP1 KO mice reflects altered neuronal 
migration, decreased cortical thickness, and increased cell density. 
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3.3.2 Loss of PARP1 increases the expression levels of genes associated with cell migration 
and adhesion in the E15.5 cortex  
To gain insights into the mechanisms through which loss of PARP1 affects brain 
development, we performed RNA-sequencing of the E15.5 wild-type and KO cortex and 
identified 48 genes whose levels are significantly altered by PARP1 loss-of-function. 
Remarkably, in contrast to reports that PARP1 promotes transcription in neuronal cells (Tapia-
Páez et al., 2008; Hau et al., 2017; Azad et al., 2018), most of the changes in expression in the 
brains of PARP1 KOs reflect increases in mRNA levels (Figure 3.3A). RT-qPCR validated the 
altered expression of Reln, Nav1, Tnc, and Txnip in the embryonic cortex (Figure 3.3B). 
Furthermore, a subset of these genes (Tnc and Reln) continue to be increased to a similar extent 
in the P0 cortex of PARP1 KO mice (data not shown). The genes altered by PARP1 loss encode 
proteins involved in various processes, with a particular enrichment for cell adhesion, axon 
development, dendrite development/morphogenesis, and cell migration (Table 3.3). Similarly, 
molecular interaction network analysis of the differentially expressed genes suggested direct 
interactions among proteins which comprise parts of the brain extracellular matrix (ECM) 
(Figure 3.3C), an important component in the regulation of neuronal migration and lamination 
(Franco and Müller, 2011). These include Laminins (Lamb1, Lama2, and Lamc1), Reelin (Reln), 
Tenascin C (Tnc), Versican (Vcan), and Phosphacan (Ptprz1). These proteins in turn interact 
with Collagen Type XII Alpha 1 Chain (Col12a1) and several cell adhesion molecules (Astn1, 
Nrcam, and Dscaml1). Taken together, these findings suggest that the brain defects in neonatal 
PARP1 KO mice could result from alterations in ECM function.  
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3.3.3 Loss of PARP1 results in an increased number of Cajal-Retzius cells in the cortex  
Reln encodes the glycoprotein Reelin, which is specifically expressed by CR cells within 
the developing brain’s marginal zone (Ogawa et al., 1995). Reelin is critical for cortical layering 
and neuronal migration, and mice lacking Reelin (known as Reeler) have severely malformed 
brains and die prematurely (Meier and Hoag, 1962; Hamburgh, 1963; Goffinet et al., 1984). 
Quantification of Reelin-expressing cells in the E15.5 brain revealed an increased number of CR 
cells along the marginal zone and a reduction in marginal zone area per field in PARP1 KO 
brains, resulting in increased density of CR cells within the marginal zone (Figure 3.4A-D), 
suggesting that PARP1 regulates the abundance of CR cells in the embryonic brain. To test if the 
number of CR cells is increased through the entire process of embryonic neurodevelopment, we 
immunostained P5 brains for Reelin, finding a similar increase in the abundance and density of 
CR cells (Figure 3.4E-H). 
3.3.4 Loss of PARP1 increases levels of genes expressed by CR cells and Reelin protein in 
NPCs 
To interrogate the mechanism by which PARP1 regulates CR cell numbers, we analyzed 
telencephalon-derived NPCs in culture. RT-qPCR demonstrated that neurospheres and adherent 
NPCs from PARP1 KO mice have increased mRNA levels of several genes expressed by CR 
cells, including Reln, the Trp73 isoforms TAp73 and ΔNp73, as well as Car10 and Calb2 
(Yamazaki et al., 2004) (Figure 3.5A, B). Moreover, acute PARP1 knockdown in wild-type 
adherent NPCs using Parp1 shRNA expressing lentivirus (Figure 3.5C) led to a significant 
increase in Reln, Calb2, and Car10, with a trend of increased Trp73 isoforms (Figure 3.5D). 
Furthermore, treatment with the PARP1 inhibitor Olaparib, which blocks PARylation (Figure 
3.5E), had similar effects on the expression of Reln, Car10, and Calb2 in wild-type NPCs 
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(Figure 3.5F). These results indicate that PARP1 PARylation influences the mRNA levels of 
genes expressed by CR cells. 
Reelin is proteolytically cleaved at three sites, resulting in multiple protein fragments 
(Lambert de Rouvroit et al., 1999; Krstic et al., 2012) (Figure 3.6A). CR cells regulate neuronal 
migration in part through secretion of Reelin, which binds to its receptors Apolipoprotein E 
Receptor 2 (ApoER2) and Very Low Density Lipoprotein Receptor (VLDLR) on nearby 
migrating neurons (Hirota and Nakajima, 2017). Full-length Reelin is hypothesized to be the 
most catalytically active, whereas N-terminal (N-t) cleavage (Kohno et al., 2009; Ogino et al., 
2017) and loss of the C-terminal region of Reelin (Nakano et al., 2007; Kohno et al., 2015) 
reduce its catalytic activity. To identify the Reelin fragments expressed in NPC cultures, we 
immunoblotted NPC lysates and conditioned media for Reelin using an N-terminal antibody. 
Analysis of cell lysates demonstrated a significant upregulation in the 430 kDa full-length Reelin 
and the 160 kDa NR2 fragment in PARP1 KO NPCs (Figure 3.6B,C). Similarly, western blotting 
of conditioned media collected from NPCs showed increased immunoreactivity for the full 
length Reelin and the NR6 and NR2 fragments, indicating increased Reelin secretion in PARP1 
KO NPC cultures (Figure 3.6D,E). Importantly, similar to the effects of medium conditioned by 
HEK293T cells transfected with a Reelin expression plasmid (Figure 3.7A,B), NPC conditioned 
medium induced Dab1 tyrosine phosphorylation (Figure 3.7C), a key component of the 
intracellular signaling cascades initiated by Reelin (Hiesberger et al., 1999; Lambert de Rouvroit 
et al., 1999), indicating that NPCs secrete active Reelin. Furthermore, the state of Dab1 
phosphorylation in NPCs was reduced when cells were incubated with Brefeldin A (BFA) to 
block protein secretion (Figure 3.7C), indicating that the Reelin acts in a paracrine or autocrine 
fashion in NPC cultures.  
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3.3.5 PARP1 loss of function increases CR cell abundance in NPC cultures  
To explore if the changes in Reelin levels in tissue culture reflect differences in levels of 
Reelin expression per cell or, alternatively, in the number of Reelin expressing cells, we 
immunostained adherent NPCs for Reelin. Cultures of PARP1 KO NPCs contained a higher 
proportion of Reelin-positive cells without changes in the intensity of Reelin staining per cell 
(Figure 3.8A-C). Similarly, shRNA-mediated PARP1 knockdown and pharmacological PARP1 
inhibition increased the proportion of Reelin-positive cells in wild-type NPC cultures (Figure 
3.8D,E). These results suggest that PARP1 and its enzymatic function are critical for regulating 
CR-like cell abundance in vitro rather than having a direct transcriptional effect on gene 
expression in existing CR cells. This finding is consistent with results from in situ hybridization 
showing that the number of Reln transcripts per CR cell in the E15.5 brain is not altered after 
PARP1 loss (data not shown). Mechanistically, this finding is further supported by the 
observation that the activity of a firefly luciferase Reln promoter reporter construct (Chen et al., 
2002) transfected into wild-type NPCs is not altered by PARP1 inhibition (Figure 3.9A). In 
addition, we observed no alteration in Reln mRNA stability in PARP1 KO NPCs (Figure 3.9B) 
and found no evidence of PARP1 binding to the Reln gene or its mRNA via chromatin or RNA 
immunoprecipitation, respectively (Figure 3.9C or data not shown). Together, these results 
suggest that PARP1 regulates the abundance of Reelin-expressing cells in vivo and in vitro and 
that this function of PARP1 is not mediated by direct transcriptional regulation of the Reln gene. 
3.3.6 PARP1 loss increases NPC adhesiveness to N-cadherin 
To test if the increased levels of Reelin present in media conditioned by PARP1 KO 
NPCs has functional consequences, we focused on cell adhesion since a prior study showed that 
Reelin increases neuronal adhesion to N-cadherin using atomic force microscopy (AFM)  
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(Matsunaga et al., 2017). Using a similar approach (Figure 3.10A), we found that treatment with 
medium conditioned by Reelin-transfected HEK293T cells increases adhesion of N-cadherin in 
wild-type NPCs (Figure 3.10B-D). Furthermore, we found that adhesion to N-cadherin is 
increased in PARP1 KO NPCs (Figure 3.11), suggesting that the increased Reelin levels alter the 
adhesive state of PARP1 KO cells. 
3.4 Discussion 
Our findings uncover a new role for PARP1, i.e., the regulation of CR cell development. 
Loss of PARP1 leads to increases in the number of Reelin-expressing cells in the cortex in vivo 
and cultured NPCs. While relative increases in Reln transcript levels were demonstrated in bulk 
RNA from the brain of PARP1 KOs, we did not detect any effects of PARP1 loss-of-function on 
Reln transcript levels per CR cell in vivo or identify any evidence of PARP1 binding to the Reln 
gene or its mRNA to directly influence Reln transcription in cultured cells. These results suggest 
that PARP1 influences CR cell generation rather than more directly impacting the expression of 
CR cell genes. The mechanism by which this occurs is unclear, but the overabundance of CR 
cells in PARP1 KO brains at E15.5, together with the fact that these cells do not undergo 
programmed cell death until P8 in wild-type mice (del Río et al., 1995), indicate that PARP1 
does not influence the number of CR cells by regulating the time-course of apoptosis. A potential 
mechanism by which PARP1 could regulate CR cell generation is through miRNAs. PARP1 has 
been shown to regulate the expression of many miRNAs (Chacon-Cabrera et al., 2015; Nozaki et 
al., 2018; Wang et al., 2019). Additionally, disruption of miRNA biogenesis through Dicer 
depletion in Nestin-expressing cells causes a similar increase in CR cell abundance and Reln 
expression (McLoughlin et al., 2012). Similar to findings in PARP1 KOs (Hong et al., 2019), 
McLoughlin et al. reported that Dicer depletion reduces cell proliferation and increases apoptosis 
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in the E15.5 cortex. Further studies will be necessary to test the links between PARP1, miRNAs, 
and CR cell generation. 
In contrast to PARP1 KOs, in which we found the number of Reelin-positive cells to be 
increased in the marginal zone, its normal site of expression, previous studies explored the 
effects of ectopic Reelin expression during embryonic development. The Nakajima group tested 
the effects of ectopic Reelin expression in deeper cortical layers using in utero electroporation of 
a Reelin-expressing plasmid into the lateral ventricle of E14.5 embryos (Kubo et al., 2010; 
Matsunaga et al., 2017). In line with our findings that Reelin overexpression is associated with 
increased NPC adhesion, this ectopic Reelin expression induced the formation of aberrant 
neuronal aggregates that appeared to be mediated by N-cadherin-dependent neuronal adhesion. 
In a transgenic mouse line with Nestin-driven Reelin expression, ectopic Reelin expression in 
ventricular and subventricular zone NPCs was shown to increase NPC proliferation, possibly 
through alterations in Notch signaling, and to result in an increased number of TBR1, TBR2, and 
CTIP2-positive neurons (Lakoma et al., 2011). These findings contrast with previous 
observations in PARP1 KOs of decreased NPC proliferation (Hong et al., 2019) and our 
observation of increased TBR1 and CTIP2-positive neuronal density without changes in cell 
number. Taken together, these findings highlight the different consequences that Reelin 
overexpression has on brain development depending upon the timing, location, and nature of its 
overexpression.   
Reelin influences cell migration in part through regulating cell adhesion via integrin 
(Sekine et al., 2012), L1 (Lutz et al., 2017), Nectins (Gil-Sanz et al., 2013), and N-cadherin 
(Franco et al., 2011; Matsunaga et al., 2017). In accordance with this, we found that Reelin 
treatment and PARP1 loss increase NPC adhesiveness to N-cadherin. Loss of PARP1 also 
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increases the expression of other cell adhesion molecules in the embryonic brain, including 
Nrcam, Dscaml1, and Astn1. In line with reports that cell adhesion molecules are critical for 
normal neuronal migration (Valiente and Marín, 2010; Franco et al., 2011; Gärtner et al., 2012; 
Hirota and Nakajima, 2017; Mitsogiannis et al., 2021), the likely increase in cellular adhesion in 
the PARP1 KO cortex is associated with the increased neuronal density and decreased number of 
early-born neurons in the deeper layers of the brain. Interestingly, alterations in Reelin 
expression (Liu et al., 2001; Niu et al., 2008), cellular adhesion complex function (Seong et al., 
2015), and neuronal density (Selemon and Goldman-Rakic, 1999) have all been previously 
associated with changes in dendritic arborization, and our findings indicate that PARP1 loss 
alters the expression of genes that are important for regulating dendritic development and 
morphology. Together, these findings indicate a possible connection between cellular adhesion, 
neuronal density, and dendritic morphology. Further studies will be needed to explore the 
mechanistic links between these findings and PARP1 function. 
PARP1 KO mice display endophenotypes associated with Schizophrenia (Hong et al., 
2019), and mutations in genes affecting PARylation have been linked to intellectual disability 
and episodic psychosis in humans (Najmabadi et al., 2011; Durmus et al., 2021). Likewise, 
defects in neurodevelopment and altered Reelin expression have been associated with 
schizophrenia and other neuropsychiatric disorders (Ayhan et al., 2011; Folsom and Fatemi, 
2013; Muraki and Tanigaki, 2015). These observations raise the possibility that the brain 
development defects and schizophrenia-like behaviors in PARP1 KO mice may be a 
consequence of increased CR cell abundance. Intriguingly, both neuropsychiatric disorders 
(Selemon et al., 1998; Selemon and Goldman-Rakic, 1999; Chana et al., 2003) and reduced 
Reelin expression (Liu et al., 2001) have been associated with increased neuronal density in 
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deeper layers of the cortex, similar to our findings in PARP1 KO mice. Together, these findings 
suggest that the regulation of Reelin expression during embryogenesis is critical for normal 
development, and slight increases or decreases in Reelin levels or patterns of expression might 
impact brain development in ways that lead to neuropsychiatric disorders. 
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Figure 3.1 Loss of PARP1 results in reduced brain weight and cortical surface area at 
birth. (A) Brain weight of wild-type (WT) (n = 28), PARP1 Heterozygous (Het) (n = 22), and 
PARP1 KO mice (n = 39) at birth (P0) shows a reduction in Het and KO mice compared with 
WT controls. ***p = 0.006; ****p < 0.0001 by Student’s unpaired t-test. (B) P0 body weight is 
reduced in KO mice compared to WT and Het animals. *p = 0.0315 by Student’s unpaired t-test. 
(C) The ratio of brain to body weight for each group shows a significant reduction in the relative 
size of KO brains compared to WT. **p = 0.0099 by Student’s unpaired t-test. (D) Litter size is 
inversely correlated with P0 brain weight in mice. WT: R2 = 0.811, p < 0.0001; KO: R2 = 
0.3725, p = 0.0043. p-values indicate the significance of correlation within each genotype. 
Slopes are significantly different (p = 0.0029). Two-way ANOVA analysis indicated no 
significant interaction between litter size and genotype (p = 0.249). (E) Surface area 
measurement from rostral to caudal portions of the PARP1 KO brain indicates a reduced size 
throughout the rostral-caudal brain axis. The section designated as bregma is indicated in the 
inset. Distance from bregma for the remaining sections is estimated. ****p <0.0001 via two-way 
ANOVA. (F) Brain volume is reduced in PARP1 KO mice. (G) Representative image showing 
reduced brain surface area in PARP1 KO mouse. This section corresponds with bregma 1.045 
mm in the adult brain. Scale bar = 1 mm. (H) PARP1 KO reduces cortical surface area and (I) 
cortical thickness. *p <0.05; ****p < 0.0001 by Student’s unpaired t-test. Quantification shown 
represents brain slices corresponding with bregma 1.045 mm in the adult mouse brain. (E-I) n = 





Figure 3.2 PARP1 KO mice have defects in cortical development. (A) Representative images 
of coronal cortical sections at P0 of mice in which proliferating cells (green) were labeled by 
injecting EdU (IP, 50 mg/kg) to the dam at day 13.5 of pregnancy. Nuclei were labeled with 
Hoechst 33342 (blue). Scale bar = 50 µm. The cortex was subdivided into 8 bins of equal size for 
quantification. (B) PARP1 loss decreases the number of EdU+ cells in the deepest portion of the 
cortex (bin #1) (n = 3 animals per genotype from 2 litters, average of 3 sections in the 
somatosensory cortex region per animal, and 3 images per section).  **p = 0.003 by Student’s 
unpaired t-test. (C) The number of EdU+ cells per field in KO animals does not change. (D) 
Cortical thickness is decreased in KO P0 brains. ***p = 0.005 by Student’s unpaired t-test. (E) 
Representative images from CTIP2+ (red, layer V) and TBR1+ (white, layer VI) cells in the 
cortex of P0 mice. Nuclei were labeled with DAPI (blue). Scale bar = 50 µm. (F) The density of 
CTIP2+ and TBR1+ cells is increased in KO P0 brains. ***p = 0.0002 by Student’s unpaired t-
test. (G) The area of TBR1 and CTIP2-expressing cells per field is decreased in KO P0 brains. 
*p = 0.0498 and **p = 0.0026 by Student’s unpaired t-test. (H) The number of TBR1 and CTIP2 
positive cells per field in P0 brains does not differ between genotypes. (E-H) n = 4 WT and 3 
KO animals from 2 litters, average of 3 sections in the somatosensory cortex region per animal, 









Figure 3.3 Expression levels of genes associated with neuronal migration and cell adhesion 
are increased at E15.5 in the cortex of PARP1 KOs. (A) Volcano plot of the differentially 
expressed genes in the PARP1 KO cortex at E15.5 identified by RNA-sequencing (n = 4 
biological replicates per genotype). Genes with significantly altered expression are indicated in 
blue (q-value < 0.05). Upregulated genes comprised 88% (42/48 total) of all genes exhibiting 
significant differential expression in KO embryonic cortex. (B) RT-qPCR validation of a subset 
of differentially expressed genes (n = 6 of each genotype). Levels of target mRNAs were 
normalized to β-actin levels. **p < 0.01; ***p < 0.001; ****p < 0.0001 by Student’s unpaired t-
test. (C) Interactions among proteins encoded by differentially expressed genes were identified 
with Cytoscape software based upon bioinformatic prediction (orange lines), co-localization 
(blue lines), or physical interaction (purple lines). Proteins involved in the extracellular matrix 




Figure 3.4 Loss of PARP1 increases the number of Cajal-Retzius cells in the E15.5 and P5 
cortex. (A) Representative images of coronal sections of brain cortex from E15.5 WT and 
PARP1 KO embryos following Reelin immunostaining (red). Nuclei are labeled with DAPI 
(blue). Scale bar = 20 µm. Marginal zone (MZ), cortical plate (CP), subplate (SP), and 
intermediate zone (IZ) are labeled. (B) The number of Reelin-expressing cells along the 
marginal zone is increased, (C) marginal zone surface area is decreased, and (D) Reelin+ cell 
density is increased in the KO E15.5 brain (n = 4 for each genotype from 7 litters, 3 sections per 
animal including rostral, medial, and caudal regions, and 3 images per section). **p < 0.01 by 
Student’s unpaired t-test. (E) Representative images of coronal sections of cortex from P5 WT 
and PARP1 KO embryos showing Reelin immunostaining in red. Nuclei are labeled with DAPI 
(blue). Scale bar = 50 µm. (F) The number of Reelin-expressing cells in layer I is increased, (G) 
surface area of layer I (LI) shows a decreasing trend, and (H) density of Reelin-expressing cells 
in layer I is increased in the P5 KO brain (n = 4 WT and 5 KO from 8 litters, 3 sections per 
animal from rostral, medial, and caudal brain regions, and 3 images per section). *p < 0.05 and 
**p <0.01 by Student’s unpaired t-test. p = 0.15 for P5 LI surface area. 
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Figure 3.5 PARP1 loss by KO, shRNA knockdown, or pharmacological inhibition increases 
mRNA levels of genes expressed by Cajal-Retzius cells. (A,B) Quantitative RT-PCR for genes 
expressed by CR cells in neurospheres (A) and adherent NPCs (B) from WT and KO cultures (n 
= 6 of each genotype) demonstrate increased expression of genes expressed by CR cells. Target 
mRNA levels were normalized to Rpl19. *p < 0.05; **p < 0.01; ***p < 0.001 by Student’s 
unpaired t-test. Relative WT versus KO expression of TAp73 in (A) is p = 0.06 and of ΔNp73 in 
(B) is p = 0.01. (C) Parp1 transcript (left) and protein (right) levels are substantially reduced 
following transduction of wild-type NPCs with Parp1 shRNA expressing lentivirus. Fold change 
in transcript levels was calculated relative to scramble (scr) shRNA control (n = 7). Parp1 
expression was normalized to Gapdh. *p = 0.0156 by Wilcoxon test. (D) mRNA transcripts 
expressed by CR cells are increased after wild-type NPC transduction with Parp1 shRNA-
expressing lentivirus (MOI 3) for 72 hrs. Gene expression was normalized to Gapdh. Fold 
change relative to scramble (scr) shRNA-transduced NPCs is plotted (n = 6); ΔNp73 and TAp73: 
p = 0.06; *p = 0.0313 by Wilcoxon test. (E) PAR western blot of wild-type NPCs after Olaparib 
pre-treatment (at indicated concentrations) for 1 hr followed by 10 min H2O2 treatment (50 µM) 
shows that Olaparib inhibits H2O2-induced PARylation. (F) Olaparib-mediated inhibition of 
PARP1 in wild-type NPCs for 48 hrs increases mRNA levels of genes expressed by CR cells. 
Gene expression was normalized to Rpl19. Fold changes were calculated relative to DMSO 
control treated cells (n = 7-8). Reln (30 nM): p = 0.056; *p < 0.05; **p < 0.01; ***p <0.001 by 
repeated measures one-way ANOVA. 
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Figure 3.6 PARP1 KO NPC cultures overexpress Reelin protein. (A) Schematic drawing of 
Reelin depicting its proteolytic cleavage sites (vertical dotted lines) and the site of recognition 
for the N-terminal clone G10 Reelin antibody. This antibody recognizes full-length (FL) Reelin 
as well as the NR6 and NR2 Reelin fragments. (B) Reelin western blot from WT and PARP1 KO 
NPC lysates shows increased Reelin protein in KO NPC cultures. Arrows indicate the FL, NR2, 
and NR6 fragments. (C) Quantification of relative band density of FL Reelin, the NR2 fragment, 
and the NR6 fragment normalized to GAPDH (n = 6). NR6: p = 0.24; *p = 0.026; **p = 0.0087 
by Mann-Whitney test. (D) Western blot for Reelin in conditioned media (CM) and GAPDH in 
cell lysates of WT and KO NPCs. (E) Quantification of band densities of FL Reelin, NR2, and 
NR6 fragments normalized to GAPDH in cell lysates (n = 6 separate cultures) indicate increased 
Reelin present in media conditioned by KO NPC cultures. *p < 0.05; **p < 0.01 by Mann-




Figure 3.7 Reelin induces Dab1 phosphorylation in NPCs. (A) Western blot of medium 
conditioned by HEK293T cells transfected with a Reelin-expressing plasmid or empty vector 
(pcDNA3) and their cell lysates indicates expression and secretion of Reelin. Lysates and 
conditioned medium (CM) were collected 24 hrs after transfection. Arrows indicate full-length 
(FL) Reelin and NR2 and NR6 fragments. (B) WT NPCs treated with 200 µL (+) or 400 µL (++) 
conditioned medium (CM) from Reelin-transfected HEK293T cells for 10 min have increased 
Dab1 phosphorylation (pDab1). (C) 20 min treatment with CM from WT NPC cultures increases 
Dab1 phosphorylation in WT NPCs (n = 4 separate cultures). Pretreatment with Brefeldin A 
(BFA, 0.75 µg/mL) for 3 hrs prior to CM treatment reduces Dab1 phosphorylation in WT NPCs, 
indicating that the state of Dab1 phosphorylation depends on the ability of cells to secrete 
proteins. Addition of BFA to CM after harvesting does not affect pDab1 induction. Relative band 
density was normalized to GAPDH. Fold change was 2.19 with p = 0.023 by one-sample t-test. 
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Figure 3.8 PARP1 loss increases CR cell abundance in NPC cultures. (A) Immunostaining 
for Reelin (red) demonstrates presence of Reelin-expressing cells in WT and PARP1 KO NPC 
cultures.  Nuclei were labeled with DAPI (blue). Scale bar = 20 µm.  (B) Quantification of the 
percentage of Reelin-expressing cells within NPC cultures shows increased proportion of 
Reelin+ cells in KO cultures (n = 6 WT and 5 KO biological replicates and 3 coverslips per 
replicate). **p = 0.0013 by Mann-Whitney test. (C) The mean fluorescence intensity of Reelin 
expression per cell does not differ between genotypes. Each point on graph represents average 
Reelin intensity per cell from 3 biological replicates of each genotype. (D) The percentage of 
Reelin-expressing cells in wild-type NPC cultures increases after shRNA-mediated PARP1 
knockdown for 72 hrs (n = 4 biological replicates per group and 3 coverslips per replicate). *p = 
0.0174 by Student’s paired t-test. (E) The percentage of Reelin-expressing cells in wild-type 
NPC cultures increases with PARP1 inhibition via Olaparib (50 nM) for 72 hrs.  Olaparib was 
re-treated every 24 hrs (n = 4 biological replicates per group and 3 coverslips per replicate). *p = 
0.022 by Student’s paired t-test. 
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Figure 3.9 PARP1 loss of function does not alter the activity of the Reln promoter or the 
stability of the Reln transcript. (A) NPCs transfected with plasmids expressing the putative 
Reln promoter (2600 base pairs prior to the transcription start site) upstream of firefly luciferase 
did not show increased luciferase activity after treatment with Olaparib (Ola, 100 nM) for 24 hrs 
or 48 hrs. Valproic Acid (VPA) is a known positive regulator of the Reln transcript and was used 
as a positive control. *p < 0.05 by One-Way ANOVA. (B) PARP1 KO or PARP1 inhibition with 
Olaparib (100 nM) does not alter the stability of the Reln transcript. RNA polymerase II was 
inhibited by treatment with Actinomycin D (10 µg/mL) for 2 hrs and 4 hrs and transcript levels 
were assessed. Reln was normalized to RPL19 expression, which did not decline over 4 hrs. No 
significant difference was observed between slopes for any of the groups. (C) PARP1 Chromatin 
IP showed no enrichment for portions of the Reln promoter from 2600 base pairs upstream of the 
transcription start site through exon 1 (numbered from 1, most distal to transcription start site, to 
9, within exon 1). Histone H3 ChIP was used as a positive control. Inset western blot shows 
pulldown of PARP1 protein. 
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Figure 3.10 Reelin increases NPC adhesiveness to N-cadherin. (A) Example trace generated 
by AFM from an N-cadherin-coated cantilever in contact with a single cell. From each trace, 
adhesive step size, maximum adhesion, and total work (yellow shading) were calculated. Thirty-
minute treatment of WT NPCs with conditioned media (CM) from Reelin-transfected HEK293T 
cells increases (B) maximum adhesion, (C) adhesive step size, and (D) total work compared to 
CM from pcDNA3-transfected HEK293T cells (control CM) (n = 402 - 536 from 2 biological 
replicates). Distributions are significantly different (p < 0.0001 by Kolmogorov-Smirnov test). 
Inset graphs show average values. ****p < 0.0001 by Mann-Whitney test. 
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Figure 3.11 PARP1 loss increases NPC adhesiveness to N-cadherin. Maximum adhesion (A), 
adhesive step size (B), and total work (C) are higher in NPCs from KOs than from WTs (n = 229 
- 742 from 4 WT and 5 KO biological replicates). Distributions are significantly different (p < 




3.10 Tables  
Table 3.1 Sequences of primers used for quantitative RT-PCR. 
Gene  Forward Sequence (5’ - 3’) Reverse Sequence (5’ - 3’) 
Reln GTCGTGTCTTCTGGATCTTCTC CAGCACTCTCTCCTCCTATCT 
Nav1 CCAGCCACCAAGTTAGCAGA CATGGGTGTCGCTGGAAGAT 
Tnc ACCATGCTGAGATAGATGTTCCAAA CTTGACAGCAGAAACACCAATCC 
Txnip GTCAGTGTCCCTGGCTCCAAGA AGCTCATCTCAGAGCTCGTCCG 
ΔNp73 CTACCATGCTTTACGTCGG CTGCCCATCTGGTCCAT 
TAp73 GCACCTACTTTGACCTCCCC GCACTGCTGAGCAAATTGAAC 
Car10 GAGAGCAAGAGCCCAGAACTC CTCACCAGTGGCAGAAATGGC 
Calb2 CGGAGCTGGCGCAGAT CTGCCTGAAGCACAAAAGGAA 
Parp1 GGCAGCCTGATGTTGAGGT GCGTACTCCGCTAAAAAGTCAC 
Gapdh TCACTGCCACCCAGAAGA GCCAAGCCCTGAGCATAA 
Rpl19 ACCTGGATGAGAAGGATGAG ACCTTCAGGTACAGGCTGTG 
β-actin TCCCATTGAACACGGAGTG CCTCGGTGAGAAGAATAGATGT 
 
Table 3.2 Sequences of primers used for chromatin immunoprecipitation. 
Gene Forward Sequence (5’ - 3’) Reverse Sequence (5’ - 3’) 
Reln 1 CACATGTCGGCTACAGCTCA GAGAAAAGGCCAATGTGAGGTC 
Reln 2 TGCAGCTAAACCGAAGCTAATC ACCGGACCACCTACTTTGG 
Reln 3 GTCAGCCTTCGTCTTACTTGG ATCCTAACACCACCACCGGAA 
Reln 4 CCAACAGGCAGTTAGGTCCTT GAGTTTGGGAGAAGGGCGTC 
Reln 5 GCTCTGTTCTCCCGTCTCTG TGAAACCGGCGTTAATGAGC 
Reln 6 CGCGCGCGGGGCACCGTC AGAGACCGACGGGCTGCC 
Reln 7 GGGCGGCGGGCCCCGAGG AGAGACCGACGGGCTGCC 
Reln 8 GGGCTTTAAGAAGGTGCGGAG CGGTGTGCACGCGACG 
Reln 9 GTAACTTCGGGAGCCTCGGT CTCTCTCATCCACTTTCGGAGG 















Table 3.3 PARP1 loss upregulates the expression of genes associated with cell adhesion, axon 
development, dendrite morphogenesis, and cell migration in the E15.5 cortex. 
 






cell adhesion (GO:0007155) 7.95 0.00001 
cell morphogenesis involved in differentiation (GO:0000904) 8.51 0.0002 
axon development (GO:0061564) 10.38 0.00072 
regulation of dendrite morphogenesis (GO:0048814) 20.51 0.00293 
neuron projection morphogenesis (GO:0048812) 8.24 0.00302 
plasma membrane bounded cell projection morphogenesis 
(GO:0120039) 8.15 0.00304 
cell projection morphogenesis (GO:0048858) 8.05 0.00322 
axonogenesis (GO:0007409) 9.91 0.00327 
regulation of cell morphogenesis involved in differentiation 
(GO:0010769) 9.74 0.00355 
regulation of dendrite development (GO:0050773) 12.47 0.0206 
establishment of organelle localization (GO:0051656) 8.77 0.0235 
cerebral cortex radially oriented cell migration (GO:0021799) 39.25 0.0276 
axon guidance (GO:0007411) 11.05 0.0336 
neuron projection guidance (GO:0097485) 10.95 0.0343 
glial cell migration (GO:0008347) 34.57 0.0361 
gliogenesis (GO:0042063) 10.25 0.041 
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Chapter 4: Discussion and Future Directions 
 
4.1 Summary of Findings 
The primary aim of this thesis was to identify roles for PARP1 during the process of 
brain development. PARP1 is a ubiquitously expressed protein with many critical functions in 
various cell types and tissues and has previously been linked with brain-associated disorders and 
diseases (Mao and Zhang, 2021). These findings suggest that PARP1 loss of function affects 
brain development; however, this has not been widely studied. Given PARP1’s important role in 
regulating the DNA repair response following DNA damage, inhibitors for PARP1 are widely 
utilized to treat certain cancers (Dziadkowiec et al., 2016; Pommier et al., 2016; Rose et al., 
2020) and have been proposed to treat pediatric cancers (Barton et al., 2009; Valanejad et al., 
2018). Therefore, we must understand the consequences of PARP1 loss of function in the brain, 
especially during developmental stages.  In this thesis, I further validated that PARP1 regulates 
GFAP expression through an interaction with the receptor tyrosine kinase ErbB4 in cultured 
mouse NPCs and the developing mouse brain (Chapter 2), I discovered that PARP1 loss reduces 
cortical thickness, disrupts early-born neuron migration, and increases neuronal density at birth 
(Chapter 3), and I found that PARP1 regulates Cajal-Retzius cell development and neuronal 
adhesion in the developing brain (Chapter 3). Together, these findings highlight the impacts of 
PARP1 loss on brain development, potentially contributing to PARP1-linked brain disorders 
observed in humans and mice. 
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In Chapter 2, I described previously unpublished data that suggests a novel interaction 
between PARP1 and the ErbB4 intracellular domain (E4ICD), which is cleaved from the ErbB4-
JMa isoform of this protein. Previous data indicate that E4ICD binds to the promoter region of 
glial genes to repress their expression during neurogenesis, thereby controlling the timing of 
astrogenesis during brain development (Sardi et al., 2006). These experiments were completed 
mainly with NPCs isolated from rat cortices. However, we wished to assess the role of PARP1 in 
this pathway using NPCs isolated from transgenic mice, so I developed an in vitro assay to test 
the effect of NRG1 on GFAP expression during differentiation in mouse NPCs. Upon FGF 
removal from NPC cultures, GFAP expression increases over 100-fold. However, concurrent 
NRG1 treatment with FGF removal reduces this increase by 50% on average in WT NPCs. 
Repeating this experiment using PARP1 KO NPCs, NRG1 lost the ability to repress GFAP 
expression, indicating that PARP1 is necessary to mediate NRG1-induced repression of GFAP 
expression.  
To assess the specific role of ErbB4-JMa in mice, our lab produced mice using CRISPR-
Cas9 gene editing that lack ErbB4-JMa but retain ErbB4-JMb. This novel mouse allowed us to 
further interrogate the specific roles ErbB4-JMa and E4ICD in vivo and in vitro without utilizing 
toxic pharmacological inhibitors or transfection-mediated overexpression, as had been previously 
completed in WT NPCs. Repeating FGF removal with concurrent NRG1 treatment in NPCs 
isolated from ErbB4-JMa-/- mice, we found that NRG1 did not repress GFAP expression, 
indicating the necessity for the cleavable isoform of ErbB4. Repeating this assay in WT NPCs 
transfected with constructs expressing the GFAP promoter region upstream of firefly luciferase 
indicated that PARP1 and ErbB4 regulate GFAP promoter activity to repress gene expression. 
Finally, we identified overexpressed GFAP in ErbB4 KO and PARP1 KO cortices at birth, 
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suggesting that PARP1-E4ICD regulates astrogenesis in the developing brain in vivo. Further 
studies are needed to identify the specific mechanism of PARP1-E4ICD regulation of the GFAP 
promoter region, which is discussed in section 4.2. 
In Chapter 3, I described altered brain morphology in the developing PARP1 KO mouse. 
Previous studies indicate that postnatal mouse brains that lack PARP1 tend to be smaller than 
their wild-type littermates (Plane et al., 2012; Hong et al., 2019). We found a similar reduction in 
brain size in PARP1 KO mice at birth, suggesting a developmental role for PARP1 in the brain. 
Furthermore, we identified that PARP1 KO brains have altered early-born neuron migration and 
increased neuronal density with a thinner cortex. To identify changes in gene expression caused 
by PARP1 loss that contribute to these alterations, we performed RNA-sequencing of the E15.5 
cortex. We identified an upregulation in genes associated with neuronal migration and adhesion 
in the PARP1 KO mouse brain, including the glycoprotein Reelin. Reelin is expressed in Cajal-
Retzius cells early in development and is critically important for regulating neuronal adhesion 
and migration in the developing brain (Ogawa et al., 1995; Meyer et al., 1998). We found that 
loss of PARP1 increases the abundance of Cajal-Retzius cells in vivo at E15.5 and P5 and in 
NPC cultures in vitro. We also demonstrated that regulation of Cajal-Rezius cell abundance is 
dependent upon PARP1 enzymatic activity. After interrogating the involvement of the Reelin 
promoter, we did not find any indication that PARP1 loss of function affected promoter activity, 
indicating an indirect or non-promoter-associated mechanism. Additionally, we found no 
evidence that PARP1 regulates Reln transcript stability. Further experiments are needed to 
identify the mechanism of regulation, which is discussed in section 4.2 
In Chapter 3, I also showed that NPCs isolated from PARP1 KO embryonic cortex 
secrete excess Reelin. A previous study indicates that Reelin increases neuronal adhesion to cell 
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adhesion molecule N-cadherin (Matsunaga et al., 2017). We repeated this experiment in WT 
NPCs using a similar experimental setup by incubating them with Reelin-containing conditioned 
media for 30 min. As found by Matsunaga and colleagues, NPCs treated with Reelin had an 
increased adhesion to N-cadherin. Since PARP1 KO NPC cultures contain excess Reelin, we 
hypothesized that PARP1 KO NPCs would similarly adhere more strongly to N-cadherin. As 
expected, PARP1 loss and exogenous Reelin increase NPC adhesion to N-cadherin to a similar 
extent. These findings suggest that PARP1 influences NPC adhesion to N-cadherin through 
Reelin. Further experiments are needed to address the potential effects of this role for PARP1 in 
vivo and are discussed below. 
4.2 Future Directions 
The findings described above lead to many interesting questions regarding the interaction 
between PARP1 and ErbB4 and their functions in regulating astrogenesis in the developing 
brain, the mechanism of PARP1 regulation of Cajal-Retzius cell development, and potential 
changes in PARP1 KO brain morphology and function associated with increased Cajal-Retzius 
cell abundance and cell adhesion. Future directions to address these questions are outlined in the 
sections below. 
4.2.1 Mechanism of PARP1-ErbB4 Regulation of Astrogenesis 
Our previously published data suggest that NRG1 stimulation of ErbB4-JMa induces 
phosphorylation, E4ICD cleavage, subsequent E4ICD interaction with N-CoR and TAB2, and 
translocation to the cell’s nucleus (Sardi et al., 2006). Our new data indicate that this protein 
complex binds to and stimulates PARP1, then acts on the GFAP promoter to repress its activity. 
However, it remains unclear whether the complex binds PARP1 in the cytoplasm or nucleus and 
whether PARP1 or ErbB4 is necessary for binding to the GFAP promoter. Additionally, while 
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NRG1 stimulation increases PARylation, it is unclear what molecules in the cell become 
PARylated, whether it is PARP1 itself, other proteins that make up this complex, chromatin, or 
multiple of these. Furthermore, our findings suggest that this complex binds to the same area of 
the GFAP promoter region as NICD, suggesting E4ICD complex occupation prevents NICD 
from binding to promote astrogenesis, yet this hypothesis has not been tested.  
PARP1 is mainly located in the cell’s nucleus, but it is sometimes localized to the 
cytoplasm (Chen et al., 2018; Xu et al., 2019). To determine if PARP1 is binding to E4ICD in 
the cytoplasm or nucleus, I would isolate cytoplasmic and nuclear cellular fractions and repeat 
the ErbB4 and PARP1 co-immunoprecipitation (co-IP) experiments. Since PARP1 is 
predominantly nuclear, I expect that the E4ICD-Tab2-NCoR complex travels to the nucleus, 
where it binds to PARP1. If this is the case, I anticipate only seeing an interaction between 
ErbB4 and PARP1 in nuclear fractions upon stimulation with NRG1. Additionally, our data 
suggest that NRG1 stimulation of ErbB4-JMa and subsequent cleavage of its intracellular 
domain activates PARP1, facilitating PARP1 binding to the GFAP promoter. To confirm the 
necessity of ErbB4-JMa, I would perform chromatin immunoprecipitation (ChIP) in ErbB4-JMa-
/- NPCs after NRG1 stimulation, predicting that the absence of ErbB4-JMa would prevent 
PARP1 from binding to the GFAP promoter. Furthermore, we hypothesize that PARP1 is 
necessary for E4ICD to bind the GFAP promoter. To test this, I would repeat the GFAP ChIP in 
PARP1 KO NPCs. In the absence of PARP1, I expect to see no E4ICD promoter binding upon 
NRG1 stimulation. 
Given that NRG1 induces E4ICD cleavage and PARylation, we expect that PARP1 is 
activated following E4ICD binding to PARP1. To confirm this, I would repeat the PARP1-
ErbB4 co-IP experiments in the presence of a PARP1 inhibitor. If inactive PARP1 can bind 
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E4ICD, it strengthens the notion that E4ICD binding activates PARP1. Additionally, our 
previous experiments suggest that PARP1 activity is necessary to subsequently repress GFAP 
promoter activity. To test if PARP1 enzymatic function is essential for binding to the GFAP 
promoter, I would pharmacologically inhibit PARP1 and repeat the ChIP. I expect that PARP1 
inhibition would prevent it from binding the GFAP promoter after treatment with NRG1, yet it 
remains possible that PARP1-E4ICD can bind the promoter but cannot repress its activity in the 
absence of PARylation. 
We found that NRG1 induces PARylation, yet it remains unclear what molecules are 
becoming PARylated. To test whether PARP1 PARylates the GFAP promoter, I would perform 
a PAR ChIP following NRG1 treatment. Similar to PARP1 ChIP, if PARP1 PARylates the 
region of the GFAP promoter at which this complex binds, I should identify the GFAP promoter 
region in chromatin pulled down with PAR following NRG1 stimulation. Similarly, I would 
determine if other proteins associated with E4ICD and PARP1 are PARylated by performing a 
PAR co-IP and immunoblotting for ErbB4 and PARP1. If any one of the proteins in the complex 
is PARylated, PAR would co-precipitate with both of these proteins. I would also execute the 
reverse IP by pulling down each of these proteins and immunoblotting for PAR. Studies indicate 
PARP1 PARylates itself and chromatin to regulate transcription (Visochek et al., 2016), so I 
expect to identify PARylation of both PARP1 and chromatin at the GFAP promoter.  
Our findings indicate that the E4ICD-PARP1 complex binds to the same region of the 
GFAP promoter as the Notch intracellular domain (NICD), which stimulates GFAP transcription 
via binding to CSL/RBPJk (Ge et al., 2002). N-CoR, which binds E4ICD, also complexes with 
CSL/RBPJk to regulate GFAP transcription; however, N-CoR binding to the GFAP promoter 
represses its transcription (Hermanson et al., 2002). Therefore, we hypothesize that E4ICD/N-
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CoR/TAB2 and PARP1 bind to CSL/RBPJk, which facilitates binding to the GFAP promoter 
during neurogenesis, preventing NICD from binding and promoting gliogenesis. Downregulation 
of ErbB4 expression later in development may allow NICD binding to CSL/RBPJk and GFAP 
activation. To test this hypothesis, I would perform a Notch ChIP for this promoter region after 
ErbB4 knockdown via the expression of a dominant-negative ErbB4 or in ErbB4 KO NPCs. If 
we observe increased NICD binding after ErbB4 knockdown or loss, that would indicate 
reciprocal binding at this site between NICD and E4ICD. To further confirm this interaction, I 
would transfect N2A cells with a GFAP-luciferase promoter construct and assess the effect of 
co-transfection of NICD and LexA-E4ICD, NICD alone, or LexA-E4ICD alone. I expect that 
NICD would stimulate GFAP activity, but that co-transfection of E4ICD would repress this 
stimulation because of competition for the promoter. If these experiments indicated a reciprocal 
occupation of the promoter, I would perform a co-IP to confirm that the ErbB4-PARP1 complex 
binds with CSL/RBPJk to facilitate transcriptional repression.  
STAT3 is well-known for its role in regulating GFAP expression (Bonni et al., 1997). 
Interestingly, a recent study found that PARP1 binds and PARylates STAT3, inhibiting its 
activity in a cancer cell line (Ding et al., 2019). This study indicates that PARP1 may 
additionally inhibit STAT3 function in neural stem cells. To test this, I would perform PARP1 
and PAR co-IPs with STAT3 in NPCs. If I observed PARP1 binding and PARylation of STAT3, 
I would then perform ChIP at the STAT3 binding sites of the GFAP promoter in PARP1 KO 
NPCs. If there is an increase in STAT3 occupation at the promoter following PARP1 loss, that 
would suggest PARP1 has an inhibitory effect on STAT3 function and promoter-binding ability. 
I would next test if the PARP1-STAT3 interaction occurs independently of ErbB4 by performing 
a co-IP between ErbB4 and STAT3. To further confirm the necessity of ErbB4, I would repeat 
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the co-IP between PARP1 and STAT3 in ErbB4 KO NPCs. If PARP1 interacts with STAT3 in 
the absence of ErbB4, that would suggest PARP1 binds and PARylates STAT3 as an 
independent mechanism of astrogenesis repression. 
4.2.2 Consequences of Precocious Astrogenesis 
Our findings show that ErbB4 KO and PARP1 KO cortices express excess GFAP at birth 
relative to their respective WT controls. However, it is unclear whether this corresponds with 
increased GFAP-expressing astrocytes or increased GFAP expression per astrocyte. To test this, 
I would collect P0 brains and perform a fluorescent in situ hybridization for GFAP mRNA, 
quantifying both the relative number of transcripts per cell and the number of GFAP-expressing 
cells. I would next determine if this change corresponded with an increase in GFAP protein 
expression or the number of GFAP-expressing astrocytes via immunohistochemistry.  
Additionally, precocious astrogenesis has previously been associated with decreased 
neurogenesis in other mouse models, as astrocytes are produced at the expense of neurons at the 
end of neurogenesis (Gauthier et al., 2007; Wu et al., 2017). Our findings show that despite a 
thinner cortex, the PARP1 KO brain has no difference in the quantity of earlier-born Tbr1 or 
Ctip2-expressing neurons at birth. However, it remains unclear if there are fewer overall neurons 
or fewer later-born neurons, such as those that express Cux1 or Cux2. Precocious astrogenesis is 
more likely to negatively impact neurons born just before the onset of astrogenesis. Therefore, if 
astrogenesis begins prematurely, IPCs abnormally differentiate into astrocytes instead of Cux1 or 
Cux2-expressing neurons. To test if specific neuronal populations are affected, I would collect 
cortical lysates from PARP1 KO and ErbB4 KO mice at various stages of embryonic 
development – E13.5 through P5, and quantify transcript levels of neuronal genes, such as DCX, 
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NeuN, Cux1, Cux2, etc. using RT-qPCR. If I identified any changes in transcript expression, I 
would look further at their associated proteins in brain slices at different developmental stages. 
4.2.3 Potential Mechanisms of PARP1 Regulation of Cajal-Retzius Cell Development 
One of the major outstanding questions from my findings is through what mechanism 
PARP1 regulates Cajal-Retzius cell development. As described, we observed an increased 
abundance and density of Cajal-Retzius cells at E15.5 and P5 with PARP1 loss. Cajal-Retzius 
cells undergo programmed cell death starting around P8 (del Río et al., 1995); therefore, our 
findings suggest that PARP1 is not responsible for mediating Cajal-Retzius cell apoptosis. We 
also found that PARP1 knockdown or inhibition increases the quantity of Cajal-Retzius-like cells 
in culture. However, we found no indication that PARP1 regulates the activity of the Reln 
promoter or stability of the transcript. Together, these findings suggest that PARP1 regulates 
Cajal-Retzius cell development through a cell-autonomous, Reelin-independent mechanism, 
likely through altered expression or activity of transcription factors or miRNAs associated with 
Cajal-Retzius cell development, differentiation, and migration. 
4.2.3.1 Cajal-Retzius Cell Subpopulations 
To further assess Cajal-Retzius cell development, it will be critical to characterize the 
different populations of Cajal-Retzius cells in the PARP1 KO brain. Cajal-Retzius cell 
progenitors arise from several portions of the developing brain, including the cortical hem, 
pallial septum, and pallial-subpallial boundary (PSB), then tangentially migrate to different areas 
of the cortex on the rostral-caudal and dorsal-ventral axes (Barber and Pierani, 2016). 
Interestingly, Cajal-Retzius cells from each of these origins express different combinations of 
proteins at the progenitor stage and following completion of migration, which makes identifying 
the subpopulations of Cajal-Retzius cells relatively straightforward (Bielle et al., 2005). Dbx1+ 
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progenitors arise from the pallial septum and the PSB and migrate to the rostral-medial cortex 
and the lateral cortex, respectively. In addition, Dbx1+ Cajal-Retzius cell progenitors that arise 
from the septum co-express Emx1 (Bielle et al., 2005). While both neuronal subtypes express 
Reelin, only Dbx1+ cells that arise from the PSB also express Calretinin (Bielle et al., 2005). In 
contrast, Cajal-Retzius cell progenitors derived from the cortical hem do not express Dbx1 and 
migrate to the caudal-medial cortex and hippocampus (Barber and Pierani, 2016) and express 
p73 and Calretinin in addition to Reelin (Barber et al., 2015). In summary, cortical hem-derived 
Cajal-Retzius cells express Reelin, p73, and Calretinin, septal pallium-derived Cajal-Retzius 
cells express p73 and Reelin, and PSB-derived Cajal-Retzius cells express Reelin and Calretinin 
(Takiguchi-Hayashi et al., 2004; Bielle et al., 2005; Barber et al., 2015).  
 To interrogate whether specific populations of Cajal-Retzius cells are altered in the 
PARP1 KO mice, I would immunolabel these different cell populations and quantify the number 
of cells in regions of the developing cortex on the dorsal-ventral and rostral-medial axis. This 
would entail collecting rostral, medial, and caudal sections from the developing brain (around 
E12.5) and quantifying the number of Reelin, p73, and Calretinin-expressing and co-expressing 
cells both medially and laterally within each section. Since we observed increased Reelin-
expressing cells in multiple brain regions on the rostral-caudal axis and increased Calretinin and 
p73 transcript expression in vitro, I do not expect a specific Cajal-Retzius cell population is 
altered. However, if I were to observe changes in one or multiple of the progenitor populations, I 
could then assess migration patterns by injecting the affected brain area(s) at E9.5-E10.5 with 
DiI and evaluating the migration of the labeled cells over time. Suppose migration is unaffected, 
but quantity is increased. In that case, I could instead assess the number of Dbx1 or Emx1-
expressing progenitors from their associated brain region(s) to determine if increased Cajal-
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Retzius cell abundance arises from an increase in the progenitor pool due to altered 
differentiation. If there is an increase in only some subtypes of Cajal-Retzius cells, that would 
also give clues as to potential dysregulated proteins, as some proteins regulating Cajal-Retzius 
cell development affect only subsets of progenitors (Stoykova et al., 2003; Borrell and Marín, 
2006; Kaddour et al., 2020). 
4.2.3.2 Proteins Associated with PARP1 and Cajal-Retzius Cell Development 
 As described in section 1.2.3.1, many proteins influence the development or migration of 
Cajal-Retzius cells. Interestingly, some of these proteins are also linked to PARP1. This includes 
the transcription factor Ascl1 (also known as Mash1), which PARP1 represses in rat neural stem 
cells in a complex containing Hes1. PARP1 knockdown, therefore, de-represses Ascl1, 
increasing its expression (Ju et al., 2004). A mouse model of Ascl1 loss indicates that Ascl1 
promotes Cajal-Retzius cell development, specifically cells expressing Reelin and p73, 
suggesting that Ascl1 regulates cortical hem and septal-derived progenitors (Dixit et al., 2011). 
Therefore, overexpression of Ascl1 may increase Cajal-Retzius cell abundance, similar to our 
observation in PARP1 KO mice. However, it remains to be seen if Ascl1 is overexpressed in 
PARP1 KO developing cortex or NPCs. If I found Ascl1 to be overexpressed, that would 
indicate that PARP1 may indirectly affect Cajal-Retzius cell development through Ascl1. 
PARP1 also regulates Pax6 expression during neuroectoderm specification early in 
neurodevelopment. Specifically, FGF activation of ERK1/2 causes PARP1 activation, which 
then binds to the Pax6 promoter to promote neuroectoderm specification and neural 
differentiation. Accordingly, inhibition of PARP1 suppresses Pax6 expression (Yoo et al., 2011). 
Among other functions, Pax6 has previously been shown to negatively regulate Cajal-Retzius 
cell development in a non-cell-autonomous mechanism, potentially influencing cell migration 
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via extracellular Pax6 (Stoykova et al., 2003; Kaddour et al., 2020). In the Pax6 knockout mouse 
brain, predominantly Reelin and Calretinin-expressing Cajal-Rezius cells are increased in 
abundance, indicating Pax6 loss causes an increase in cells that arise from the cortical hem or 
PSB (Stoykova et al., 2003); however, extracellular Pax6 was shown to alter the migration of 
cortical hem and septal-derived progenitors, though PSB-derived progenitor migration was not 
tested (Kaddour et al., 2020). These studies indicate that Pax6 may be a master regulator of 
Cajal-Retzius cell development and migration. Therefore, PARP1 loss or inhibition may 
decrease Pax6 expression at very early stages of development, leading to excess Cajal-Retzius 
cells through changes in progenitor cell differentiation or migration. To test this, I would 
measure Pax6 mRNA and protein expression in PARP1 KO brains at multiple time points during 
early development, as changes in its expression profile may contribute to our observations. 
The chemokine Cxcl12, signaling through its G-protein coupled receptor Cxcr4, regulates 
the migration of cortical hem-derived Cajal-Retzius progenitor cells (Borrell and Marín, 2006). 
Cxcl12 is secreted from cells located in the meninges and is chemoattractive for Cajal-Retzius 
progenitor cells that express Cxcr4. Therefore, loss of Cxcr4 disrupts Cajal-Retzius cell 
tangential migration and results in ectopic clusters of cells in deeper portions of the cortex 
(Borrell and Marín, 2006). PARP1 negatively regulates Cxcl12 transcription by binding to the 
gene promoter, first identified in pancreatic beta cells (Marković et al., 2013). Further 
experiments showed that loss of PARP1 from mouse embryonic fibroblasts decreases the 
methylation state of the Cxcl12 promoter, likely due to increased expression of Tet1, a DNA de-
methylase (Tolić et al., 2019).  DNA methylation represses transcription; therefore, PARP1-
mediated repression of Tet1 expression increases the methylation state of the Cxcl12 promoter, 
repressing transcription of the gene. These studies present the intriguing possibility that loss of 
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PARP1 increases Cxcl12 expression and secretion from the marginal zone, increasing the 
migration of Cajal-Retzius cell progenitors toward the meninges. To test this, I would measure 
the mRNA and protein of Cxcl12 between E10.5-E12.5 in the developing brain and cultured 
NPCs. Cortical hem-derived progenitors express p73 and Calretinin in addition to Reelin (Barber 
et al., 2015), so if this population of cells is increased in the PARP1 KO brain and Cxcl12 is 
overexpressed, PARP1 may be regulating Cajal-Retzius cell abundance through Cxcl12. 
Cajal-Retzius cell development is also regulated through miRNAs, small RNAs that bind 
to target mRNAs, cleave them, destabilize them, or prevent transcription (Huntzinger and 
Izaurralde, 2011; O’Brien et al., 2018). A total disruption of miRNA biogenesis through 
knockout of Dicer, which cleaves immature miRNAs into mature miRNAs, increases Cajal-
Retzius cell abundance, indicating a critical role for miRNAs in their development (McLoughlin 
et al., 2012). Specifically, miRNA-9 affects Foxg1 expression, a transcription factor that 
regulates cortical hem development, which is a vital source of Cajal-Retzius cell progenitors 
(Shibata et al., 2008; Liu et al., 2018). Additionally, miRNA-128 and miRNA-200c specifically 
target Reln, which may affect Cajal-Retzius cell development and function, although this has yet 
to be tested (Evangelisti et al., 2009; Stary Creed M. et al., 2015). PARP1 regulates the 
expression of miRNAs, presenting an additional possibility by which it modulates Cajal-Retzius 
cell abundance (Nozaki et al., 2018). I would test this hypothesis by measuring the expression of 
miRNAs known to influence Cajal-Retzius cell development or Reln expression, such as 
miRNA-9, miRNA-128, or miRNA-200c, in the PARP1 KO cortex. I would also perform RNA-
sequencing to identify altered miRNA expression in the developing PARP1 KO cortex, 
comparing the profile of altered miRNAs in the PARP1 KO brain to altered miRNAs after Dicer 
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loss. Any overlapping miRNAs could indicate candidate miRNAs that influence Cajal-Retzius 
cell development due to PARP1 loss.  
4.2.4 Phenotypes Associated with Reelin Function 
In addition to regulation of neuronal migration and adhesion, Reelin is well-known for its 
role in regulating preplate splitting and cortical plate formation very early during 
neurodevelopment, around E12.5. Without Reelin to anchor migrating neurons to the marginal 
zone during somal translocation, the preplate fails to form correctly (Magdaleno et al., 2002). We 
observed changes in early-born neuron migration, so there may be alterations in cortical plate 
formation in the PARP1 KO embryonic brain. To test this, I would immunostain E14.5-E15.5 
PARP1 KO brains for MAP2 and CSPGs, which label the subplate and marginal zone. In a wild-
type brain, there is a lack of labeling in the cortical plate between the subplate and marginal 
zone, indicating proper splitting of the preplate. In reeler mice, MAP2 and CSPG staining is 
diffuse and spread throughout the cortex, indicating the presence of an abnormal “superplate” 
(Sheppard and Pearlman, 1997; Magdaleno et al., 2002). If early-born neuron migration in 
PARP1 KO mice is altered due to abnormal preplate splitting, I would expect to see changes in 
the distribution or abundance of subplate and marginal zone cells.  
Reelin also regulates dendrite development and dendritic spine density (Stanfield et al., 
1979; Liu et al., 2001; Niu et al., 2004, 2008). This function is intriguing because we found that 
PARP1 KO results in increased neuronal density, similar to that observed in reeler heterozygous 
mice (Liu et al., 2001). Increased neuronal density has also been associated with decreased 
dendritic arborization in schizophrenic patients (Selemon and Goldman-Rakic, 1999). 
Additionally, schizophrenic-like behaviors have been observed in PARP1 KO mice (Hong et al., 
2019). These findings suggest that dendritic morphology or dendritic spine density is abnormal 
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in the PARP1 KO cortex. To test this, I would assess dendritic morphology and quantify 
dendritic spines of neurons in the developing and adult cortex and hippocampus of PARP1 KO 
mice utilizing Golgi staining and 3D reconstruction of individual neurons. This experiment could 
be completed in parallel in vitro in neuron cultures derived from WT and PARP1 KO cortex 
and/or hippocampus. Interestingly, Reelin overexpression in the adult mouse brain causes an 
opposite phenotype as Reelin haploinsufficiency, causing enlarged dendritic spines and increased 
numbers of synapses per dendritic spine (Pujadas et al., 2010); however, it remains unclear how 
Reelin overexpression may affect dendritic spine density in the developing brain. 
4.2.5 Phenotypes Associated with Extracellular Matrix Function and Abnormal Neuronal 
Migration 
Loss of PARP1 causes changes in gene expression of corresponding proteins that make 
up the extracellular matrix, including scaffolding proteins, CSPGs, signaling molecules, and cell 
adhesion molecules. These changes in gene expression are associated with the altered migration 
of early-born neurons in the PARP1 KO cortex. The extracellular matrix regulates many aspects 
of cortical morphology and neuronal migration, including radial glial cell organization and 
neuronal process orientation (Barros et al., 2011). Alterations in radial glia cause many 
phenotypes, including misorientation of migrating neuron apical and basal processes, disruptions 
in endfeet formation, microcephaly, defective proliferation, and premature differentiation (Ferent 
et al., 2020). To further assess the organization of radial glial cells in the embryonic PARP1 KO 
cortex, I would immunostain E13.5 cortex for RC2 and GFAP, which are commonly expressed 
in radial glial cells at this stage of development, and co-label with BLBP, which is expressed in 
the endfeet of radial glial cells (Haubst et al., 2006). The resulting stain would allow me to 
determine if radial glial cell orientation and endfeet attachment are affected. With altered Reelin 
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and laminin expression, attachment of radial glial endfeet to the basement membrane at the pial 
surface of the PARP1 KO brain may be disrupted, especially early in development when 
neuronal migration is altered.  
Adhesion molecules are also critical components of the extracellular matrix. We found 
that PARP1 loss increases the adhesion of NPCs to N-cadherin in vitro, and the expression of 
several adhesion molecules is upregulated in the developing PARP1 KO cortex. Together, these 
findings suggest altered neuronal adhesion in vivo. N-cadherin overexpression has been 
previously shown to reduce the distance between a migrating cell and radial glial fiber and 
reduce neuronal migration into the cortical plate (Shikanai et al., 2011). To test whether neurons 
are more adhesive to radial glial fibers in the PARP1 KO brain, I would electroporate E13.5 
embryos with a GFP-expressing construct into the lateral ventricle, collect embryos the 
following day, and co-label for a radial glial cell marker, such as Nestin or RC2. Then, I would 
quantify the distance between the RC2-labeled radial glial fiber and the GFP-transfected 
migrating neuron, with shorter distances indicating increased adhesion. If I found changes in 
adhesion in vivo, I would test if N-cadherin is mediating this interaction by electroporating 
embryos with a dominant-negative N-cadherin-GFP construct and repeat the experiment in WT 
and KO embryos. If N-cadherin knockdown restored the distance between the neuron and radial 
glial cell fiber back to baseline, that would suggest N-cadherin is mediating increased adhesion 
in vivo. If I saw no difference, I would repeat this experiment with knockdown of adhesion 
molecules Dscaml1 or Nrcam, which are overexpressed in the PARP1 KO cortex. 
If I observe changes in adhesion in vivo, that may suggest downstream changes in the 
orientation of neuronal processes. N-cadherin is essential for orienting the leading process of 
migrating neurons radially; thus, neurons that express a mutated dominant-negative N-cadherin 
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protein have processes that tend to be more horizontally oriented than vertical (Gärtner et al., 
2012). To test the orientation of migrating neurons in PARP1 KO mice, I would perform a 
similar experiment as previously described, electroporating a construct expressing GFP into the 
lateral ventricle of WT and KO embryos at E13.5. GFP would be expressed in ventricular 
neurons and their processes, allowing me to assess their respective positioning with regards to 
the ventricular wall. If migration is disrupted due to misorientation of neuronal processes, I 
should observe an increased proportion of neuronal processes that lack a vertical orientation in 
the PARP1 KO cortex. 
Given that we observed changes in neuronal migration in vivo, I would assess the 
migration rate of PARP1 KO NPCs or premature neurons in vitro. Our data suggest that 
migrating neurons in the PARP1 KO brain tend to mislocalize to more superficial brain areas in 
vivo, which may indicate an increased migration rate. I would test migration in vitro using a 
scratch assay, whereby a scratch in the cell monolayer removes neurons from a specific area. I 
would then image the scratch area over many hours and quantify the time it takes for neurons to 
repopulate the area. If PARP1 KO causes increased migration rate cell-autonomously, I would 
expect to see PARP11 KO neurons move into the scratch area at an earlier time point than WT 
neurons. This finding would suggest that migration rate is regulated by molecules secreted from 
or present within the neurons, which then act upon other nearby neurons. However, if migration 
rate is controlled by factors present in vivo, or non-cell autonomously, I may not observe changes 
in cell migration in vitro. Therefore, I could utilize ex vivo time-lapse imaging of migrating 
neurons. With this method, GFP-expressing vectors are electroporated into the lateral ventricle of 
embryonic brains, where it is taken up by dividing neurons. Migrating neurons expressing GFP 
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can then be live imaged in brain slice cultures via time-lapse imaging to assess the dynamics of 
migrating cells more carefully.  
4.2.6 Final Thoughts and Conclusions 
Taken together, the data presented in this dissertation show that PARP1 has a more 
significant and complex role in neurodevelopment than previously known. Specifically, I have 
demonstrated that PARP1 regulates cortical thickness, Cajal-Retzius cell development, neuronal 
adhesion, and gliogenesis. Although the effects of PARP1 loss are relatively minor in scale, the 
accumulation of multiple of these defects may be contributing to PARP1-associated neurological 
disorders. Additionally, inhibition of PARP1 is currently utilized to treat cancers and has been 
proposed to treat conditions associated with PARP1 overexpression (Dziadkowiec et al., 2016; 
Pommier et al., 2016; Rose et al., 2020; Mao and Zhang, 2021). Our findings, however, show 
that PARP1 loss of function during neurodevelopment negatively impacts brain formation, 
perhaps indicating that PARP1 inhibition should be used sparingly to treat pediatric cancer 
patients. Future experiments outlined in this dissertation to elucidate the specific mechanisms 
behind PARP1 regulation of Cajal-Retzius cell development and astrogenesis will increase our 
understanding of PARP1’s roles in brain development and further expand our knowledge of 
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